"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2021/0294088 A1,011-459-587-580-583,2021-09-23,2021,US 202117338356 A,2021-06-03,US 202117338356 A;;US 201816048293 A,2018-07-29,OPTICAL ELEMENT SUPPORT SYSTEM AND METHOD,"An optical element support system and a method of supporting an optical element are provided. The optical element includes an optical axis, an arcuate front surface, and a back surface. The optical element support system includes an axial support system that provides axial support to the optical element in a direction parallel to the optical axis of the optical element, and further includes a lateral support system that provides lateral support to the optical element in one or more directions perpendicular to the optical axis of the optical element that is offset from a center-of-gravity of the optical element.",BOEING CO,GREENWALD DAVID,THE BOEING COMPANY (2018-07-26),https://lens.org/011-459-587-580-583,Patent Application,yes,3,0,4,4,0,G02B7/183;;G02B23/16;;G02B7/182;;G02B7/02,G02B23/16;;G02B7/02;;G02B7/182,,0,0,,,,ACTIVE
2,US,A,US 1830653 A,129-968-445-779-794,1931-11-03,1931,US 48353530 A,1930-09-22,US 48353530 A,1930-09-22,Airplane hangar door,,DAVID GREENWALD,DAVID GREENWALD,,https://lens.org/129-968-445-779-794,Granted Patent,no,0,0,1,1,0,E06B3/01;;E06B3/01,E06B3/01,,0,0,,,,EXPIRED
3,US,B2,US 11061217 B2,006-153-226-353-497,2021-07-13,2021,US 201816048293 A,2018-07-29,US 201816048293 A,2018-07-29,Optical element support system and method,"An optical element support system and a method of supporting an optical element are provided. The optical element includes an optical axis, an arcuate front surface, and a back surface. The optical element support system includes an axial support system that provides axial support to the optical element in a direction parallel to the optical axis of the optical element, and further includes a lateral support system that provides lateral support to the optical element in one or more directions perpendicular to the optical axis of the optical element that is offset from a center-of-gravity of the optical element.",BOEING CO,GREENWALD DAVID,THE BOEING COMPANY (2018-07-26),https://lens.org/006-153-226-353-497,Granted Patent,yes,2,0,4,4,0,G02B7/183;;G02B23/16;;G02B7/182;;G02B7/02,G02B23/16;;G02B7/02;;G02B7/182,,4,2,060-240-388-944-322;;002-068-540-193-813,10.1364/ao.11.000575;;20111550;;20862138;;10.1364/ao.33.001198,"Malvick, A. J., “Theoretical Elastic Deformations of the Steward Observatory 230-cm and the Optical Sciences Center 154-cm Mirrors”, Applied Optics, Mar. 1972, pp. 575-585.;;Vukobratovich, Daniel et al., “Roller chain supports for large optics”, Proc. SPIE, Mar. 1, 1991, pp. 522-534.;;Schwesinger, Gerhard, “Nondistorting lateral edge support of large telescope mirrors”, Applied Optics, Mar. 1, 1994, pp. 1198-1202.;;Kimbrell, James E., et al., “AEOS 3.67-m telescope primary mirror active control system”, Proc. SPIE, Aug. 25, 1998, pp. 400-411.",ACTIVE
4,US,S,US D0353284 S,124-489-364-385-734,1994-12-13,1994,US 1049293 F,1993-07-12,US 1049293 F,1993-07-12,Watchstrap display,,GENAL STRAP INC,GREENWALD DAVID,GENAL STRAP INC (1993-06-30),https://lens.org/124-489-364-385-734,Design Right,yes,9,2,1,1,0,,,D 6457,1,0,,,"Jewelers' Circular-Keystone, Nov. 1985, p. 159, bottom left, Stylecraft Cabinet ""C-53"".",EXPIRED
5,US,A,US 1817619 A,015-250-852-192-919,1931-08-04,1931,US 32076828 A,1928-11-21,US 32076828 A,1928-11-21,Roof,,DAVID GREENWALD,DAVID GREENWALD,,https://lens.org/015-250-852-192-919,Granted Patent,no,0,11,1,1,0,E04B7/08;;E04B7/08,E04B7/08,,0,0,,,,EXPIRED
6,US,B2,US 11768365 B2,079-185-828-641-052,2023-09-26,2023,US 202117338356 A,2021-06-03,US 202117338356 A;;US 201816048293 A,2018-07-29,Optical element support system and method,"An optical element support system and a method of supporting an optical element are provided. The optical element includes an optical axis, an arcuate front surface, and a back surface. The optical element support system includes an axial support system that provides axial support to the optical element in a direction parallel to the optical axis of the optical element, and further includes a lateral support system that provides lateral support to the optical element in one or more directions perpendicular to the optical axis of the optical element that is offset from a center-of-gravity of the optical element.",BOEING CO,GREENWALD DAVID,THE BOEING COMPANY (2018-07-26),https://lens.org/079-185-828-641-052,Granted Patent,yes,3,0,4,4,0,G02B7/183;;G02B23/16;;G02B7/182;;G02B7/02,G02B23/16;;G02B7/02;;G02B7/182,,4,2,060-240-388-944-322;;002-068-540-193-813,10.1364/ao.11.000575;;20111550;;20862138;;10.1364/ao.33.001198,"Malvick, A. J., “Theoretical Elastic Deformations of the Steward Observatory 230-cm and the Optical Sciences Center 154-cm Mirrors”, Applied Optics, Mar. 1972, pp. 575-585.;;Vukobratovich, Daniel et al., “Roller chain supports for large optics”, Proc. SPIE, Mar. 1, 1991, pp. 522-534.;;Schwesinger, Gerhard, “Nondistorting lateral edge support of large telescope mirrors”, Applied Optics, Mar. 1, 1994, pp. 1198-1202.;;Kimbrell, James E., et al., “AEOS 3.67-m telescope primary mirror active control system”, Proc. SPIE, Aug. 25, 1998, pp. 400-411.",ACTIVE
7,US,A1,US 2020/0033582 A1,125-827-882-626-345,2020-01-30,2020,US 201816048293 A,2018-07-29,US 201816048293 A,2018-07-29,OPTICAL ELEMENT SUPPORT SYSTEM AND METHOD,"An optical element support system and a method of supporting an optical element are provided. The optical element includes an optical axis, an arcuate front surface, and a back surface. The optical element support system includes an axial support system that provides axial support to the optical element in a direction parallel to the optical axis of the optical element, and further includes a lateral support system that provides lateral support to the optical element in one or more directions perpendicular to the optical axis of the optical element that is offset from a center-of-gravity of the optical element.",BOEING CO,GREENWALD DAVID,THE BOEING COMPANY (2018-07-26),https://lens.org/125-827-882-626-345,Patent Application,yes,3,0,4,4,0,G02B7/183;;G02B23/16;;G02B7/182;;G02B7/02,G02B7/02;;G02B23/16;;G02B7/182,,0,0,,,,ACTIVE
8,CA,A1,CA 2856968 A1,144-614-393-123-122,2013-06-06,2013,CA 2856968 A,2012-11-28,US 201161564020 P;;US 2012/0066883 W,2011-11-28,PHARMACEUTICAL/LIFE SCIENCE TECHNOLOGY EVALUATION AND SCORING,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles, Tiie method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are aiso described.",RELAY TECHNOLOGY MAN INC,HYDE BRIGHAM;;GREENWALD DAVID,,https://lens.org/144-614-393-123-122,Patent Application,no,0,0,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/00;;G06F19/00,,0,0,,,,ACTIVE
9,CA,C,CA 2856968 C,106-473-460-917-009,2017-06-27,2017,CA 2856968 A,2012-11-28,US 201161564020 P;;US 2012/0066883 W,2011-11-28,PHARMACEUTICAL/LIFE SCIENCE TECHNOLOGY EVALUATION AND SCORING,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles, Tiie method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are aiso described.",RELAY TECH MAN INC,HYDE BRIGHAM;;GREENWALD DAVID,,https://lens.org/106-473-460-917-009,Granted Patent,no,0,0,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/00;;G06F19/00,,0,0,,,,ACTIVE
10,EP,A4,EP 2786267 A4,116-046-111-740-344,2016-12-21,2016,EP 12854440 A,2012-11-28,US 201161564020 P;;US 2012/0066883 W,2011-11-28,PHARMACEUTICAL/LIFE SCIENCE TECHNOLOGY EVALUATION AND SCORING,,DR/DECISION RESOURCES LLC,HYDE BRIGHAM;;GREENWALD DAVID,,https://lens.org/116-046-111-740-344,Search Report,no,10,0,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/00;;G06F19/00,,0,0,,,,DISCONTINUED
11,WO,A1,WO 2013/082177 A1,058-530-330-177-531,2013-06-06,2013,US 2012/0066883 W,2012-11-28,US 201161564020 P,2011-11-28,PHARMACEUTICAL/LIFE SCIENCE TECHNOLOGY EVALUATION AND SCORING,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles, Tiie method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are aiso described.",RELAY TECHNOLOGY MAN INC;;HYDE BRIGHAM;;GREENWALD DAVID,HYDE BRIGHAM;;GREENWALD DAVID,,https://lens.org/058-530-330-177-531,Patent Application,yes,5,3,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/00;;G06F19/00,,0,0,,,,PENDING
12,EP,A1,EP 2786267 A1,107-202-732-719-770,2014-10-08,2014,EP 12854440 A,2012-11-28,US 201161564020 P;;US 2012/0066883 W,2011-11-28,PHARMACEUTICAL/LIFE SCIENCE TECHNOLOGY EVALUATION AND SCORING,,DECISION RESOURCES LLC DR,HYDE BRIGHAM;;GREENWALD DAVID,,https://lens.org/107-202-732-719-770,Patent Application,yes,0,0,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/00;;G06F19/00,,0,0,,,,DISCONTINUED
13,GB,A,GB 2457375 A,050-565-045-780-998,2009-08-19,2009,GB 0902355 A,2009-02-12,US 3060308 A,2008-02-13,Lidar arrangement for mapping the environment around a vehicle,"A laser detection and ranging system 300 for a vehicle is disclosed comprising a fan beam generation unit 302,304, a detector 310, a streak unit 308, and a data processing unit. The fan beam generation unit 302,304 transmits a fan beam onto an environment around the vehicle. The detector 310 has a plurality of rows of sensors for detecting a return signal from the fan beam. The streak unit 308 shifts the return signal from the fan beam onto different rows of the detector 310 based on when each portion of the return signal is received. The data processing unit generates range and angle data from the return signal detected by the detector 310. An image of the environment around the vehicle is formed from the angle and range data. The shifting may be achieved by passing the return signal from the fan beam through a focusing lenticular array and: a collimating lenticular array; or a field lenticular array and a collimating lenticular array; or an optical relay, a tilt mirror, and a collimating lenticular array.",BOEING CO,CRAMBLITT ROBERT M;;GREENWALD DAVID,,https://lens.org/050-565-045-780-998,Patent Application,no,4,2,5,5,0,G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931;;G01S7/4811;;G01S17/89;;G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931,G01S7/481;;G01S17/89;;G01S17/931,,0,0,,,,ACTIVE
14,US,B2,US 11809387 B2,049-293-684-985-285,2023-11-07,2023,US 201916598405 A,2019-10-10,US 201916598405 A;;US 201514871616 A;;US 201414275163 A;;US 201213688101 A;;US 201161564020 P,2011-11-28,Pharmaceutical/life science technology evaluation and scoring,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles. The method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are also described.",DR/DECISION RESOURCES LLC,HYDE BRIGHAM B;;GREENWALD DAVID,RELAY TECHNOLOGY MANAGEMENT INC (2013-05-13);;DR/DECISION RESOURCES LLC (2014-01-03),https://lens.org/049-293-684-985-285,Granted Patent,yes,47,0,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F16/21;;G06F16/2457;;G06F16/33;;G06Q10/10;;G06Q30/02;;G06Q30/0204,,5,0,,,"“Definition Parallel processing”, whatis.com, 2007, 4 pages.;;12854440, “European Application Serial No. 12854440, European Search Report dated Nov. 16, 2016”, Decision Resources LLC DR, Nov. 16, 2016, 5 pages.;;PCT/US2012/066883, “International Application Serial No. PCT/US2012/066883, International Preliminary Report on Patentability dated Mar. 27, 2013”, DR/Decision Resources, LLC, 5 pages.;;PCT/US2012/066883, “International Application Serial No. PCT/US2012/066883, International Search Report and Written Opinion dated Mar. 27, 2013”, DR/Decision Resources, LLC, 7 pages.;;U.S. Appl. No. 15/263,998, filed Jun. 15, 2017, Pending, Travis Donia.",ACTIVE
15,US,A1,US 2009/0201486 A1,056-696-095-786-616,2009-08-13,2009,US 3060308 A,2008-02-13,US 3060308 A,2008-02-13,SCANNED LASER DETECTION AND RANGING APPARATUS,"A method and apparatus for obtaining information about an environment having objects located around a vehicle. The laser detection and ranging system comprises a fan beam generation unit, a streak unit, a telescope, a switch, and a detector unit. The fan beam generation unit transmits a fan beam. The streak unit streaks a received beam generated in response to the fan beam to form a streaked beam. The telescope propagates the fan beam to a portion of the environment around the vehicle. The switch directs the fan beam generated by the fan beam generation unit through the telescope along an azimuth onto the environment around the vehicle and directing a response signal to the fan beam to the streak unit. The detector unit detects the streaked beam and generating range and angle data to generate an image of the environment.",CRAMBLITT ROBERT MERRILL;;GREENWALD DAVID,CRAMBLITT ROBERT MERRILL;;GREENWALD DAVID,THE BOEING COMPANY (2008-02-11),https://lens.org/056-696-095-786-616,Patent Application,yes,9,35,5,5,0,G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931;;G01S7/4811;;G01S17/89;;G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931,G01C3/08;;G01B11/14;;G01S17/89;;G01S17/931,356/4.01;;702/159,0,0,,,,ACTIVE
16,US,A1,US 2020/0151157 A1,032-498-234-739-329,2020-05-14,2020,US 201916598405 A,2019-10-10,US 201916598405 A;;US 201514871616 A;;US 201414275163 A;;US 201213688101 A;;US 201161564020 P,2011-11-28,PHARMACEUTICAL/LIFE SCIENCE TECHNOLOGY EVALUATION AND SCORING,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles. The method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are also described.",DR/DECISION RESOURCES LLC,HYDE BRIGHAM B;;GREENWALD DAVID,,https://lens.org/032-498-234-739-329,Patent Application,yes,7,1,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F16/21;;G06F16/2457;;G06F16/33;;G06Q10/10;;G06Q30/02,,0,0,,,,ACTIVE
17,US,A1,US 2016/0275112 A1,135-077-806-969-680,2016-09-22,2016,US 201514871616 A,2015-09-30,US 201514871616 A;;US 201414275163 A;;US 201213688101 A;;US 201161564020 P,2011-11-28,Pharmaceutical/Life Science Technology Evaluation And Scoring,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles. The method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are also described.",DR/DECISION RESOURCES LLC,HYDE BRIGHAM B;;GREENWALD DAVID,RELAY TECHNOLOGY MANAGEMENT INC (2013-05-13);;DR/DECISION RESOURCES LLC (2014-01-03),https://lens.org/135-077-806-969-680,Patent Application,yes,2,2,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/30,,1,0,,,WhatIs.com. “parallel processing” definition. Last updated March 2007. URL Link: <https://searchdatacenter.techtarget.com/definition/parallel-processing>. Accessed Apr 2019. (Year: 2007),DISCONTINUED
18,US,A1,US 2014/0330846 A1,137-413-174-593-162,2014-11-06,2014,US 201414275163 A,2014-05-12,US 201414275163 A;;US 201213688101 A;;US 201161564020 P,2011-11-28,Pharmaceutical/Life Science Technology Evalution and Scoring,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles. The method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are also described.",DECISION RESOURCES LLC DR,HYDE BRIGHAM B;;GREENWALD DAVID,RELAY TECHNOLOGY MANAGEMENT INC (2013-05-11);;DR/DECISION RESOURCES LLC (2014-01-03),https://lens.org/137-413-174-593-162,Patent Application,yes,1,2,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/30,707/749,0,0,,,,DISCONTINUED
19,US,B2,US 8725552 B2,053-766-112-706-051,2014-05-13,2014,US 201213688101 A,2012-11-28,US 201213688101 A;;US 201161564020 P,2011-11-28,Pharmaceutical/life science technology evaluation and scoring,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles. The method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are also described.",HYDE BRIGHAM B;;GREENWALD DAVID;;DECISION RESOURCES LLC DR,HYDE BRIGHAM B;;GREENWALD DAVID,RELAY TECHNOLOGY MANAGEMENT INC (2013-12-31);;DR/DECISION RESOURCES LLC (2014-01-03),https://lens.org/053-766-112-706-051,Granted Patent,yes,3,3,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06F17/00,705/7.33,0,0,,,,ACTIVE
20,GB,B,GB 2457375 B,199-318-207-570-842,2010-08-04,2010,GB 0902355 A,2009-02-12,US 3060308 A,2008-02-13,Scanned laser detection and ranging apparatus,,BOEING CO,CRAMBLITT ROBERT M;;GREENWALD DAVID,,https://lens.org/199-318-207-570-842,Granted Patent,no,4,0,5,5,0,G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931;;G01S7/4811;;G01S17/89;;G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931,G01S7/481;;G01S17/89;;G01S17/931,,0,0,,,,ACTIVE
21,US,A1,US 2013/0138478 A1,048-882-915-852-316,2013-05-30,2013,US 201213688101 A,2012-11-28,US 201213688101 A;;US 201161564020 P,2011-11-28,Pharmaceutical/Life Science Technology Evaluation and Scoring,"A method for evaluating and/or scoring pharmaceutical/life science technology is provided. The method includes importing data of a publication; transforming the data into a structured schema; ingesting the structured schema to determine a context of the data and draw associations between the data and a plurality of profiles; and generating a score based on the associations between the raw data and the profiles. The method may also include generating meta-data based on the determined context of the data and/or one or more quantitative metrics having a temporal component based on the ingested data. Related apparatus, systems, techniques and articles are also described.",HYDE BRIGHAM B;;GREENWALD DAVID,HYDE BRIGHAM B;;GREENWALD DAVID,RELAY TECHNOLOGY MANAGEMENT INC (2013-12-31);;DR/DECISION RESOURCES LLC (2014-01-03),https://lens.org/048-882-915-852-316,Patent Application,yes,3,21,11,11,0,G06Q10/10;;G06Q30/02;;G06F16/3344;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/0204;;G06F16/212;;G06F16/24578;;G06Q30/02;;G06Q10/10;;G06F16/3344,G06Q50/22;;G06Q30/02,705/7.33,0,0,,,,ACTIVE
22,US,B2,US 7710545 B2,140-901-384-366-495,2010-05-04,2010,US 3060308 A,2008-02-13,US 3060308 A,2008-02-13,Scanned laser detection and ranging apparatus,"A method and apparatus for obtaining information about an environment having objects located around a vehicle. The laser detection and ranging system comprises a fan beam generation unit, a streak unit, a telescope, a switch, and a detector unit. The fan beam generation unit transmits a fan beam. The streak unit streaks a received beam generated in response to the fan beam to form a streaked beam. The telescope propagates the fan beam to a portion of the environment around the vehicle. The switch directs the fan beam generated by the fan beam generation unit through the telescope along an azimuth onto the environment around the vehicle and directing a response signal to the fan beam to the streak unit. The detector unit detects the streaked beam and generating range and angle data to generate an image of the environment.",BOEING CO,CRAMBLITT ROBERT MERRILL;;GREENWALD DAVID,THE BOEING COMPANY (2008-02-11),https://lens.org/140-901-384-366-495,Granted Patent,yes,10,19,5,5,0,G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931;;G01S7/4811;;G01S17/89;;G01S7/4811;;G01S7/4817;;G01S17/89;;G01S17/931,G01C3/08;;G01S17/89;;G01S17/931,356/4.01,2,1,011-929-872-187-821,10.1117/12.580235,"Juberts et al., ""Status report on next generation LADAR for driving unmanned ground vehicles"", Mobile Robots XVII, Proceedings of SPIE vol. 5609, SPIE Bellingham WA, 2004, pp. 1-12.;;""66-Laser Sensor"", NIST Intelligent Systems Division RFQ #SB1341-07-RQ-0083, Feb. 26, 2007, pp. 1-4.",ACTIVE
23,DE,T2,DE 69706849 T2,034-906-007-211-340,2002-04-11,2002,DE 69706849 T,1997-06-23,US 66876196 A;;US 9710873 W,1996-06-24,FLÜSSIGKRISTALLINE POLYESTERAMIDE,,DU PONT,PLOTZKER GREENWALD;;CITRON DAVID;;WAGGONER GLEN,,https://lens.org/034-906-007-211-340,Granted Patent,no,0,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,EXPIRED
24,NZ,A,NZ 230103 A,122-424-255-994-821,1991-10-25,1991,NZ 23010389 A,1989-07-27,US 33733689 A,1989-04-13,"HOMOGENEOUS, SINGLE COMPONENT, STORAGE-STABLE, ANTIMICROBIAL FILM-FORMING COMPOSITION CONTAINING QUATERNARY AMMONIUM SALT AS GERMICIDE, AND METHOD OF COATING SURFACES",,ECOLAB INC,GREENWALD RICHARD B;;HALSRUD DAVID A,,https://lens.org/122-424-255-994-821,Patent Application,no,0,0,4,5,0,,A23L3/00;;A01N25/10;;A01N33/12;;A61L2/16;;A61L2/18;;C08K5/19;;C08L33/00;;C08L33/02;;C08L35/00;;C08L101/02;;C09D5/00;;C09D7/12;;C09D201/02,,0,0,,,,PENDING
25,US,A,US 4113738 A,033-977-111-859-042,1978-09-12,1978,US 78466977 A,1977-04-05,US 76486277 A,1977-02-02,Conversion of N-tosylsulfoximides to sulfoximines,"This application is directed to a novel cleavage reaction whereby N-tosylsulfoximides of the following formula are converted to the corresponding sulfoximines. The relevant sulfoximides are represented by the formula: ##STR1## wherein R.sup.1 and R.sup.2 when taken individually (1) each represent an alkyl moiety containing up to 20 carbon atoms, unsubstituted with an alkali-stable group or (2) R.sup.1 is an alkyl moiety containing up to 20 carbon atoms and R.sup.2 is --(CH.sub.2).sub.n --S--R.sup.3 wherein n is greater than or equal to 2 and R.sup.3 is an alkyl moiety containing up to 20 carbon atoms and R.sup.1 and R.sup.2 when taken together represents (a) an alkylene moiety having 5 or 6 carbon atoms unsubstituted or substituted with an alkali-stable group; (b) --CH.sub.2 --.sub.x SO.sub.2 --CH.sub.2 -- wherein x is 3 or 4; or (c) --CHR--SO.sub.2 --CH.sub.2 CR'R""CH.sub.2 -- where R is hydrogen, or thioether R' and R"" when taken individually are hydrogen or alkyl and R' and R"" when taken together is a spiro group, preferably 1,3-dioxolane-2. This cleavage is accomplished by the use of ammonia and an alkali metal under defined reaction conditions which method affords a higher yield of sulfoximine and a product which is thereby more readily isolated and purified.",POLAROID CORP,EVANS DAVID H;;GREENWALD RICHARD B,,https://lens.org/033-977-111-859-042,Granted Patent,yes,8,0,1,1,0,C07D339/08;;C07D339/08,C07D339/08,260327M,0,0,,,,EXPIRED
26,EP,A4,EP 2033120 A4,133-317-417-484-097,2011-06-08,2011,EP 07795195 A,2007-05-23,US 2007/0012212 W;;US 43828906 A,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS,,LEXISNEXIS DIVISION OF REED ELSEVIER INC,GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR,,https://lens.org/133-317-417-484-097,Search Report,no,1,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F17/21;;G06F7/00;;G06F17/30;;G06F40/00,,5,4,010-924-044-244-65X;;051-946-836-028-730;;022-660-838-341-143;;010-612-466-946-616,10.1145/146370.146380;;10.1109/t-c.1974.223971;;10.1016/0306-4573(90)90052-4;;10.1109/tai.1990.130323,"KUKICH K: ""TECHNIQUE FOR AUTOMATICALLY CORRECTING WORDS IN TEXT"", ACM COMPUTING SURVEYS, ACM, NEW YORK, NY, US, US, vol. 24, no. 4, 1 January 1992 (1992-01-01), pages 1 - 14, XP001152274, ISSN: 0360-0300, DOI: 10.1145/146370.146380;;MARTINS B ET AL: ""Spelling correction for search engine queries"", FQAS 2009, LNAI 5822 (EDS. T. ANDERSON ET AL), SPRINGER, DE, vol. 3230, 1 January 2004 (2004-01-01), pages 372 - 383, XP002423041, ISBN: 978-3-540-24128-7, DOI: 10.1007/978-3-540-30228-5_33;;E.M. RISEMAN, A.R.HANSON: ""A contextual Postprocessing System for Error Correction Using Binary n-Grams"", IEEE TRANSACTIONS ON COMPUTERS, vol. c-23, no. 5, 5 May 1974 (1974-05-05), pages 480 - 493, XP002634241;;FRED. J. DAMERAU: ""Evaluating computer-generated domain-oriented vocabularies"", INFORMATION PROCESSING AND MANAGEMENT, vol. 26, no. 6, 1990, pages 791 - 801, XP002634242;;CHERKASSKY V ET AL: ""Conventional and associative memory-based spelling checkers"", PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON TOOLS FOR ARTIFICIAL INTELLIGENCE. HERNDON, NOV. 6 - 9, 1990; [PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON TOOLS FOR ARTIFICIAL INTELLIGENCE], LOS ALAMITOS, CA : IEEE. COMPUTER SOC, US, vol. CONF. 2, 6 November 1990 (1990-11-06), pages 138 - 144, XP010021128, ISBN: 978-0-8186-2084-3, DOI: 10.1109/TAI.1990.130323",DISCONTINUED
27,US,B2,US 11108882 B2,054-901-746-491-836,2021-08-31,2021,US 201916707853 A,2019-12-09,US 201916707853 A,2019-12-09,System for assessing and enhancing role defining parameters associated with access to resources in a network,"Embodiments of the present invention provide a system for assessing role defining parameters associated with access to resources in a network. The system is configured for extracting information associated with one or more resources, one or more users, and one or more authorizations, determining one or more metrics associated with one or more roles within an entity based on the extracted information, calculating a role defining parameter that defines a condition of the one or more roles based on the one or more metrics associated with the one or more roles, wherein the role defining parameter is associated with access to the one or more resources, determining if the parameter is below a predefined threshold, and performing one or more actions.",BANK OF AMERICA,GOPINATHAPAI RAJESH;;GREENWALD JENNIFER;;PRITCHARD DAVID,BANK OF AMERICA CORPORATION (2019-11-19),https://lens.org/054-901-746-491-836,Granted Patent,yes,35,0,2,2,0,H04L67/306;;H04L63/104;;H04L67/306;;H04L67/535,H04L29/08,,1,0,,,"Menegaz, Gery. “Enterprise Entitlements Management: Moving beyond authentication.” Between the Lines, Jun. 7, 2012, https://www.zdnet.com/article/enterprise-entitlements-management-moving-beyond-authentication/.",ACTIVE
28,US,A,US 4302612 A,042-116-756-988-484,1981-11-24,1981,US 87261478 A,1978-01-26,US 87261478 A;;US 70541176 A,1976-07-15,Synthesis of perfluorodialdehydes,This invention is concerned with the synthesis of perfluorodialdehydes from the corresponding perfluorodiesters and with intermediates useful in the preparation of the perfluorodialdehydes.,POLAROID CORP,EVANS DAVID H;;GREENWALD RICHARD B,,https://lens.org/042-116-756-988-484,Granted Patent,yes,4,2,1,1,0,C07C43/313;;C07C43/315;;C07C45/41;;C07C45/52;;C07C47/14;;C07C251/72;;C07D303/08;;C07D309/10;;C07C251/72;;C07C45/52;;C07D303/08;;C07D309/10;;C07C43/313;;C07C43/315;;C07C45/41;;C07C47/14,C07C43/12;;C07C43/313;;C07C43/315;;C07C45/41;;C07C45/52;;C07C47/14;;C07D303/08;;C07D309/10,568/604,3,0,,,"Pierce et al., ""J. Amer. Chem. Soc."" vol. 76, pp. 300-301.;;Husted et al., ""J. Amer. Chem. Soc."" vol. 74, pp. 5422-5426.;;Braid et al., ""J. Amer. Chem. Soc."" vol. 76, p. 4027.",EXPIRED
29,CA,C,CA 1338804 C,002-774-304-717-898,1996-12-17,1996,CA 605991 A,1989-07-18,US 33733689 A,1989-04-13,STORAGE STABLE AQUEOUS SOLUBLE GERMICIDAL FILM FORMING COMPOSITION,"A single-part aqueous, storage stable, antimicrobial film-forming composition comprising a major portion of water, an antimicrobially effective amount of a cationic germicidal agent having the structure (R) (R1) (R2) (R3) N+ X- , wherein R, R1, R2, and R3 are independently selected from groups including benzyl, alkyl benzyl, halo benzyl, C1-14 alkyl, C5-24 alkyl or C1-4 hydroxyalkyl and Xrepresents an anion capable of imparting water solubility or dispersability to the compound, and a stoichiometrically effective amount of acid functional anionic polymer, wherein said cationic germicidal agent and anionic polymer remain dissolved as a homogeneous aqueous solution until used.",ECOLAB INC,GREENWALD RICHARD B;;HALSRUD DAVID A,,https://lens.org/002-774-304-717-898,Granted Patent,no,0,0,4,5,0,,A23L3/00;;A01N25/10;;A01N33/12;;A61L2/16;;A61L2/18;;C08K5/19;;C08L33/00;;C08L33/02;;C08L35/00;;C08L101/02;;C09D5/00;;C09D7/12;;C09D201/02,D24007022    M;;1170202    S;;16700228   S;;4001345    S;;4008102    S;;4009288    S,0,0,,,,EXPIRED
30,WO,A2,WO 2007/139798 A2,014-983-400-084-820,2007-12-06,2007,US 2007/0012212 W,2007-05-23,US 43828906 A,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS,"A system and method for multilingual spelling corrections employs a lexicon builder, which uses a metadata build process that extracts all words from the data source with which a user will be working, along with their frequencies, to build a lexicon file using the data source; and a spell checker algorithm, which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against it to determine a correct spelling or other spelling variant for the user to select.",LEXISNEXIS A DIVISION OF REED;;GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR,GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR,,https://lens.org/014-983-400-084-820,Patent Application,yes,0,2,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F40/00;;G06F17/21,,0,0,,,,PENDING
31,US,A,US 4107176 A,127-886-617-259-532,1978-08-15,1978,US 76486277 A,1977-02-02,US 67948776 A,1976-04-23,"Mono-N-tosylsulfimides, their preparation and their reaction products",This application is directed to cycloalkanes containing the moiety --SO.sub.2 --CH.sub.2 --X-- wherein X represents ##STR1## wherein R is hydrogen or alkyl and R' is alkyl and to the preparation of these compounds which find utility as silver halide complexing agents. This application is also concerned with cycloalkanes containing the moiety ##STR2## useful as intermediates in the preparation of the aforementioned compounds. Also included within the confines of this disclosure are the 2-thioether-substituted derivatives of certain of the above-identified cycloalkanes and with the synthesis of all of these compounds.,POLAROID CORP,EVANS DAVID H;;GREENWALD RICHARD B,,https://lens.org/127-886-617-259-532,Granted Patent,yes,3,3,1,1,0,C07D339/08;;C07D495/10;;G03C5/38;;G03C8/10;;G03C8/365;;C07D495/10;;G03C5/38;;G03C8/10;;G03C8/365;;C07D339/08,C07D339/08;;C07D495/10;;G03C5/38;;G03C8/10;;G03C8/36,260327M,5,3,173-290-486-350-862;;008-723-227-287-422;;031-436-147-493-316,10.1016/s0040-4039(01)97201-6;;10.1021/ja01486a037;;10.1039/ct9222101052,"Emerson, et al., Tetrahedron Letters, No. 37, pp. 3445-3448 (1971).;;Breslow, et al., Chem. of Het. Compounds, vol. 21, Part 2, pp. 998-1007.;;Howard, et al., J.A.C.S. 82: 158-164 (1-1960).;;Mann et al., J. Chem. Soc., 1922: T1052-1055.;;Nicolet, et al., Science 53: 217 (1921).",EXPIRED
32,US,A,US 5158766 A,059-830-655-554-754,1992-10-27,1992,US 54576890 A,1990-06-28,US 54576890 A;;US 33733689 A,1989-04-13,Storage stable aqueous soluble germicidal film forming composition,"A single-part aqueous, storage stable, antimicrobial film-forming composition comprising a major portion of water, an antimicrobially effective amount of a cationic germicidal agent having the structure (R) (R.sub.1) (R.sub.2) (R.sub.3) N.sup.+ X.sup.-, wherein R, R.sub.1, R.sub.2, and R.sub.3 are independently selected from groups including benzyl, alkyl, benzyl, halo benzyl, C.sub.1-14 alkyl, C.sub.5-24 alkyl or C.sub.1-4 hydroxyalkyl and X.sup.- represents an anion capable of imparting water solubility or dispersability to the compound, and a stoichemetrically effective amount of acid functional anionic polymer, wherein said cationic germicidal agent and anionic polymer remain dissolved as a homogeneous aqueous solution until used.",ECOLAB INC,GREENWALD RICHARD B;;HALSRUD DAVID A,,https://lens.org/059-830-655-554-754,Granted Patent,yes,10,83,1,5,0,A01N25/24;;A01N33/12;;A61K9/7015;;A61K31/14;;A61K31/14;;A01N25/24;;A61K9/7015;;A01N33/12,A01N25/24;;A01N33/12;;A61K9/70;;A61K31/14,424/78.33;;424/78.37,1,0,,,Precipitation Phenomena in Mixtures of Anionic and Cationic Surfactants in Aqueous Solutions by Stellner et al.,EXPIRED
33,AU,A1,AU 2007/268059 A1,033-365-521-607-457,2007-12-06,2007,AU 2007/268059 A,2007-05-23,US 43828906 A;;US 2007/0012212 W,2006-05-23,Method and apparatus for multilingual spelling corrections,,LEXIS NEXIS A DIVISION OF REED,NAYFELD VLADIMIR;;GREENWALD CHARLES;;HILTON DAVID,,https://lens.org/033-365-521-607-457,Patent Application,no,0,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F17/21;;G06F40/00,,0,0,,,,ACTIVE
34,WO,A1,WO 2000/025877 A1,114-153-245-124-599,2000-05-11,2000,US 9926151 W,1999-11-05,US 18685698 A,1998-11-05,MULTIPLAYER ELECTRONIC GAMES,"An electronic game (fig. 1) for multiple, preferably two, players requires that the players act independently and cooperatively at different points in the game in order to complete the game. Different modes of cooperation are provided within the context of the game story and include, for example, holding a door for a player, handing a tool to a player, giving an item to a player, helping a player lift an object. The cooperation required by the game includes requiring the result that only both players can complete the game together; neither player can complete the game without the other. A split-screen mode (fig. 1) and a single-screen mode (fig. 2) are utilized to enhance the difference between independent action and cooperative action. When players are cooperating, generally a single-screen mode (fig. 2) is used and when players are acting independently, generally a split-screen mode (fig. 1) is used. The game is stored in a medium readable by a personal computer such as a CDROM or DVD. However, the game may be saved in any several types of electronic game formats such as video game cartridges, dedicated hardware device.",GORDON MERYL GREENWALD;;GORDON DAVID P,GORDON MERYL GREENWALD;;GORDON DAVID P,,https://lens.org/114-153-245-124-599,Patent Application,yes,2,1,3,3,0,A63F2011/0095;;A63F2300/632;;A63F2300/8088;;A63F13/847;;A63F13/843;;A63F2300/66;;A63F13/52;;A63F13/47;;A63F13/847;;A63F13/843;;A63F2300/8088;;A63F2011/0095;;A63F2300/632;;A63F2300/807,A63F9/00;;A63F11/00;;A63F13/00,,0,0,,,,PENDING
35,WO,A3,WO 2007/139798 A3,024-375-218-680-54X,2008-11-27,2008,US 2007/0012212 W,2007-05-23,US 43828906 A,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS,"A system and method for multilingual spelling corrections employs a lexicon builder (10), which uses a metadata build process that extracts all words from the data source with which a user will be working, along with their frequencies, to build a lexicon file using the data source (120); and a spell checker algorithm (200), which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against it to determine a correct spelling or other spelling variant for the user to select.",LEXISNEXIS A DIVISION OF REED;;GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR,GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR,,https://lens.org/024-375-218-680-54X,Search Report,yes,2,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F7/00;;G06F17/21;;G06F17/30;;G06F40/00,,1,1,010-924-044-244-65X,10.1145/146370.146380,"KUKICH K.: ""Technique for Automatically Correcting Words in Text"", ACM COMPUTING SURVEYS, vol. 24, no. 4, December 1992 (1992-12-01), pages 1 - 63, XP001152274",PENDING
36,AU,A,AU 2000/013436 A,130-871-098-461-101,2000-05-22,2000,AU 2000/013436 A,1999-11-05,US 18685698 A;;US 9926151 W,1998-11-05,Multiplayer electronic games,,GORDON MERYL GREENWALD;;GORDON DAVID P,GORDON MERYL GREENWALD;;GORDON DAVID P,,https://lens.org/130-871-098-461-101,Patent Application,no,0,0,3,3,0,A63F2011/0095;;A63F2300/632;;A63F2300/8088;;A63F13/847;;A63F13/843;;A63F2300/66;;A63F13/52;;A63F13/47;;A63F13/847;;A63F13/843;;A63F2300/8088;;A63F2011/0095;;A63F2300/632;;A63F2300/807,A63F9/00;;A63F11/00;;A63F13/00,,0,0,,,,DISCONTINUED
37,US,A1,US 2021/0176331 A1,111-677-322-032-793,2021-06-10,2021,US 201916707853 A,2019-12-09,US 201916707853 A,2019-12-09,SYSTEM FOR ASSESSING AND ENHANCING ROLE DEFINING PARAMETERS ASSOCIATED WITH ACCESS TO RESOURCES IN A NETWORK,"Embodiments of the present invention provide a system for assessing role defining parameters associated with access to resources in a network. The system is configured for extracting information associated with one or more resources, one or more users, and one or more authorizations, determining one or more metrics associated with one or more roles within an entity based on the extracted information, calculating a role defining parameter that defines a condition of the one or more roles based on the one or more metrics associated with the one or more roles, wherein the role defining parameter is associated with access to the one or more resources, determining if the parameter is below a predefined threshold, and performing one or more actions.",BANK OF AMERICA,GOPINATHAPAI RAJESH;;GREENWALD JENNIFER;;PRITCHARD DAVID,BANK OF AMERICA CORPORATION (2019-11-19),https://lens.org/111-677-322-032-793,Patent Application,yes,0,0,2,2,0,H04L67/306;;H04L63/104;;H04L67/306;;H04L67/535,H04L29/08,,0,0,,,,ACTIVE
38,DE,D1,DE 69706849 D1,014-494-355-784-176,2001-10-25,2001,DE 69706849 T,1997-06-23,US 66876196 A;;US 9710873 W,1996-06-24,FLÜSSIGKRISTALLINE POLYESTERAMIDE,,DU PONT,PLOTZKER GREENWALD;;CITRON DAVID;;WAGGONER GLEN,,https://lens.org/014-494-355-784-176,Granted Patent,no,0,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,EXPIRED
39,US,A1,US 2003/0190940 A1,061-784-830-011-982,2003-10-09,2003,US 18685698 A,1998-11-05,US 18685698 A,1998-11-05,MULTIPLAYER ELECTRONIC GAMES,"
   An electronic game for multiple, preferably two, players requires that the players act independently and cooperatively at different points in the game in order to complete the game. Different modes of cooperation are provided within the context of the game story and include, for example, holding a door for a player, handing a tool to a player, giving an item to a player, helping a player lift an object, etc. The cooperation required by the game includes requiring the result that only both players can complete the game together; neither player can complete the game without the other. A split-screen mode and a single-screen mode are utilized to enhance the difference between independent action and cooperative action. When players are cooperating, generally a single-screen mode is used and when players are acting independently, generally a split-screen mode is used. The game is preferably embodied in a medium readable by a personal computer such as a CDROM or DVD. However, the game may be embodied in any of several types of electronic game formats such as video game cartridges, dedicated hardware device, etc. 
",GORDON MERYL GREENWALD;;GORDON DAVID P.,GORDON MERYL GREENWALD;;GORDON DAVID P,,https://lens.org/061-784-830-011-982,Patent Application,yes,1,34,3,3,0,A63F2011/0095;;A63F2300/632;;A63F2300/8088;;A63F13/847;;A63F13/843;;A63F2300/66;;A63F13/52;;A63F13/47;;A63F13/847;;A63F13/843;;A63F2300/8088;;A63F2011/0095;;A63F2300/632;;A63F2300/807,A63F9/00;;A63F11/00;;A63F13/00,463/9,0,0,,,,DISCONTINUED
40,EP,A2,EP 2033120 A2,187-560-406-171-000,2009-03-11,2009,EP 07795195 A,2007-05-23,US 2007/0012212 W;;US 43828906 A,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS,,LEXISNEXIS A DIVISION OF REED,GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR,,https://lens.org/187-560-406-171-000,Patent Application,yes,0,1,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F17/21;;G06F7/00;;G06F17/30;;G06F40/00,,0,0,,,,DISCONTINUED
41,US,A,US 1860815 A,038-139-642-270-199,1932-05-31,1932,US 53947431 A,1931-05-23,US 53947431 A,1931-05-23,Paper-dispensing machine,,EUGENE LUCKS-OSTEN;;JULIUS GREENWALD;;DAVID OSTERN,EUGENE LUCKS-OSTEN;;JULIUS GREENWALD;;DAVID OSTERN,,https://lens.org/038-139-642-270-199,Granted Patent,no,0,2,1,1,0,B26D1/08;;Y10T83/4632;;Y10T83/4518;;Y10T83/4556;;Y10T83/4632;;Y10T83/4518;;Y10T83/4556;;B26D1/08,B26D1/08,,0,0,,,,EXPIRED
42,US,B2,US 11755927 B2,029-043-020-208-195,2023-09-12,2023,US 201916549325 A,2019-08-23,US 201916549325 A,2019-08-23,Identifying entitlement rules based on a frequent pattern tree,"Aspects of the disclosure relate to identifying entitlement rules based on a frequent pattern tree. A computing platform may retrieve entitlement data associated with a relational database, where the entitlement data is indicative of user entitlements to computing resources in an enterprise network. Then, the computing platform may generate, for the entitlement data, a frequent pattern tree. Then, the computing platform may compare a pair of branches and may detect a pattern associated with a pair of entitlements. Then, the computing platform may determine, based on the frequent pattern tree, a frequency of occurrence of the pattern. Then, the computing platform may identify, based on the frequency of occurrence, a rule associated with the pattern. Subsequently, the computing platform may trigger, via the computing device and based on the rule, an action related to one or more of the entitlements of the pair of entitlements.",BANK OF AMERICA,PRITCHARD DAVID;;GOPINATHAPAI RAJESH;;GREENWALD JENNIFER LYNN,BANK OF AMERICA CORPORATION (2019-08-22),https://lens.org/029-043-020-208-195,Granted Patent,yes,19,0,2,2,0,G06F21/6245;;G06N5/025;;G06N5/025;;H04L67/306;;G06F16/2246;;G06F16/288,G06N5/02;;G06F16/22;;G06F16/28;;G06N5/025;;H04L67/306,,1,0,,,"FP tree example (How to identify frequent patterns using FP tree algorithm), hareenlaks—sharing knowledge and experience, Jun. 9, 2011, four pages, found at http://hareenlaks.blogspot.com/2001/06/fp-tree-example-how-to-identify.html.",ACTIVE
43,US,A1,US 2021/0056442 A1,114-801-233-580-493,2021-02-25,2021,US 201916549325 A,2019-08-23,US 201916549325 A,2019-08-23,IDENTIFYING ENTITLEMENT RULES BASED ON A FREQUENT PATTERN TREE,"Aspects of the disclosure relate to identifying entitlement rules based on a frequent pattern tree. A computing platform may retrieve entitlement data associated with a relational database, where the entitlement data is indicative of user entitlements to computing resources in an enterprise network. Then, the computing platform may generate, for the entitlement data, a frequent pattern tree. Then, the computing platform may compare a pair of branches and may detect a pattern associated with a pair of entitlements. Then, the computing platform may determine, based on the frequent pattern tree, a frequency of occurrence of the pattern. Then, the computing platform may identify, based on the frequency of occurrence, a rule associated with the pattern. Subsequently, the computing platform may trigger, via the computing device and based on the rule, an action related to one or more of the entitlements of the pair of entitlements.",BANK OF AMERICA,PRITCHARD DAVID;;GOPINATHAPAI RAJESH;;GREENWALD JENNIFER LYNN,BANK OF AMERICA CORPORATION (2019-08-22),https://lens.org/114-801-233-580-493,Patent Application,yes,9,0,2,2,0,G06F21/6245;;G06N5/025;;G06N5/025;;H04L67/306;;G06F16/2246;;G06F16/288,G06N5/02;;G06F16/22;;G06F16/28;;H04L29/08,,0,0,,,,ACTIVE
44,US,B2,US 8206225 B2,186-392-270-102-412,2012-06-26,2012,US 19102208 A,2008-08-13,US 19102208 A,2008-08-13,System and method for forming interdiction device,A reusable interdiction apparatus that makes use of a housing of dimensions making the housing suitable to be carried and thrown by an individual. A light source is disposed within the housing and adapted to project an optical signal through a portion of the housing. A controller is used for controlling operation of the light source. A power source is disposed within the housing and used for powering the controller and the light source.,VOELKER JEFFREY J;;VILCHECK MICHAEL J;;GREENWALD DAVID;;BOEING CO,VOELKER JEFFREY J;;VILCHECK MICHAEL J;;GREENWALD DAVID,THE BOEING COMPANY (2008-08-12),https://lens.org/186-392-270-102-412,Granted Patent,yes,5,1,2,2,0,F41H13/0087;;F41H13/0087;;F42B12/365;;F42B12/365;;F42B12/42;;F42B12/42,A63F9/24,463/46;;463/53,1,0,,,"http://en.wikipedia.org/wiki/Grenade#Stud-grenades, 3 pages.",ACTIVE
45,US,A1,US 2020/0358778 A1,002-596-714-590-675,2020-11-12,2020,US 201916404871 A,2019-05-07,US 201916404871 A,2019-05-07,Role Discovery for Identity and Access Management in a Computing System,"Methods, apparatuses, and systems are described for provisioning access rights in a computing system. A data structure may be created that corresponds to the access rights of a computing system. The data structure may be traversed to identify candidate bundles of access rights that correspond to patterns of access rights in the computing system. The candidate bundles of access rights may be evaluated to select one or more bundles to define as one or more roles in the computing system. The defined roles may then be provisioned to the users of the computing system as a replacement for the individual access rights. Various constraints may be applied to reduce the number of candidate bundles of access rights to evaluate.",BANK OF AMERICA,GOPINATHAPAI RAJESH;;GREENWALD JENNIFER LYNN;;HARTE DAVID PATRICK,BANK OF AMERICA CORPORATION (2019-04-29),https://lens.org/002-596-714-590-675,Patent Application,yes,0,12,2,2,0,G06F21/604;;H04L67/306;;H04L63/104;;H04L63/102;;G06N5/01;;H04L63/102;;G06F21/62;;G06F16/2246;;G06F16/2272;;H04L63/105;;H04L63/104;;H04L67/535;;G06F18/22;;G06F21/604,H04L29/06;;G06F16/22;;G06F21/62;;G06K9/62;;H04L29/08,,0,0,,,,ACTIVE
46,US,B2,US 11451554 B2,054-111-415-960-566,2022-09-20,2022,US 201916404871 A,2019-05-07,US 201916404871 A,2019-05-07,Role discovery for identity and access management in a computing system,"Methods, apparatuses, and systems are described for provisioning access rights in a computing system. A data structure may be created that corresponds to the access rights of a computing system. The data structure may be traversed to identify candidate bundles of access rights that correspond to patterns of access rights in the computing system. The candidate bundles of access rights may be evaluated to select one or more bundles to define as one or more roles in the computing system. The defined roles may then be provisioned to the users of the computing system as a replacement for the individual access rights. Various constraints may be applied to reduce the number of candidate bundles of access rights to evaluate.",BANK OF AMERICA,GOPINATHAPAI RAJESH;;GREENWALD JENNIFER LYNN;;HARTE DAVID PATRICK,BANK OF AMERICA CORPORATION (2019-04-29),https://lens.org/054-111-415-960-566,Granted Patent,yes,77,0,2,2,0,G06F21/604;;H04L67/306;;H04L63/104;;H04L63/102;;G06N5/01;;H04L63/102;;G06F21/62;;G06F16/2246;;G06F16/2272;;H04L63/105;;H04L63/104;;H04L67/535;;G06F18/22;;G06F21/604,H04L9/40;;G06F16/22;;G06F21/62;;G06K9/62;;H04L67/50,,6,2,005-071-655-787-001;;067-988-816-850-264,10.1109/tpds.2012.97;;10.1109/mcom.2018.1700333,"M. Li, S. Yu, Y. Zheng, K. Ren and W. Lou, “Scalable and Secure Sharing of Personal Health Records in Cloud Computing Using Attribute-Based Encryption,” in IEEE Transactions on Parallel and Distributed Systems, vol. 24, No. 1, pp. 131-143, Jan. 2013, doi: 10.1109/TPDS.2012.97. (Year: 2013).;;P. Zhang, J. K. Liu, F. R. Yu, M. Sookhak, M. H. Au and X. Luo, “A Survey on Access Control in Fog Computing,” in IEEE Communications Magazine, vol. 56, No. 2, pp. 144-149, Feb. 2018, doi: 10.1109/MCOM.2018.1700333. (Year: 2018).;;“CA Identity Governance—12.6.02CR1: Access Governance and RBAC.” Retrieved from [https://docops.ca.com/ca-identity-governance/12-6-02-cr1/EN/getting-started/access-governance-and-rbac] on Apr. 4, 2019.;;“Data Mining Algorithms In R/Frequent Pattern Mining/The FP-Growth Algorithm.” Retrieved from [https://en wikibooks.org/wiki/Data_Mining_Algorithms_In_R/Frequent_Pattern_Mining/The_FP-Growth_Algorithm] on Apr. 30, 2019.;;“An FP-Growth Approach to Mining Association Rules.” Soni et al. International Journal of Computer Science and Mobile Computing. vol. 2. Issue 2. Feb. 2013.;;“FP-growth.” Retrieved from [https://fenix.tecnico.ulisboa.pt/downloadFile/3//9571250081/licao_10.pdf] on Apr. 29, 2019.",ACTIVE
47,US,A1,US 2010/0285909 A1,108-298-692-532-631,2010-11-11,2010,US 19102208 A,2008-08-13,US 19102208 A,2008-08-13,SYSTEM AND METHOD FOR FORMING INTERDICTION DEVICE,A reusable interdiction apparatus that makes use of a housing of dimensions making the housing suitable to be carried and thrown by an individual. A light source is disposed within the housing and adapted to project an optical signal through a portion of the housing. A controller is used for controlling operation of the light source. A power source is disposed within the housing and used for powering the controller and the light source.,BOEING CO,VOELKER JEFFREY J;;VILCHECK MICHAEL J;;GREENWALD DAVID,THE BOEING COMPANY (2008-08-12),https://lens.org/108-298-692-532-631,Patent Application,yes,5,38,2,2,0,F41H13/0087;;F41H13/0087;;F42B12/365;;F42B12/365;;F42B12/42;;F42B12/42,A63B43/06,473/570;;348/143;;340/384.1;;340/541,0,0,,,,ACTIVE
48,US,A,US 5688895 A,134-290-947-043-538,1997-11-18,1997,US 66876196 A,1996-06-24,US 66876196 A,1996-06-24,Liquid crystalline poly(ester-amides),"Disclosed herein are thermotropic liquid crystalline poly(ester-amides) containing repeat units derived from alipatic diamines and other monomers, such as aromatic diols, aromatic dicarboxylic acids, aromatic hydroxycarboxylic acids, and optionally aliphatic diols. The polymers are particularly useful as films and in multilayer structures as barrier layers because of their relatively low permeability to various compounds.",DU PONT,PLOTZKER IRENE GREENWALD;;CITRON JOEL DAVID;;WAGGONER MARION GLEN,E. I. DU PONT DE NEMOURS AND COMPANY (1996-06-21);;TICONA LLC (2010-05-05),https://lens.org/134-290-947-043-538,Granted Patent,yes,3,5,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,528/183;;528/176;;528/183;;528/185;;528/190;;528/193;;528/194;;528/335;;528/344;;528/361,0,0,,,,EXPIRED
49,US,A,US 6126856 A,041-656-637-902-714,2000-10-03,2000,US 33107599 A,1999-06-16,US 33107599 A;;US 3389896 P;;US 9722905 W,1996-12-20,Composition containing liquid crystalline polymer,"When small amounts of zeolite or titanosilicates are added to thermotropic liquid crystalline aromatic polyester, poly(ester-amide) or poly(ester-imide) compositions, the compositions become less flammable. In many cases addition of the zeolite or titanosilicates does not significantly affect other properties of the composition, which may be used as molding resins, for instance to make parts useful in the electrical, electronic or automotive industry.",DU PONT,CORBIN DAVID RICHARD;;COTTIS STEVEN GUST;;PLOTZKER IRENE GREENWALD,E.I. DU PONT DE NEMOURS AND COMPANY (1998-01-21);;TICONA LLC (2010-05-05),https://lens.org/041-656-637-902-714,Granted Patent,yes,4,1,7,7,0,C08K3/34;;C08K3/34;;C08K2003/2237;;C08K2003/2237,C08L67/00;;C08K3/34;;C08L77/12;;C08L79/08,252/299.01;;252/601;;252/609;;523/521,0,0,,,,EXPIRED
50,CA,C,CA 2653090 C,071-516-795-616-610,2014-07-15,2014,CA 2653090 A,2007-05-23,US 43828906 A;;US 2007/0012212 W,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS,"A system and method for multilingual spelling corrections employs a lexicon builder (10), which uses a metadata build process that extracts all words from the data source with which a user will be working, along with their frequencies, to build a lexicon file using the data source (120); and a spell checker algorithm (200), which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against it to determine a correct spelling or other spelling variant for the user to select.",LEXISNEXIS DIVISION OF REED ELSEVIER INC,GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR;;YOUNG KEITH D,,https://lens.org/071-516-795-616-610,Granted Patent,no,0,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F17/27;;G06F17/30;;G06F40/00,,0,0,,,,ACTIVE
51,CA,A1,CA 2653090 A1,127-991-891-848-043,2007-12-06,2007,CA 2653090 A,2007-05-23,US 43828906 A;;US 2007/0012212 W,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS,"A system and method for multilingual spelling corrections employs a lexic on builder (10), which uses a metadata build process that extracts all words from the data source with which a user will be working, along with their fr equencies, to build a lexicon file using the data source (120); and a spell checker algorithm (200), which determines the correct spelling of words used as input for a search of the data source by calculating a score value for w ords in the lexicon file according to a formula that distinguishes similarit y between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against it to determine a correct spelling or o ther spelling variant for the user to select.",LEXISNEXIS A DIVISION OF REED,HILTON DAVID;;NAYFELD VLADIMIR;;GREENWALD CHARLES;;YOUNG KEITH D,,https://lens.org/127-991-891-848-043,Patent Application,no,0,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F17/21;;G06F7/00;;G06F17/30;;G06F40/00,,0,0,,,,ACTIVE
52,CA,C,CA 2257270 C,168-171-699-417-407,2001-12-11,2001,CA 2257270 A,1997-06-23,US 66876196 A;;US 9710873 W,1996-06-24,LIQUID CRYSTALLINE POLY(ESTER-AMIDES),"Disclosed herein are thermotropic liquid crystalline poly(ester-amides) containing repeat units derived from aliphatic diamines and other monomers, such as aromatic diols, aromatic dicarboxylic acids, aromatic hydroxycarboxylic acids, and optionally aliphatic diols. The polymers are particularly useful as films and in multilayer structures as barrier layers because of their relatively low permeability to various compounds.",DU PONT,CITRON JOEL DAVID;;PLOTZKER IRENE GREENWALD;;WAGGONER MARION GLEN,,https://lens.org/168-171-699-417-407,Granted Patent,no,0,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,EXPIRED
53,EP,B1,EP 0904312 B1,060-943-613-391-770,2001-09-19,2001,EP 97932248 A,1997-06-23,US 9710873 W;;US 66876196 A,1996-06-24,LIQUID CRYSTALLINE POLY(ESTER-AMIDES),,DU PONT,PLOTZKER IRENE GREENWALD;;CITRON JOEL DAVID;;WAGGONER MARION GLEN,"TICONA LLC, FLORENCE, US (2012-04-23)",https://lens.org/060-943-613-391-770,Granted Patent,yes,7,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,EXPIRED
54,WO,A1,WO 1997/049753 A1,101-041-358-289-690,1997-12-31,1997,US 9710873 W,1997-06-23,US 66876196 A,1996-06-24,LIQUID CRYSTALLINE POLY(ESTER-AMIDES),"Disclosed herein are thermotropic liquid crystalline poly(ester-amides) containing repeat units derived from aliphatic diamines and other monomers, such as aromatic diols, aromatic dicarboxylic acids, aromatic hydroxycarboxylic acids, and optionally aliphatic diols. The polymers are particularly useful as films and in multilayer structures as barrier layers because of their relatively low permeability to various compounds.",DU PONT,PLOTZKER IRENE GREENWALD;;CITRON JOEL DAVID;;WAGGONER MARION GLEN,,https://lens.org/101-041-358-289-690,Patent Application,yes,7,2,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,PATENTED
55,EP,A1,EP 0946674 A1,010-210-547-606-806,1999-10-06,1999,EP 97949805 A,1997-12-15,US 9722905 W;;US 3389896 P,1996-12-20,COMPOSITION CONTAINING LIQUID CRYSTALLINE POLYMER,,DU PONT,CORBIN DAVID RICHARD;;COTTIS STEVEN GUST;;PLOTZKER IRENE GREENWALD,"TICONA LLC, FLORENCE, US (2012-04-23)",https://lens.org/010-210-547-606-806,Patent Application,yes,0,0,7,7,0,C08K3/34;;C08K3/34;;C08K2003/2237;;C08K2003/2237,C08L67/00;;C08K3/34;;C08L77/12;;C08L79/08,,1,0,,,See references of WO 9828380A1,EXPIRED
56,AU,B2,AU 2007/268059 B2,168-287-624-205-893,2012-05-17,2012,AU 2007/268059 A,2007-05-23,US 43828906 A;;US 2007/0012212 W,2006-05-23,Method and apparatus for multilingual spelling corrections,"A system and method for multilingual spelling corrections employs a lexicon builder, which uses a metadata build process that extracts all words from the data source with which a user will be working, along with their frequencies, to build a lexicon file using the data source; and a spell checker algorithm, which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against it to determine a correct spelling or other spelling variant for the user to select.",LEXIS NEXIS A DIV OF REED ELSEVIER INC,NAYFELD VLADIMIR;;GREENWALD CHARLES;;YOUNG KEITH D;;HILTON DAVID,,https://lens.org/168-287-624-205-893,Granted Patent,no,2,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F17/21;;G06F7/00;;G06F17/30;;G06F40/00,,1,1,010-924-044-244-65X,10.1145/146370.146380,"KAREN KUKICH ""Techniques for Automatically Correcting Words in Text"", ACM Computing Surveys, Vol. 24, No. 4, December 1992.",ACTIVE
57,EP,A1,EP 0426811 A1,071-194-143-919-545,1991-05-15,1991,EP 90907867 A,1990-04-25,US 34294389 A,1989-04-25,BEVERAGE DISPENSER WITH INTERCONNECTED SYNTHETIC RESIN EXTERIOR PANELS.,"L'invention concerne un appareil de distribution de boissons adapté pour supporter un conteneur d'eau buvable aisément remplaçable. Les distributeurs de l'art antérieur étaient généralement construits en tôle, coûteux et nécessitaient beaucoup d'entretien. L'invention résout ces problèmes en proposant un appareil de distribution construit avec des panneaux verticaux porteurs de charge, en résine synthétique qui sont aisément assemblés. Les panneaux verticaux (33-35) porteurs, en résine synthétique et le dessus horizontal (32) sont formés de manière solidaire à l'aide d'éléments de fixation (34A-35G) qui tiennent les panneaux et le dessus ensemble avec les bords en bout à bout. Les panneaux verticaux frontal (33) et latéraux (34) sont adaptés pour être utilisés sur des distributeurs d'eau refroidie et d'eau à température ambiante. Le distributeur à température ambiante est en outre pourvu d'un panneau vertical arrière (35), et le distributeur d'eau froide utilise une paire de panneaux en coin arrière espacés entre eux latéralement. Les panneaux sont moulés pour supporter un réservoir d'eau (36) à l'intérieur.",EBCO MFG CO,CHANEY DAVID B;;GREENWALD RONALD I;;THOMAS MARC M,,https://lens.org/071-194-143-919-545,Patent Application,yes,0,0,6,6,0,B67B1/00;;B67D1/06;;B67D2210/00039,B67D1/00;;B67D1/06,,0,0,,,,DISCONTINUED
58,US,B2,US 8246354 B2,169-177-696-221-744,2012-08-21,2012,US 201213342463 A,2012-01-03,US 201213342463 A;;US 201113182575 A;;US 29494205 A;;US 67576805 P,2005-04-28,Training system and method using a dynamic perturbation platform,"A new apparatus, system and method for fall prevention training is provided that delivers, studies and analyzes the biomechanics of a disturbance event, such as a slip or trip incident, so that an appropriate response can be executed by the person to reduce or eliminate the number of falls experienced. The apparatus includes a platform that delivers a disturbance event in less than about 500 ms and preferably in the range of about 100 ms to about 200 ms. The method includes a unique protocol for fall prevention training using the apparatus. The disturbance event can create instability in the joint of the individual. An individual's walking gait can be monitored with the portions thereof detected. A disturbance event can be triggered when a given portion of the walking gait is detected. Also, the disturbance even can be triggered manually, at preset intervals or according to preset script.",CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D;;SIMBEX LLC,CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D,SIMBEX LLC A LIMITED LIABILITY COMPANY OF NEW HAMPSHIRE (2011-07-13),https://lens.org/169-177-696-221-744,Granted Patent,yes,21,24,4,6,0,A61B5/1038;;A61B5/1117;;A63B22/0235;;A63B24/0006;;A63B26/003;;A63B69/0053;;A63B69/0064;;A63B71/0622;;A63B2022/0278;;A63B2024/0009;;A63B2071/0636;;A63B2071/0638;;A63B2071/0655;;A63B2071/0683;;A63B2220/13;;A63B2220/16;;A63B2220/40;;A63B2220/51;;A63B2220/58;;A63B2220/801;;A63B2220/805;;A63B2220/806;;A63B2225/50;;A61H3/008;;A61H2201/1616;;A61H2201/1621;;A61H2201/1635;;A61H2201/164;;A63B22/0292;;A63B26/003;;A61B5/1117;;A63B24/0006;;A63B2024/0009;;A63B69/0053;;A63B2071/0683;;A63B71/0622;;A63B2022/0278;;A63B2220/16;;A61B5/1038;;A63B2220/801;;A63B2220/13;;A63B2220/806;;A63B2071/0655;;A63B2225/50;;A63B69/0064;;A63B2220/40;;A63B22/0235;;A63B2220/58;;A63B2220/805;;A63B2220/51;;A63B2071/0636;;A63B2071/0638;;A61H2201/164;;A61H2201/1621;;A61H2201/1616;;A61H3/008;;A61H2201/1635;;A63B22/0292,G09B19/00,434/258,4,4,096-065-395-594-333;;033-400-101-109-727;;071-006-599-071-326;;038-489-147-157-033,10.1097/01.phm.0000130025.54168.91;;15213472;;15543446;;10.1682/jrrd.2004.03.0283;;10.1093/ptj/85.8.740;;16048422;;10.1002/jor.20754;;19023893;;pmc3597104,"Shimada Hiroyuki, et al., ""New Intervention Program for Preventing Falls Among Frail Elderly People"", American Journal of Physical Medicine & Rehabilitation, vol. 83, No. 7, pp. 493-499, Lippincott Williams & Wilkins.;;Jaffe.pdf-""Stepping Over Obstacles to Improve Walking in Individuals With Post Stroke Hemiplegia""-Journal of Rehabilitation Research and Development-May/Jun. 2004-vol. 41, No. 3A, pp. 283-292.;;Chmielewski, Terese L. et al., ""Perturbation Training Improves Knee Kinematics and Reduces Muscle Co-contraction After Complete Unilateral Anterior Cruciate Ligament Rupture"", Research Report, Thysical Therapy-vol. 85, Nov. 8, Aug. 2005.;;Hartigan, Erin et al., ""Perturbation Training prior to ACL Reconstruction Improves Gait Asymmetries in Non-Copers"", Journal of Orthopaedic Research, pp. 724-729, Jun. 2009.",ACTIVE
59,US,B2,US 8622747 B2,059-668-780-693-347,2014-01-07,2014,US 201113182575 A,2011-07-14,US 201113182575 A;;US 29494205 A;;US 67576805 P,2005-04-28,Training system and method using a dynamic perturbation platform,"A new apparatus, system and method for fall prevention training is provided that delivers, studies and analyzes the biomechanics of a disturbance event, such as a slip or trip incident, so that an appropriate response can be executed by the person to reduce or eliminate the number of falls experienced. The apparatus includes a platform that delivers a disturbance event in less than about 500 ms and preferably in the range of about 100 ms to about 200 ms. The method includes a unique protocol for fall prevention training using the apparatus. The disturbance event can create instability in the joint of the individual. An individual's walking gait can be monitored with the portions thereof detected. A disturbance event can be triggered when a given portion of the walking gait is detected. Also, the disturbance even can be triggered manually, at preset intervals or according to preset script.",CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D;;SIMBEX LLC,CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D,SIMBEX LLC A LIMITED LIABILITY COMPANY OF NEW HAMPSHIRE (2011-07-13),https://lens.org/059-668-780-693-347,Granted Patent,yes,21,20,4,6,0,A61B5/1038;;A61B5/1117;;A63B22/0235;;A63B24/0006;;A63B26/003;;A63B69/0053;;A63B69/0064;;A63B71/0622;;A63B2022/0278;;A63B2024/0009;;A63B2071/0636;;A63B2071/0638;;A63B2071/0655;;A63B2071/0683;;A63B2220/13;;A63B2220/16;;A63B2220/40;;A63B2220/51;;A63B2220/58;;A63B2220/801;;A63B2220/805;;A63B2220/806;;A63B2225/50;;A61H3/008;;A61H2201/1616;;A61H2201/1621;;A61H2201/1635;;A61H2201/164;;A63B22/0292;;A63B26/003;;A61B5/1117;;A63B24/0006;;A63B2024/0009;;A63B69/0053;;A63B2071/0683;;A63B71/0622;;A63B2022/0278;;A63B2220/16;;A61B5/1038;;A63B2220/801;;A63B2220/13;;A63B2220/806;;A63B2071/0655;;A63B2225/50;;A63B69/0064;;A63B2220/40;;A63B22/0235;;A63B2220/58;;A63B2220/805;;A63B2220/51;;A63B2071/0636;;A63B2071/0638;;A61H2201/164;;A61H2201/1621;;A61H2201/1616;;A61H3/008;;A61H2201/1635;;A63B22/0292,G09B19/00,434/258,4,4,096-065-395-594-333;;033-400-101-109-727;;071-006-599-071-326;;038-489-147-157-033,10.1097/01.phm.0000130025.54168.91;;15213472;;15543446;;10.1682/jrrd.2004.03.0283;;10.1093/ptj/85.8.740;;16048422;;10.1002/jor.20754;;19023893;;pmc3597104,"Shimada Hiroyuki, et al., ""New Intervention Program for Preventing Falls Among Frail Elderly People"", American Journal of Physical Medicine & Rehabilitation, vol. 83, No. 7, pp. 493-499, Lippincott Williams & Wilkins, (Jul. 2004).;;Jaffe.pdf-""Stepping Over Obstacles to Improve Walking in Individuals With Post Stroke Hemiplegia""-Journal of Rehabilitation Research and Development-May/Jun. 2004-vol. 41, No. 3A, pp. 283-292.;;Chmielewski, Terese L. et al., ""Perturbation Training Improves Knee Kinematics and Reduces Muscle Co-contraction After Complete Unilateral Anterior Cruciate Ligament Rupture"", Research Report, Thysical Therapy-vol. 85, Nov. 8, Aug. 2005.;;Hartigan, Erin et al., ""Perturbation Training prior to ACL Reconstruction Improves Gait Asymmetries in Non-Copers"", Journal of Orthopaedic Research, pp. 724-729, Jun. 2009.",ACTIVE
60,WO,A1,WO 1998/028380 A1,136-332-054-274-473,1998-07-02,1998,US 9722905 W,1997-12-15,US 3389896 P,1996-12-20,COMPOSITION CONTAINING LIQUID CRYSTALLINE POLYMER,"When small amounts of zeolites or titanosilicates are added to thermotropic liquid crystalline aromatic polyester, poly(ester-amide) or poly(ester-imide) compositions, the compositions become less flammable. In many cases addition of the zeolite or titanosilicate does not significantly affect other properties of the compositions, which may be used as molding resins, for instance to make parts useful in the electrical, electronic or automotive industry.",DU PONT;;CORBIN DAVID RICHARD;;COTTIS STEVEN GUST;;PLOTZKER IRENE GREENWALD,CORBIN DAVID RICHARD;;COTTIS STEVEN GUST;;PLOTZKER IRENE GREENWALD,,https://lens.org/136-332-054-274-473,Patent Application,yes,0,1,7,7,0,C08K3/34;;C08K3/34;;C08K2003/2237;;C08K2003/2237,C08L67/00;;C08K3/34;;C08L77/12;;C08L79/08,,3,0,,,"DATABASE WPI Section Ch Week 9413, Derwent World Patents Index; Class A23, AN 94-106962, XP002059774;;DATABASE WPI Section Ch Derwent World Patents Index; Class F09, AN 71-55725S, XP002059775;;DATABASE WPI Section Ch Week 8305, Derwent World Patents Index; Class A85, AN 83-10411K, XP002059776",PATENTED
61,EP,B1,EP 0946674 B1,150-195-470-843-726,2002-11-13,2002,EP 97949805 A,1997-12-15,US 9722905 W;;US 3389896 P,1996-12-20,COMPOSITION CONTAINING LIQUID CRYSTALLINE POLYMER,,DU PONT,CORBIN DAVID RICHARD;;COTTIS STEVEN GUST;;PLOTZKER IRENE GREENWALD,"TICONA LLC, FLORENCE, US (2012-04-23)",https://lens.org/150-195-470-843-726,Granted Patent,yes,0,0,7,7,0,C08K3/34;;C08K3/34;;C08K2003/2237;;C08K2003/2237,C08L67/00;;C08K3/34;;C08L77/12;;C08L79/08,,3,0,,,"DATABASE WPI Section Ch, Week 9413 Derwent Publications Ltd., London, GB; Class A23, AN 94-106962 XP002059774 & JP 06 057 117 A (SUMITOMO CHEM CO LTD) , 1 March 1994;;DATABASE WPI Section Ch, Derwent Publications Ltd., London, GB; Class F09, AN 71-55725S XP002059775 & JP 46 026 883 B (KOBAYASHI S) , 4 August 1971;;DATABASE WPI Section Ch, Week 8305 Derwent Publications Ltd., London, GB; Class A85, AN 83-10411K XP002059776 & JP 57 204 512 A (SHARP KK) , 15 December 1982",EXPIRED
62,TW,B,TW 487729 B,107-893-154-635-705,2002-05-21,2002,TW 86108141 A,1997-06-12,US 66876196 A,1996-06-24,Liquid crystalline poly(ester-amides),"Disclosed herein are thermotropic liquid crystalline poly(ester-amides) containing repeat units derived from alipatic diamines and other monomers, such as aromatic diols, aromatic dicarboxylic acids, aromatic hydroxycarboxylic acids, and optionally aliphatic diols. The polymers are particularly useful as films and in multilayer structures as barrier layers because of their relatively low permeability to various compounds.",DU PONT,PLOTZKER IRENE GREENWALD;;CITRON JOEL DAVID;;WAGGONER MARION GLEN,,https://lens.org/107-893-154-635-705,Granted Patent,no,0,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,EXPIRED
63,CA,A1,CA 2257270 A1,000-270-354-288-401,1997-12-31,1997,CA 2257270 A,1997-06-23,US 66876196 A;;US 9710873 W,1996-06-24,LIQUID CRYSTALLINE POLY(ESTER-AMIDES),"Disclosed herein are thermotropic liquid crystalline poly(ester-amides) containing repeat units derived from aliphatic diamines and other monomers, such as aromatic diols, aromatic dicarboxylic acids, aromatic hydroxycarboxylic acids, and optionally aliphatic diols. The polymers are particularly useful as films and in multilayer structures as barrier layers because of their relatively low permeability to various compounds.",DU PONT,CITRON JOEL DAVID;;WAGGONER MARION GLEN;;PLOTZKER IRENE GREENWALD,,https://lens.org/000-270-354-288-401,Patent Application,no,0,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,0,0,,,,EXPIRED
64,US,A1,US 2011/0312473 A1,037-459-246-540-106,2011-12-22,2011,US 201113182575 A,2011-07-14,US 201113182575 A;;US 29494205 A;;US 67576805 P,2005-04-28,TRAINING SYSTEM AND METHOD USING A DYNAMIC PERTURBATION PLATFORM,"A new apparatus, system and method for fall prevention training is provided that delivers, studies and analyzes the biomechanics of a disturbance event, such as a slip or trip incident, so that an appropriate response can be executed by the person to reduce or eliminate the number of falls experienced. The apparatus includes a platform that delivers a disturbance event in less than about 500 ms and preferably in the range of about 100 ms to about 200 ms. The method includes a unique protocol for fall prevention training using the apparatus. The disturbance event can create instability in the joint of the individual. An individual's walking gait can be monitored with the portions thereof detected. A disturbance event can be triggered when a given portion of the walking gait is detected. Also, the disturbance even can be triggered manually, at preset intervals or according to preset script.",CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D;;SIMBEX LLC,CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D,SIMBEX LLC A LIMITED LIABILITY COMPANY OF NEW HAMPSHIRE (2011-07-13),https://lens.org/037-459-246-540-106,Patent Application,yes,0,72,4,6,0,A61B5/1038;;A61B5/1117;;A63B22/0235;;A63B24/0006;;A63B26/003;;A63B69/0053;;A63B69/0064;;A63B71/0622;;A63B2022/0278;;A63B2024/0009;;A63B2071/0636;;A63B2071/0638;;A63B2071/0655;;A63B2071/0683;;A63B2220/13;;A63B2220/16;;A63B2220/40;;A63B2220/51;;A63B2220/58;;A63B2220/801;;A63B2220/805;;A63B2220/806;;A63B2225/50;;A61H3/008;;A61H2201/1616;;A61H2201/1621;;A61H2201/1635;;A61H2201/164;;A63B22/0292;;A63B26/003;;A61B5/1117;;A63B24/0006;;A63B2024/0009;;A63B69/0053;;A63B2071/0683;;A63B71/0622;;A63B2022/0278;;A63B2220/16;;A61B5/1038;;A63B2220/801;;A63B2220/13;;A63B2220/806;;A63B2071/0655;;A63B2225/50;;A63B69/0064;;A63B2220/40;;A63B22/0235;;A63B2220/58;;A63B2220/805;;A63B2220/51;;A63B2071/0636;;A63B2071/0638;;A61H2201/164;;A61H2201/1621;;A61H2201/1616;;A61H3/008;;A61H2201/1635;;A63B22/0292,A63B22/02,482/54,0,0,,,,ACTIVE
65,US,A1,US 2012/0108392 A1,110-230-704-843-463,2012-05-03,2012,US 201213342463 A,2012-01-03,US 201213342463 A;;US 201113182575 A;;US 29494205 A;;US 67576805 P,2005-04-28,TRAINING SYSTEM AND METHOD USING A DYNAMIC PERTURBATION PLATFORM,"A new apparatus, system and method for fall prevention training is provided that delivers, studies and analyzes the biomechanics of a disturbance event, such as a slip or trip incident, so that an appropriate response can be executed by the person to reduce or eliminate the number of falls experienced. The apparatus includes a platform that delivers a disturbance event in less than about 500 ms and preferably in the range of about 100 ms to about 200 ms. The method includes a unique protocol for fall prevention training using the apparatus. The disturbance event can create instability in the joint of the individual. An individual's walking gait can be monitored with the portions thereof detected. A disturbance event can be triggered when a given portion of the walking gait is detected. Also, the disturbance even can be triggered manually, at preset intervals or according to preset script.",CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D;;SIMBEX LLC,CHU JEFFREY J;;GREENWALD RICHARD M;;JOHNSON DAVID D,SIMBEX LLC A LIMITED LIABILITY COMPANY OF NEW HAMPSHIRE (2011-07-13),https://lens.org/110-230-704-843-463,Patent Application,yes,0,13,4,6,0,A61B5/1038;;A61B5/1117;;A63B22/0235;;A63B24/0006;;A63B26/003;;A63B69/0053;;A63B69/0064;;A63B71/0622;;A63B2022/0278;;A63B2024/0009;;A63B2071/0636;;A63B2071/0638;;A63B2071/0655;;A63B2071/0683;;A63B2220/13;;A63B2220/16;;A63B2220/40;;A63B2220/51;;A63B2220/58;;A63B2220/801;;A63B2220/805;;A63B2220/806;;A63B2225/50;;A61H3/008;;A61H2201/1616;;A61H2201/1621;;A61H2201/1635;;A61H2201/164;;A63B22/0292;;A63B26/003;;A61B5/1117;;A63B24/0006;;A63B2024/0009;;A63B69/0053;;A63B2071/0683;;A63B71/0622;;A63B2022/0278;;A63B2220/16;;A61B5/1038;;A63B2220/801;;A63B2220/13;;A63B2220/806;;A63B2071/0655;;A63B2225/50;;A63B69/0064;;A63B2220/40;;A63B22/0235;;A63B2220/58;;A63B2220/805;;A63B2220/51;;A63B2071/0636;;A63B2071/0638;;A61H2201/164;;A61H2201/1621;;A61H2201/1616;;A61H3/008;;A61H2201/1635;;A63B22/0292,A63B22/02;;A63B24/00;;A63B71/00,482/4;;482/8;;482/54,0,0,,,,ACTIVE
66,EP,A4,EP 0426811 A4,010-689-015-167-950,1992-06-24,1992,EP 90907867 A,1990-04-25,US 34294389 A,1989-04-25,BEVERAGE DISPENSER WITH INTERCONNECTED SYNTHETIC RESIN EXTERIOR PANELS,,EBCO MANUFACTURING COMPANY,"CHANEY, DAVID B.;;GREENWALD, RONALD I.;;THOMAS, MARC M.",,https://lens.org/010-689-015-167-950,Search Report,no,0,0,6,6,0,B67B1/00;;B67D1/06;;B67D2210/00039,B67D1/00;;B67D1/06,,2,0,,,No further relevant documents disclosed;;See also references of WO 9012752A1,DISCONTINUED
67,MX,A,MX 2008014865 A,182-943-068-027-108,2009-06-30,2009,MX 2008014865 A,2007-05-23,US 43828906 A;;US 2007/0012212 W,2006-05-23,METHOD AND APPARATUS FOR MULTILINGUAL SPELLING CORRECTIONS.,"A system and method for multilingual spelling corrections employs a lexicon builder, which uses a metadata build process that extracts all words from the data source with which a user will be working, along with their frequencies, to build a lexicon file using the data source; and a spell checker algorithm, which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against it to determine a correct spelling or other spelling variant for the user to select.",LEXISNEXIS A DIVISION OF REED,GREENWALD CHARLES;;HILTON DAVID;;NAYFELD VLADIMIR;;YOUNG KEITH D,,https://lens.org/182-943-068-027-108,Patent Application,no,0,0,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F40/00;;G06F17/21,,0,0,,,,ACTIVE
68,CA,A1,CA 2031533 A1,033-249-088-829-500,1990-10-26,1990,CA 2031533 A,1990-04-25,US 34294389 A,1989-04-25,BEVERAGE DISPENSER WITH INTERCONNECTED SYNTHETIC RESIN EXTERIOR PANELS,"2031533 9012752 PCTABS00002 The invention relates to beverage dispensing apparatus adapted to support a readily replacable drinking water container. The prior art dispensers, which were typically constructed of sheet metal, were limited in cost effective exterior configurations, expensive, and required maintenance. The invention solves these problems by providing a dispensing apparatus constructed of synthetic resin, load-bearing vertical panels that are readily assembled. Load-bearing, synthetic resin vertical panels (33-35) and horizontal top (32) are integrally formed with cooperative, interlocking fasteners (34A-35G) which hold the panels and top in edgewise abutment with one another. The front (33) and opposing side (34) vertical panels are adapted for use on both room temperature and chilled water dispensers. The room temperature dispenser is additionally provided with a rear vertical panel (35), and the chilled water dispenser employs a pair of laterally spaced apart rear corner panels. The panels are molded to support a water reservoir (36) therein.",EBCO MFG CO,CHANEY DAVID B;;GREENWALD RONALD I;;THOMAS MARC M,,https://lens.org/033-249-088-829-500,Patent Application,no,0,0,6,6,0,B67B1/00;;B67D1/06;;B67D2210/00039,B67D1/00;;B67D1/06,D122200081   M,0,0,,,,DISCONTINUED
69,EP,A1,EP 0904312 A1,066-666-593-851-770,1999-03-31,1999,EP 97932248 A,1997-06-23,US 9710873 W;;US 66876196 A,1996-06-24,LIQUID CRYSTALLINE POLY(ESTER-AMIDES),,DU PONT,PLOTZKER IRENE GREENWALD;;CITRON JOEL DAVID;;WAGGONER MARION GLEN,"TICONA LLC, FLORENCE, US (2012-04-23)",https://lens.org/066-666-593-851-770,Patent Application,yes,0,0,11,11,0,C09K19/3809;;C09K19/3809;;C08G69/44;;C08G69/44,C08G69/44;;C09K19/38,,1,0,,,See references of WO 9749753A1,EXPIRED
70,US,A1,US 2005/0282786 A1,164-803-379-825-759,2005-12-22,2005,US 51953405 A,2005-08-04,US 39546602 P;;US 0321740 W;;US 51953405 A,2002-07-12,Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations,"The present invention is for a method for decreasing C-reactive protein levels (CRP) in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial amount of an antibacterial tetracycline. In another embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial tetracycline.",BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT,RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK THE (2005-06-28);;MONTEFIORE MEDICAL CENTER (2005-07-28),https://lens.org/164-803-379-825-759,Patent Application,yes,5,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,514/152,0,0,,,,DISCONTINUED
71,US,B1,US 11252160 B1,081-921-513-328-517,2022-02-15,2022,US 202017077085 A,2020-10-22,US 202017077085 A,2020-10-22,Artificial intelligence software access bundling,"Artificial intelligence (“AI”) systems and methods are provided for bundling software permissions across an enterprise organization. An AI engine may be deployed to maximize wellness of a software bundle. Maximizing the wellness may include adding a software permission to the bundle. Maximizing the wellness may include associating additional members with the bundle. Maximizing the wellness may include removing a software permission from the bundle. Maximizing the wellness may include disassociating a member from the bundle. The AI engine may streamline allocation of software permissions in an enterprise organization that would otherwise be unmanageable by human role engineers. For example, the AI engine may be deployed in enterprise organizations that utilize over 4,000 different software application across over 750,000 members. Utilizing the AI engine to streamline software permissions may limit exposure of the organization to an increased risk of a cyberattack on its information systems.",BANK OF AMERICA,PRITCHARD DAVID;;THOMAS TINKU;;GOPINATHAPAI RAJESH M;;GREENWALD JENNIFER LYNN,BANK OF AMERICA CORPORATION (2020-10-15),https://lens.org/081-921-513-328-517,Granted Patent,yes,13,0,1,1,0,H04L63/104;;H04L63/145;;H04L63/105;;H04L63/104;;H04L41/16;;H04L67/34,H04L41/16;;H04L67/00,,2,1,173-393-636-590-522,10.53347/rid-75057,"“Jaccard Index,” https://en.wikipedia-org/wiki/Jaccard_index. Wikimedia Foundation, Inc., Sep. 6, 2020.;;“Understand Jaccard Index, Jaccard Similarity in Minutes,” https://medium.com/data-science-bootcamp/understand-jaccard-index-jaccard-similarity-in-minutes-2Sa703fbf9d7, Data Science Bootcamp, Aug. 20, 2020.",ACTIVE
72,US,A1,US 2001/0022719 A1,043-751-597-980-758,2001-09-20,2001,US 79022101 A,2001-02-21,US 79022101 A;;US 12766298 A,1998-07-31,Case for a modular tablet computer system,"
   A computer housing or case contains computer system components including a display unit, a processor, and a computer power supply unit. One or more handles are positioned at a side of the case to allow a user to hold the encased computer system while viewing the display. A case has a support interface structure to hold the case steady in an upright position. The support interface structure of the case mates with a complimentary support interface in the weight-supporting base unit and mates with guides to align a power supply port in the case to contact a power supply port in the base unit. A base unit has a keyboard guide to receive a keyboard by lifting the keyboard above a support surface. A modular computer system comprises a tablet computer, a base unit, and a remote keyboard. A first infrared communication device couples the tablet computer to the remote keyboard and other input peripherals. A second infrared communication device couples the tablet computer to a remote printer. A radio frequency network adapter couples the tablet computer to the base unit, which provides additional communications to an external communications network. 
",ARMITAGE DAVID L.;;ROECKER DAVID;;GREENWALD JERRY;;KAPUSHION JOE;;KEEN JIM;;LEANDER RANDY,ARMITAGE DAVID L;;ROECKER DAVID;;GREENWALD JERRY;;KAPUSHION JOE;;KEEN JIM;;LEANDER RANDY,,https://lens.org/043-751-597-980-758,Patent Application,yes,0,75,2,2,0,G06F1/1698;;G06F1/1698;;G06F1/16;;G06F1/16;;G06F1/1626;;G06F1/1626;;G06F1/1632;;G06F1/1632;;G06F1/166;;G06F1/166;;G06F2200/1631;;G06F2200/1631,G06F1/16,361/681,0,0,,,,DISCONTINUED
73,US,A,US 6157958 A,105-162-871-964-358,2000-12-05,2000,US 12754798 A,1998-07-31,US 12754798 A,1998-07-31,Modular tablet computer system,"A computer housing or case contains computer system components including a display unit, a processor, and a computer power supply unit. One or more handles are positioned at a side of the case to allow a user to hold the encased computer system while viewing the display. A case has a support interface structure to hold the case steady in an upright position. The support interface structure of the case mates with a complimentary support interface in the weight-supporting base unit and mates with guides to align a power supply port in the case to contact a power supply port in the base unit. A base unit has a drawer guide to receive a keyboard by lifting the keyboard above a support surface. A modular computer system comprises a tablet computer, a base unit, and a remote keyboard. A first infrared communication device couples the tablet computer to the remote keyboard and other input peripherals. A second infrared communication device couples the tablet computer to a remote printer. A radio frequency network adapter couples the tablet computer to the base unit, which provides additional communications to an external communications network.",QUBIT LLC,ARMITAGE DAVID L;;ROECKER DAVID;;GREENWALD JERRY;;KAPUSHION JOE;;KEEN JIM;;LEANDER RANDY,QUBIT LLC (1998-07-30);;ADT SERVICES AG (2001-12-14),https://lens.org/105-162-871-964-358,Granted Patent,yes,5,99,1,1,0,G06F1/1626;;G06F1/1632;;G06F1/166;;G06F1/1698;;G06F1/1698;;G06F1/166;;G06F1/1626;;G06F1/1632,G06F1/16,709/250,0,0,,,,EXPIRED
74,US,B1,US 6282082 B1,024-625-701-795-784,2001-08-28,2001,US 12766298 A,1998-07-31,US 12766298 A,1998-07-31,Case for a modular tablet computer system,"A computer housing or case contains computer system components including a display unit, a processor, and a computer power supply unit. One or more handles are positioned at a side of the case to allow a user to hold the encased computer system while viewing the display. A case has a support interface structure to hold the case steady in an upright position. The support interface structure of the case mates with a complimentary support interface in the weight-supporting base unit and mates with guides to align a power supply port in the case to contact a power supply port in the base unit. A base unit has a keyboard guide to receive a keyboard by lifting the keyboard above a support surface. A modular computer system comprises a tablet computer, a base unit, and a remote keyboard. A first infrared communication device couples the tablet computer to the remote keyboard and other input peripherals. A second infrared communication device couples the tablet computer to a remote printer. A radio frequency network adapter couples the tablet computer to the base unit, which provides additional communications to an external communications network.",QUBIT LLC,ARMITAGE DAVID L;;ROECKER DAVID;;GREENWALD JERRY;;KAPUSHION JOE;;KEEN JIM;;LEANDER RANDY,QUBIT LLC (1998-07-30);;ADT SERVICES AG (2001-12-14),https://lens.org/024-625-701-795-784,Granted Patent,yes,10,231,2,2,0,G06F1/1698;;G06F1/1698;;G06F1/16;;G06F1/16;;G06F1/1626;;G06F1/1626;;G06F1/1632;;G06F1/1632;;G06F1/166;;G06F1/166;;G06F2200/1631;;G06F2200/1631,G06F1/16,361/681;;361/683;;345/169;;312/223.2,13,0,,,"Lucent Technologies, WaveLan Wireless Computing (visited Jun. 5, 1998) <http://www.wavelan.com/about/about.htm>.;;Lucent Technologies, WaveLan Wireless Computing (visited Jun. 5, 1998) <http://www.wavelan.com/about/wlconfig.htm>.;;Lucent Technologies, WaveLan Wireless Computing (visited Jun. 8, 1998) <http://www.wavelan.com/>.;;Honeywell, Honeywell Consumer Products: Parts and Accessories Finder, Model No. S7350A Honeywell WebPAD(R) Internet Appliance,http://hcpretail.Honeywell.com/HCP_Store/catalog/product display (3pp.); User Guide (43 pp.).;;Honeywell, ""Introducing the Honeywell WebPAD(R) Internet Appliance""; http://content.honeywell.com80/My Home/webpad/webpad_faq.htm (8 pp.).;;Your Home Expert -Honeywell's Webpad, http://content.Honeywell.com/yourhome/webpad/webpad_faq.htm (4 pp.).;;Sony Computing Products: SDM-N50PS Computer Display, 10/24/00, http://www.ita.sel.sony.com/products/displays/led/sdmn50ps.htm (5 pp.).;;Hitachi ePlate HPW-630ETR, http://www.Hitachi.com/products/informa...timedia/handheld3/halp-ZZZDTISNQ7C.htm (5 pp.) with Overview of Handheld PCs (22 pp.).;;Palm, ""Simplicity, Function and Fun"", m100 Handheld product description (2 pp.).;;Gateway, Handheld product description, http://www.gateway.com/promotion/handheld/spec, (2 pp.).;;Compaq, Pocket PC product features and description, wysiwyg://77/http://www5.Compaq.com/products/handhelds/pocketpc/features, (28 pp.).;;epods Internet service, http://www.epods.com/ (4 pp.).;;ergo(R) by 3COM(R), products meet Audrey, computer site, product and accessory description, http://ergo.3com.com/ergo/htm/homepage.htm (4 pp.).",EXPIRED
75,US,A1,US 2007/0276653 A1,127-744-579-767-654,2007-11-29,2007,US 43828906 A,2006-05-23,US 43828906 A,2006-05-23,Method and apparatus for multilingual spelling corrections,"A system and method for multilingual spelling corrections employs a lexicon builder, which uses a metadata build process that extracts all words from the data source, along with their frequencies, to build a lexicon file using the data source with which a user will be working; and a spell checker algorithm, which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against the input word to determine a correct spelling or other spelling variant for the user to select.",GREENWALD CHARLES M;;HILTON DAVID E;;NAYFELD VLADIMIR;;YOUNG KEITH D,GREENWALD CHARLES M;;HILTON DAVID E;;NAYFELD VLADIMIR;;YOUNG KEITH D,LEXISNEXIS A DIVISION OF REED ELSEVIER INC (2006-05-18);;RELX INC (2015-09-16),https://lens.org/127-744-579-767-654,Patent Application,yes,20,27,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F40/00;;G06F17/21,704/10,0,0,,,,ACTIVE
76,EP,A4,EP 1531830 A4,143-180-010-611-689,2007-09-05,2007,EP 03764515 A,2003-07-11,US 0321740 W;;US 39546602 P,2002-07-12,METHOD FOR REDUCING C-RECTIVE PROTEIN LEVELS WITH NON-ANTIBACTERIAL TETRACYCLINE FORMULATIONS,,UNIV NEW YORK STATE RES FOUND,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT A,,https://lens.org/143-180-010-611-689,Search Report,no,2,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,3,2,003-579-470-367-603;;123-188-477-790-546,10.1016/0162-3109(95)00041-0;;8861742;;10.1177/003693300004500601;;11216304,"KLOPPENBURG MARGREET ET AL: ""Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline"", IMMUNOPHARMACOLOGY, vol. 31, no. 2-3, 1996, pages 163 - 169, XP009087609, ISSN: 0162-3109;;KHOGALI S E O ET AL: ""Should antibiotics now be part of routine treatment of coronary heart disease?"", SCOTTISH MEDICAL JOURNAL, vol. 45, no. 6, December 2000 (2000-12-01), pages 163 - 166, XP009087611, ISSN: 0036-9330;;See also references of WO 2004006938A1",DISCONTINUED
77,WO,A1,WO 2004/006938 A1,147-611-220-001-798,2004-01-22,2004,US 0321740 W,2003-07-11,US 39546602 P,2002-07-12,METHOD FOR REDUCING C-RECTIVE PROTEIN LEVELS WITH NON-ANTIBACTERIAL TETRACYCLINE FORMULATIONS,"The present invention is for a method for decreasing C-reactive protein levels (CRP) in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial amount of an antibacterial tetracycline. In another embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial tetracycline.",UNIV NEW YORK STATE RES FOUND;;BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT A,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT A,,https://lens.org/147-611-220-001-798,Patent Application,yes,1,3,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,0,0,,,,PENDING
78,NZ,A,NZ 538198 A,101-855-896-169-12X,2006-11-30,2006,NZ 53819803 A,2003-07-11,US 39546602 P;;US 0321740 W,2002-07-12,Method for reducing C-reactive protein (CRP) levels by administering a non-antibacterial tetracycline formulation or a low dose of an antibacterial tetracycline formulation,"Described is a method for decreasing C-reactive protein (CRP) levels in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial amount of an antibacterial tetracycline. In another embodiment, the non-antibacterial tetracycline formulation is a chemically-modified non-antibacterial tetracycline (CMT).",UNIV NEW YORK STATE RES FOUND;;MONTEFIORE MEDICAL CT,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT A,"THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF, US (2006-09-29);;MONTEFIORE MEDICAL CENTER, US (2006-09-29)",https://lens.org/101-855-896-169-12X,Patent Application,no,0,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,0,0,,,,PENDING
79,AU,A1,AU 2003/256496 A1,086-048-203-138-927,2004-02-02,2004,AU 2003/256496 A,2003-07-11,US 39546602 P;;US 0321740 W,2002-07-12,METHOD FOR REDUCING C-RECTIVE PROTEIN LEVELS WITH NON-ANTIBACTERIAL TETRACYCLINE FORMULATIONS,,UNIV NEW YORK STATE RES FOUND,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT A,,https://lens.org/086-048-203-138-927,Patent Application,no,0,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,0,0,,,,DISCONTINUED
80,CA,A1,CA 2491655 A1,196-632-934-914-572,2004-01-22,2004,CA 2491655 A,2003-07-11,US 39546602 P;;US 0321740 W,2002-07-12,METHOD FOR REDUCING C-RECTIVE PROTEIN LEVELS WITH NON-ANTIBACTERIAL TETRACYCLINE FORMULATIONS,"The present invention is for a method for decreasing C-reactive protein leve ls (CRP) in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial amount of an antibacterial tetracycline. In another embodiment, the non-antibacterial tetracycline formulation is a non- antibacterial tetracycline.",UNIV NEW YORK STATE RES FOUND,BROWN DAVID;;GREENWALD ROBERT A;;LEE HSI-MING;;GOLUB LORNE M,,https://lens.org/196-632-934-914-572,Patent Application,no,0,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,0,0,,,,DISCONTINUED
81,US,B2,US 7558725 B2,153-423-813-922-778,2009-07-07,2009,US 43828906 A,2006-05-23,US 43828906 A,2006-05-23,Method and apparatus for multilingual spelling corrections,"A system and method for multilingual spelling corrections employs a lexicon builder, which uses a metadata build process that extracts all words from the data source, along with their frequencies, to build a lexicon file using the data source with which a user will be working; and a spell checker algorithm, which determines the correct spelling of words used as input for a search of the data source by calculating a score value for words in the lexicon file according to a formula that distinguishes similarity between the input word from the user's search request and words contained in the lexicon file; and then rates the frequency of the input word against the words contained in the lexicon file. When a user inputs a word, words in the lexicon file are scored against the input word to determine a correct spelling or other spelling variant for the user to select.",LEXISNEXIS A DIVISION OF REED,GREENWALD CHARLES M;;HILTON DAVID E;;NAYFELD VLADIMIR;;YOUNG KEITH D,LEXISNEXIS A DIVISION OF REED ELSEVIER INC (2006-05-18);;RELX INC (2015-09-16),https://lens.org/153-423-813-922-778,Granted Patent,yes,20,51,11,11,0,G06F16/3322;;G06F40/232;;G06F40/242;;G06F16/3322;;G06F40/232;;G06F40/242,G06F40/00,704/1;;704/10;;704/9,2,2,010-924-044-244-65X;;115-154-779-532-862,10.1145/146370.146380;;10.1002/spe.4380250307,"K. Kukich, ""Techniques for automically correcting words in text,"" ACM Comput. Surveys 24 4 (1992).;;Zobel and Dart, ""Finding approximate matches in large lexicons,"" Software-Practice and Experience 25 3 (1994), pp. 331-345.",ACTIVE
82,KR,A,KR 20050034713 A,048-423-349-394-134,2005-04-14,2005,KR 20057000506 A,2005-01-11,US 39546602 P,2002-07-12,METHOD FOR REDUCING C-REACTIVE PROTEIN LEVELS WITH NON-ANTIBACTERIAL TETRACYCLINE FORMULATIONS,"The present invention is for a method for decreasing C-reactive protein levels (CRP) in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial amount of an antibacterial tetracycline. In another embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial tetracycline.",UNIV NEW YORK STATE RES FOUND,BROWN DAVID;;GOLUB LORNE M;;GREENWALD ROBERT A;;LEE HSI-MING,,https://lens.org/048-423-349-394-134,Patent Application,no,0,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61K31/65;;A61P1/02;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,0,0,,,,DISCONTINUED
83,US,A1,US 2002/0171546 A1,160-620-820-364-969,2002-11-21,2002,US 12410402 A,2002-04-17,US 12410402 A;;US 28453601 P,2001-04-18,"Universal, customizable security system for computers and other devices","
   A universal, customizable computer security system including a set of security input signals each relating to a possible security event and a rules engine with a universal software interface responsive to the security input signals. The rules engine is configurable to perform one or more security actions in response to each security input signal. The rules engine further includes a user interface program to allow a user to select one or more customized security actions for a combination of one or more chosen security input signals, and a universal software output interface responsive to the selected security actions. 
",EVANS THOMAS P.;;LEE W. DAVID;;GREENWALD C. GAIL;;VERPLAETSE CHRISTOPHER,EVANS THOMAS P;;LEE W DAVID;;GREENWALD C GAIL;;VERPLAETSE CHRISTOPHER,CAVEO TECHNOLOGY LLC (2002-07-02),https://lens.org/160-620-820-364-969,Patent Application,yes,4,294,2,2,0,G06F21/554;;G06F21/554;;G06F21/57;;G06F21/57;;G06F21/88;;G06F21/88,G06F21/00;;H04L9/10,34054;;340/568.1;;340/571;;340/5.2;;340/5.8;;340/5.85;;713/182,0,0,,,,DISCONTINUED
84,EP,A1,EP 1531830 A1,168-376-184-916-599,2005-05-25,2005,EP 03764515 A,2003-07-11,US 0321740 W;;US 39546602 P,2002-07-12,METHOD FOR REDUCING C-RECTIVE PROTEIN LEVELS WITH NON-ANTIBACTERIAL TETRACYCLINE FORMULATIONS,,RES FOUNDATION OFSTATE UNIVERS,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT A,,https://lens.org/168-376-184-916-599,Patent Application,yes,0,0,9,9,0,A61K31/65;;A61P1/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P9/10;;A61K31/65;;A61K31/65,A61P1/02;;A61K31/65;;A61P9/10;;A61P11/06;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,0,0,,,,DISCONTINUED
85,WO,A1,WO 2002/087152 A1,051-382-638-972-797,2002-10-31,2002,US 0211955 W,2002-04-17,US 28453601 P,2001-04-18,"UNIVERSAL, CUSTOMIZABLE SECURITY SYSTEM FOR COMPUTERS AND OTHER DEVICES","A universal, customizable computer security system (50) including a set of security input signals (52) each relating to a possible security event and a rules engine (72) with a universal software interface (74) responsive to the security input signals (54-70). The rules engine (72) is configurable to perform one or more security actions (76-92) in response to each security input signal (54-70). The rules engine (72) further includes a user interface program (94) to allow a user to select one or more customized security actions for a combination of one or more chosen security input signals (54-70) and a universal software output interface (75) responsive to the selected security actions (76-92).",CAVEO TECHNOLOGY LLC,EVANS THOMAS P;;LEE DAVID W;;GREENWALD GAIL C;;VERPLAETSE CHRISTOPHER,,https://lens.org/051-382-638-972-797,Patent Application,yes,7,0,2,2,0,G06F21/554;;G06F21/554;;G06F21/57;;G06F21/57;;G06F21/88;;G06F21/88,G06F21/00;;H04L9/10,,3,0,,,"LEON MARK: ""Distributed management tools mature: Tivoli improves console GUI"", INFOWORLD, 28 August 1995 (1995-08-28), SAN MATEO, pages 1 - 2, XP002957722;;ANONYMOUS: ""Java beans shake up component software world"", COMPUTER RESELLER NEWS, 28 October 1996 (1996-10-28), MANHASSET, pages 1 - 9, XP002957721;;""Signal processing provides time-saving system-level event trace tool for developing parallel DSP applications: New event trace tool enhances real-time debug for SHARC-based applications"", BUSINESS WIRE, 3 November 1998 (1998-11-03), NEW YORK, pages 1 - 2, XP002957720",PENDING
86,US,A1,US 2002/0043137 A1,033-538-011-224-74X,2002-04-18,2002,US 97501701 A,2001-10-12,US 97501701 A;;US 23990900 P,2000-10-13,Brake lathe suspension arm,"
   An articulated arm assembly adapted to carry machine means comprising a first member, a second member pivotally connected at one end thereof to said first member for pivotal movement thereabout, a third member extending outwardly from another end of said second member, said third member including means for connection to said machine means, means for adjusting the position of said machine means. 
",YEO HAROLD O.;;GREENWALD CHRISTOPHER L.;;HASTINGS JEFFREY P.;;COX DAVID E.,YEO HAROLD O;;GREENWALD CHRISTOPHER L;;HASTINGS JEFFREY P;;COX DAVID E,,https://lens.org/033-538-011-224-74X,Patent Application,yes,0,14,2,8,0,B23B5/04;;B25J9/026;;B25J9/042;;B66C23/20;;B66F7/26;;Y10T82/25;;Y10T82/21;;Y10T82/25;;Y10T82/21;;B25J9/042;;B66F7/26;;B66C23/20;;B23B5/04;;B25J9/026,B23B5/04;;B25J9/02;;B25J9/04;;B66C23/20;;B66F7/26,82/112;;82/117,0,0,,,,EXPIRED
87,US,B2,US 10945601 B2,094-423-466-326-841,2021-03-16,2021,US 201314042133 A,2013-09-30,US 201314042133 A;;US 32844506 A;;US 22588005 A;;US 99783204 A;;US 97456601 A;;US 64224005 P;;US 23937900 P;;US 60955504 P,2000-10-11,System and method for evaluating and providing treatment to sports participants,"The invention relates to a system and method for monitoring a physiological parameter of a player(s) from a larger group of players engaged in a contact sport. The system includes a helmet having a protective outer shell and an internal padding assembly, a portable signaling device, and a reporting unit positioned within the helmet. The reporting unit includes a sensor, a wireless transmitter and a control unit. The reporting unit has a flexible configuration to enable removable positioning within the helmet's internal padding assembly while maintaining overall comfort and fit of the helmet. The method involves monitoring impacts sustained by the specific player; computing impact results and comparing impact results to at least one impact-related threshold; defining an alert event when an impact result surpasses a predetermined threshold value; sending an alert from the reporting unit to the signaling device; and providing an impact assessment protocol on the signaling device.",RIDDELL,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,RIDDELL SPORTS GROUP INC (2006-04-13);;RIDDELL INC (2020-08-19),https://lens.org/094-423-466-326-841,Granted Patent,yes,117,1,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/00;;A61B5/11,,26,9,063-943-484-119-680;;099-459-811-348-272;;129-168-409-350-768;;065-355-132-165-351;;021-681-313-113-54X;;012-680-425-405-28X;;093-675-656-661-282;;118-155-698-872-850;;028-168-064-784-648,10.1207/s15324826an1001_6;;12734074;;10.1249/00005768-197323000-00021;;4747643;;5095335;;10.1249/00005768-197100310-00008;;10.1109/51.775490;;10429903;;10.1177/036354657400200204;;1186180;;10.1115/1.3423640;;10.1152/jn.1998.79.4.2025;;9535966;;10.1117/12.317434;;10.1097/00005373-200005000-00020;;10823540,"Schatz, P., et al., “Computer-Based Assessment of Sports-Related Concussion”, Applied Neuropsychology, 2003, vol. 10, No. 1, pp. 42-47.;;Murray, C., Smart Helmets Monitor Football Injuries, Dec. 18, 2003, Embedded.com.;;Merono et al., Movement Evaluator System Via R.F. Transmission, 1995 IEEE, pp. 94-97.;;Coleman et al., Ambient Head Temperature and Football Helmet Design, Mar. 1972, Medicine, Science, Exercise and Sports Journal, 19 pp.;;Moon et al., Peak Head Acceleration of Athletes during Competition—Football, Spring 1971, Medicine and Science in Sports,vol. 3, No. 1, pp. 44-50.;;Bai et al., A Portable ECG and Blood Pressure Telemonitoring System, Jul./Aug. 1999, IEEE Engineering in Medicine and Biology, pp. 63-70.;;Puers et al., A Telemetry System for the Detection of Hip Prosthesis Loosening by Vibration Analysis, Aug. 25, 2000, Sensors and Actuators, vol. 85, pp. 42-47.;;Reid et al., Head Protection in Football, Sports Medicine, Mar./Apr. 1974, pp. 86-92.;;Padgaonkar et al., Measurement of Angular Acceleration of a Rigid Body Using Linear Accelerometers, Journal of Applied Mechanics, Sep. 1975, pp. 552-556.;;Medendorp et al., Off-centric Rotation Axes in Natural Head Movements: Implications for Vestibular Reafference and Kinematic Redundancy, The American Physiological Society, 1998, pp. 2025-2039.;;Foxlin et al., Miniature 6-DOF Inertial System for Tracking HMDs, SPIE, Helmet and Head-Mounted Displays III, AeroSense 98, vol. 3362.;;King et al., Mechanics of the Head/Neck. The Biomedical Engineering Handbook: Second Edition. Dec. 28, 1999. CRC Press LLC. pp. 23-1:23-12.;;Naunheim et al., Comparison of Impact Data in Hockey, Football, and Soccer. Journal of Trauma and Acute Care Surgery 48.5, 2000, pp. 938-941.;;Gibilisco, ed. Encode, The Illustrated Dictionary of Electronics. McGraw-Hill. 2001. Eighth edition. p. 257.;;International Search Report for PCT/US2005/032903 dated Mar. 10, 2006.;;International Search Report for PCT/US2006/000536 dated Oct. 2, 2006.;;International Search Report for PCT/US2006/000536 dated Jul. 10, 2007.;;Declaration from Nelson Kraemer regarding the discovery of the Radio Telemetry Project materials, Dec. 5, 2017 (2 pages).;;Report No. 1062—Radio Telemetry Project, Progress Report No. 1, Jun. 9, 1964 (253 ages).;;Report No. 1062—Radio Telemetry Project, Appendix A-C, Apr. 1963 (115 pages).;;Report No. 1062—Radio Telemetry Project, Appendix D, Book 1, 1964 (108 pages).;;Report No. 1062—Radio Telemetry Project, Appendix D, 1963 (159 pages).;;Radio Telemetry Project Test Data, Aug. 25, 1964 (24 pages).;;Radio Station License for Radio Telemetry Project, Jul. 7, 1965 (2 pages).;;Operating Instructions for Radio Telemetry System, Apr. 1967 (10 pages).;;Various Photographs related to Radio Telemetry Project, Oct. 1966 (84 pages).",EXPIRED
88,WO,A3,WO 2006/074411 A3,191-078-123-661-973,2006-12-07,2006,US 2006/0000536 W,2006-01-09,US 64224005 P,2005-01-07,SYSTEM AND METHOD FOR EVALUATING AND PROVIDING TREATMENT TO SPORTS PARTICIPANTS,"The application relates to a system (10) for monitoring a physiological parameter of players engaged in a sports activity. The application further relates to a method for evaluating and treating players when the parameter exceeds a predetermined level. The system measures, calculates and records the parameter and then alerts trained personnel to apply the method to evaluate and treat players. When the system is configured for use with football, hockey or lacrosse, the system generally includes reporting units (20), a sideline controller (40), a database, and a signaling device (60), such as a wireless personal digital assistant (64) . The physiological parameter data measured and collected by the reporting units are processed by the sideline controller for meaningful analysis or use. When the physiological parameter (s) exceeds a predetermined threshold level the sideline controller generates an alert that is received by the signaling device. The signaling device includes software that prompts the sideline personnel to perform the method through a series of interactive steps and tests. The signaling device prompts the personnel to conduct the appropriate sideline examination, records the responses, compares the results to established baselines and prompts further testing, a return to play decision, or a no-play decision.",RIDDELL;;GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,,https://lens.org/191-078-123-661-973,Search Report,yes,5,0,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/11;;A42B3/04;;A63B71/10,,0,0,,,,PENDING
89,US,A1,US 2003/0149919 A1,150-979-866-552-306,2003-08-07,2003,US 25890802 A,2002-10-29,US 25890802 A;;US 20229600 P;;US 20229800 P;;US 20229900 P;;US 0114618 W,2000-05-05,Systems and methods for diagnosing faults in computer networks,"
    A network management system ( 10 ) includes a fault diagnosis system ( 12 ) connectable to a communications network ( 20 ). The fault diagnosis system includes a fault object factory, a path determination module, and a fault diagnosis engine. The fault object factory is constructed and arranged to receive fault data and create fault objects. The path determination module is constructed to determine, in a communications network, a path related to the fault data. The fault diagnosis engine is constructed to perform, using the determined path, a fault analysis on the fault data to diagnose a fault related to the communications network. The network management may also include a help desk system ( 18 ), a topology mapper ( 14 ) or an impact analyzer ( 16 ). 
",GREENWALD JOSEPH;;BALL SCOTT;;BUIA CHRISTOPHER;;CARON JONATHAN P.;;TAYLOR DAVID K.,GREENWALD JOSEPH;;BALL SCOTT;;BUIA CHRISTOPHER;;CARON JONATHAN P;;TAYLOR DAVID K,APRISMA MANAGEMENT TECHNOLOGIES INC (2004-10-29);;COMPUTER ASSOCIATES THINK INC (2007-02-08);;CONCORD COMMUNICATIONS INC (2007-02-08),https://lens.org/150-979-866-552-306,Patent Application,yes,98,203,2,21,0,G06F11/2257;;G06F11/2257,G06F11/25;;H02H3/05,714/43,0,0,,,,EXPIRED
90,US,A1,US 2002/0066341 A1,075-208-590-310-088,2002-06-06,2002,US 73125800 A,2000-12-06,US 73125800 A,2000-12-06,Brake lathe station,"
   An improved brake lathe station has an on-vehicle brake lathe and a lift with one or more support posts for raising a vehicle. A support structure is provided to support the lathe while allowing it to be moved with respect to a horizontal plane about the vehicle to assist the lathe operator in positioning the lathe with respect to wheel hubs of the vehicle. The lathe is preferably connected to the support structure by an adjustable coupling which allows vertically tilting a lathe rotation axis of the lathe, as well as allowing rotation of the lathe substantially about its lathe rotation axis. Preferably, the lathe can also be moved with respect to a vertical plane. To prevent transmission of vibrations during the machining process, it is preferred for the lathe to be floated with respect to the support structure while the lathe is mounted on the wheel hub. The coupling can be designed to allow attaching a dolly to the lathe while it is still supported by the support structure, and to allow the lathe thereafter to be released from the support structure so the lathe can be moved on the dolly. 
",GREENWALD CHRISTOPHER L.;;HASTINGS JEFFREY P.;;YEO HAROLD O.;;COX DAVID E.,GREENWALD CHRISTOPHER L;;HASTINGS JEFFREY P;;YEO HAROLD O;;COX DAVID E,PRO-CUT LICENSING LLC (2002-12-03);;WHEELTRONIC LTD (2003-02-17),https://lens.org/075-208-590-310-088,Patent Application,yes,0,3,4,8,0,B23B5/04;;Y10T82/2522;;Y10T82/21;;Y10T82/2522;;Y10T82/21;;B23B5/04,B23B5/04,82/112;;82/128,0,0,,,,EXPIRED
91,US,B2,US 7237138 B2,110-451-728-075-285,2007-06-26,2007,US 25890802 A,2002-10-29,US 25890802 A;;US 20229600 P;;US 20229800 P;;US 20229900 P;;US 0114618 W,2000-05-05,Systems and methods for diagnosing faults in computer networks,"A network management system ( 10 ) includes a fault diagnosis system ( 12 ) connectable to a communications network ( 20 ). The fault diagnosis system includes a fault object factory, a path determination module, and a fault diagnosis engine. The fault object factory is constructed and arranged to receive fault data and create fault objects. The path determination module is constructed to determine, in a communications network, a path related to the fault data. The fault diagnosis engine is constructed to perform, using the determined path, a fault analysis on the fault data to diagnose a fault related to the communications network. The network management may also include a help desk system ( 18 ), a topology mapper ( 14 ) or an impact analyzer ( 16 ).",COMPUTER ASS THINK INC,GREENWALD JOSEPH;;BALL SCOTT;;BUIA CHRISTOPHER;;CARON JONATHAN P;;TAYLOR DAVID K,APRISMA MANAGEMENT TECHNOLOGIES INC (2004-10-29);;COMPUTER ASSOCIATES THINK INC (2007-02-08);;CONCORD COMMUNICATIONS INC (2007-02-08),https://lens.org/110-451-728-075-285,Granted Patent,yes,106,65,2,21,0,G06F11/2257;;G06F11/2257,G06F11/00;;G06F11/25;;H02H3/05,714/4,3,0,,,"Harry Newton, Newton's Telecom Dictionary, 2004, CMP Books, Twentieth Edition, p. 491.;;Microsoft Computer Dictionary, 2002, Microsoft Press, Fifth Edition, p. 291.;;Peregrine Systems Partners with Motive Communications to Offer IT Solutions that Enhance Employee Self-Service, 1999, Peregrine Systems, Inc., 4 pages.",EXPIRED
92,US,B2,US 8548768 B2,084-372-607-072-372,2013-10-01,2013,US 32844506 A,2006-01-09,US 32844506 A;;US 22588005 A;;US 99783204 A;;US 97456601 A;;US 64224005 P;;US 60955504 P;;US 23937900 P,2000-10-11,System and method for evaluating and providing treatment to sports participants,"The invention relates to a system for monitoring a physiological parameter of players engaged in a sports activity and a method for evaluating and treating players when the parameter exceeds a predetermined level. The system measures, calculates and records the parameter and then alerts trained personnel to apply the method to evaluate and treat players. When the system is configured for use with football, hockey or lacrosse, the system generally includes reporting units, a sideline controller, a database, and a signaling device, such as a wireless personal digital assistant. The physiological parameter data measured and collected by the reporting units are processed by the sideline controller for meaningful analysis or use. When the physiological parameter(s) exceeds a predetermined threshold level the sideline controller generates an alert that is received by the signaling device, which is typically worn by sideline personnel, such as coaching staff or trainers. After an alert occurs, the method for evaluating and treating a player is initiated.",GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M;;RIDDELL,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,RIDDELL SPORTS GROUP INC (2006-04-13);;RIDDELL INC (2007-09-11),https://lens.org/084-372-607-072-372,Granted Patent,yes,34,44,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,G01P15/00;;A61B5/103;;G08B23/00,702/141;;600/595;;340/573.1,7,3,065-355-132-165-351;;129-168-409-350-768;;099-459-811-348-272,10.1109/51.775490;;10429903;;5095335;;10.1249/00005768-197100310-00008;;10.1249/00005768-197323000-00021;;4747643,"Murray, C., smart Helmets Monitor Football Injuries, Dec. 18, 2003, Embedded.com.;;Puers et al., A Telemetry System for the Detection of Hip Prosthesis Loosening by Vibration Analysis, Aug. 25, 2000, Sensors and Actuators, vol. 85, pp. 42-47.;;Bai et al., A Portable ECG and Blood Pressure Telemonitoring System, Jul./Aug. 1999, IEEE Engineering in Medicine and Biology, pp. 63-70.;;Moon et al., Peak Head Acceleration of Athletes during Competition-Football, Spring 1971, Medicine and Science in Sports, vol. 3, No. 1, pp. 44-50.;;Merono et al., Movement Evaluator System Via R.F. Transmission, 1995 IEEE, pp. 94-97.;;Coleman et al., Ambient Head Temperature and Football Helmet Design, Mar. 1972, Medicine, Science, Exercise and Sports Journal, 19 pp.;;International Search Report for PCT/US2006/000536 mailed Oct. 2, 2006.",ACTIVE
93,MX,A,MX 2007008304 A,117-710-490-071-185,2008-01-18,2008,MX 2007008304 A,2006-01-09,US 64224005 P;;US 2006/0000536 W,2005-01-07,SYSTEM AND METHOD FOR EVALUATING AND PROVIDING TREATMENT TO SPORTS PARTICIPANTS.,"The invention relates to a system for monitoring a physiological parameter of players engaged in a sports activity. The invention further relates to a method for evaluating and treating players when the parameter exceeds a predetermined level. The system measures, calculates and records the parameter and then alerts trained personnel to apply the method to evaluate and treat players. When the system is configured for use with football, hockey or lacrosse, the system generally includes reporting units, a sideline controller, a database, and a signaling device, such as a wireless personal digital assistant. The physiological parameter data measured and collected by the reporting units are processed by the sideline controller for meaningful analysis or use. When the physiological parameter(s) exceeds a predetermined threshold level the sideline controller generates an alert that is received by the signaling device, which is typically worn by sideline personnel, such as coaching staff or trainers. After an alert occurs, the method for evaluating and treating a player is initiated. The signaling device includes software that prompts the sideline personnel to perform the method through a series of interactive steps and tests. The signaling device prompts the personnel to conduct the appropriate sideline examination, records the responses, compares the results to established baselines and prompts further testing, a return to play decision, or a no-play decision.",RIDDELL,IDE THAD M;;GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W,,https://lens.org/117-710-490-071-185,Patent Application,no,0,0,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/11;;A42B3/04;;A63B71/10,,0,0,,,,ACTIVE
94,WO,A2,WO 2006/074411 A2,089-346-878-837-050,2006-07-13,2006,US 2006/0000536 W,2006-01-09,US 64224005 P,2005-01-07,SYSTEM AND METHOD FOR EVALUATING AND PROVIDING TREATMENT TO SPORTS PARTICIPANTS,"The application relates to a system (10) for monitoring a physiological parameter of players engaged in a sports activity. The application further relates to a method for evaluating and treating players when the parameter exceeds a predetermined level. The system measures, calculates and records the parameter and then alerts trained personnel to apply the method to evaluate and treat players. When the system is configured for use with football, hockey or lacrosse, the system generally includes reporting units (20), a sideline controller (40), a database, and a signaling device (60), such as a wireless personal digital assistant (64) . The physiological parameter data measured and collected by the reporting units are processed by the sideline controller for meaningful analysis or use. When the physiological parameter (s) exceeds a predetermined threshold level the sideline controller generates an alert that is received by the signaling device. The signaling device includes software that prompts the sideline personnel to perform the method through a series of interactive steps and tests. The signaling device prompts the personnel to conduct the appropriate sideline examination, records the responses, compares the results to established baselines and prompts further testing, a return to play decision, or a no-play decision.",RIDDELL;;GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,,https://lens.org/089-346-878-837-050,Patent Application,yes,0,7,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A42B3/04;;A61B5/11;;A63B71/10,,0,0,,,,PENDING
95,US,A1,US 2014/0039354 A1,029-407-909-597-513,2014-02-06,2014,US 201314042133 A,2013-09-30,US 201314042133 A;;US 32844506 A;;US 22588005 A;;US 99783204 A;;US 97456601 A;;US 64224005 P;;US 23937900 P;;US 60955504 P,2000-10-11,SYSTEM AND METHOD FOR EVALUATING AND PROVIDING TREATMENT TO SPORTS PARTICIPANTS,"The invention relates to a system and method for monitoring a physiological parameter of a player(s) from a larger group of players engaged in a contact sport. The system includes a helmet having a protective outer shell and an internal padding assembly, a portable signaling device, and a reporting unit positioned within the helmet. The reporting unit includes a sensor, a wireless transmitter and a control unit. The reporting unit has a flexible configuration to enable removable positioning within the helmet's internal padding assembly while maintaining overall comfort and fit of the helmet. The method involves monitoring impacts sustained by the specific player; computing impact results and comparing-impact results to at least one impact-related threshold; defining an alert event when an impact result surpasses a predetermined threshold value; sending an alert from the reporting unit to the signaling device; and providing an impact assessment protocol on the signaling device.",RIDDELL,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,RIDDELL SPORTS GROUP INC (2006-04-13);;RIDDELL INC (2020-08-19),https://lens.org/029-407-909-597-513,Patent Application,yes,26,23,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/00;;A61B5/11,600/595,1,1,063-943-484-119-680,10.1207/s15324826an1001_6;;12734074,"Schatz, P., et al., ""Computer-Based Assessment of Sports-Related Concussion"", Applied Neuropsychology, 2003, Vol. 10, No. 1, pages 42-47.",EXPIRED
96,US,A1,US 2006/0189852 A1,164-813-027-673-148,2006-08-24,2006,US 32844506 A,2006-01-09,US 32844506 A;;US 22588005 A;;US 99783204 A;;US 97456601 A;;US 64224005 P;;US 60955504 P;;US 23937900 P,2000-10-11,System and method for evaluating and providing treatment to sports participants,"The invention relates to a system for monitoring a physiological parameter of players engaged in a sports activity. The invention further relates to a method for evaluating and treating players when the parameter exceeds a predetermined level. The system measures, calculates and records the parameter and then alerts trained personnel to apply the method to evaluate and treat players. When the system is configured for use with football, hockey or lacrosse, the system generally includes reporting units, a sideline controller, a database, and a signaling device, such as a wireless personal digital assistant. The physiological parameter data measured and collected by the reporting units are processed by the sideline controller for meaningful analysis or use. When the physiological parameter(s) exceeds a predetermined threshold level the sideline controller generates an alert that is received by the signaling device, which is typically worn by sideline personnel, such as coaching staff or trainers. After an alert occurs, the method for evaluating and treating a player is initiated. The signaling device includes software that prompts the sideline personnel to perform the method through a series of interactive steps and tests. The signaling device prompts the personnel to conduct the appropriate sideline examination, records the responses, compares the results to established baselines and prompts further testing, a return to play decision, or a no-play decision.",GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,RIDDELL SPORTS GROUP INC (2006-04-13);;RIDDELL INC (2007-09-11),https://lens.org/164-813-027-673-148,Patent Application,yes,30,111,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/00;;A61B5/103,600/300;;600/595;;600/549;;128/903;;128/920,2,1,099-459-811-348-272,10.1249/00005768-197323000-00021;;4747643,"Merono et al., Movement Evaluator System Via R.F. Transmission, 1995 IEEE, Pages 94-97;;Coleman et al., Ambient Head Temperature and Football Helmet Design, March 1972, Medicine, Science, Exercise and Sports Journal, 19 pp.",EXPIRED
97,CA,C,CA 2590034 C,169-240-750-824-984,2016-03-22,2016,CA 2590034 A,2006-01-09,US 64224005 P;;US 2006/0000536 W,2005-01-07,SYSTEM AND METHOD FOR EVALUATING AND PROVIDING TREATMENT TO SPORTS PARTICIPANTS,"The application relates to a system (10) for monitoring a physiological parameter of players engaged in a sports activity. The application further relates to a method for evaluating and treating players when the parameter exceeds a predetermined level. The system measures, calculates and records the parameter and then alerts trained personnel to apply the method to evaluate and treat players. When the system is configured for use with football, hockey or lacrosse, the system generally includes reporting units (20), a sideline controller (40), a database, and a signaling device (60), such as a wireless personal digital assistant (64) . The physiological parameter data measured and collected by the reporting units are processed by the sideline controller for meaningful analysis or use. When the physiological parameter (s) exceeds a predetermined threshold level the sideline controller generates an alert that is received by the signaling device. The signaling device includes software that prompts the sideline personnel to perform the method through a series of interactive steps and tests. The signaling device prompts the personnel to conduct the appropriate sideline examination, records the responses, compares the results to established baselines and prompts further testing, a return to play decision, or a no-play decision.",RIDDELL,GREENWALD RICHARD M;;CHU JEFFREY J;;BERTONI DAVID W;;IDE THAD M,,https://lens.org/169-240-750-824-984,Granted Patent,no,0,0,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/11;;A42B3/04;;A63B71/10,,0,0,,,,ACTIVE
98,CA,A1,CA 2590034 A1,017-897-023-380-939,2006-07-13,2006,CA 2590034 A,2006-01-09,US 64224005 P;;US 2006/0000536 W,2005-01-07,SYSTEM AND METHOD FOR EVALUATING AND PROVIDING TREATMENT TO SPORTS PARTICIPANTS,,RIDDELL,GREENWALD RICHARD M;;BERTONI DAVID W;;CHU JEFFREY J;;IDE THAD M,,https://lens.org/017-897-023-380-939,Patent Application,no,0,0,9,9,0,A61B5/0002;;A61B5/0008;;A61B5/11;;A61B5/6814;;A61B5/6895;;A61B5/7475;;A61B2562/0219;;A61B5/6803;;A61B5/4076;;A61B5/6803;;A61B5/11;;A61B5/7475;;A61B5/0008;;A61B2562/0219;;A61B5/6814;;A61B5/0002;;A61B5/6895;;A61B5/4076;;A61B5/0004;;A61B5/7246;;A61B5/7282;;A61B5/742;;A61B5/746,A61B5/11;;A42B3/04;;A63B71/10,,0,0,,,,ACTIVE
99,CA,A1,CA 2364070 A1,077-621-330-579-058,2002-06-06,2002,CA 2364070 A,2001-11-30,US 73125800 A;;US 97501701 A,2000-12-06,BRAKE LATHE SUSPENSION ARM,"An articulated arm assembly adapted to carry machine means comprising a first member, a second member pivotally connected at one end thereof to said first member for pivotal movement thereabout, a third member extending outwardly from another end of said second member, said third member including means for connection to said machine means, means for adjusting the position of said machine means.",COX DAVID E JR;;HASTINGS JEFFREY P;;GREENWALD CHRISTOPHER L;;YEO HAROLD O,COX DAVID E JR;;HASTINGS JEFFREY P;;GREENWALD CHRISTOPHER L;;YEO HAROLD O,,https://lens.org/077-621-330-579-058,Patent Application,no,0,0,2,8,0,,B23B5/04,,0,0,,,,EXPIRED
100,US,A1,US 2003/0014660 A1,136-943-849-743-176,2003-01-16,2003,US 12838402 A,2002-04-23,US 12838402 A;;US 28685901 P,2001-04-26,PC card security system,"
   A security system including a removable circuit card having an unauthorized movement detection subsystem including a motion sensor, a processor responsive to the motion sensor for detecting whether motion sensed thereby is indicative of unauthorized movement and a response circuit activated by the processor in response to unauthorized movement. The security system also includes a power source integrated with the circuit card for powering the unauthorized movement detection subsystem in the event of a lack of available external power including removal of the circuit card. 
",VERPLAETSE CHRISTOPHER;;LEE W. DAVID;;EVANS THOMAS P.;;GREENWALD C. GAIL;;KELLY RICHARD,VERPLAETSE CHRISTOPHER;;LEE W DAVID;;EVANS THOMAS P;;GREENWALD C GAIL;;KELLY RICHARD,CAVEO TECHNOLOGY LLC (2002-04-16),https://lens.org/136-943-849-743-176,Patent Application,yes,10,48,3,3,0,G08B13/1418;;G08B13/1418;;G06F21/88;;G06F21/88;;G08B13/1436;;G08B13/1436,G06F21/00;;G08B13/14;;H04L9/10,7132,0,0,,,,DISCONTINUED
101,US,A1,US 2019/0235099 A1,092-860-814-613-568,2019-08-01,2019,US 201916378168 A,2019-04-08,US 201916378168 A;;US 201715566252 A;;US 2015/0050934 W;;US 201562147306 P,2015-04-14,"DETECTOR ARRAY FOR A RADIATION SYSTEM, AND RELATED SYSTEM","A detector array for a radiation system includes a radiation detection sub-assembly, a routing sub-assembly, and an electronics sub-assembly. The routing sub-assembly is disposed between the radiation detection sub-assembly and the electronics sub-assembly and includes one or more layers of shielding material. For example, the routing sub-assembly may include a printed circuit board having embedded therein a shielding material configured to shield the electronics sub-assembly from at least some radiation. In some embodiments, the shielding material defines at least one opening through which a conductive element(s) passes to deliver signals between the radiation detection sub-assembly and the electronics sub-assembly.",ANALOGIC CORP,LUHTA RANDY;;MARSDEN LANE;;DEYCH RUVIN;;GREENWALD JEFFREY;;CHOQUETTE MARTIN;;TIBBETTS CHRISTOPHER DAVID,,https://lens.org/092-860-814-613-568,Patent Application,yes,2,1,10,10,0,G01T1/2018;;H01L27/14661;;G01T1/2019;;H01L27/14661;;G01T1/2018;;G01T7/00;;H01L27/14623;;H01L27/14634;;H01L27/14663;;H05K1/0218;;H05K1/025,G01T7/00;;G01T1/20,,0,0,,,,ACTIVE
102,US,B2,US 10802166 B2,118-508-576-682-881,2020-10-13,2020,US 201916378168 A,2019-04-08,US 201916378168 A;;US 201715566252 A;;US 2015/0050934 W;;US 201562147306 P,2015-04-14,"Detector array for a radiation system, and related system","A detector array for a radiation system includes a radiation detection sub-assembly, a routing sub-assembly, and an electronics sub-assembly. The routing sub-assembly is disposed between the radiation detection sub-assembly and the electronics sub-assembly and includes one or more layers of shielding material. For example, the routing sub-assembly may include a printed circuit board having embedded therein a shielding material configured to shield the electronics sub-assembly from at least some radiation. In some embodiments, the shielding material defines at least one opening through which a conductive element(s) passes to deliver signals between the radiation detection sub-assembly and the electronics sub-assembly.",ANALOGIC CORP,LUHTA RANDY;;MARSDEN LANE;;DEYCH RUVIN;;GREENWALD JEFFREY;;CHOQUETTE MARTIN;;TIBBETTS CHRISTOPHER DAVID,,https://lens.org/118-508-576-682-881,Granted Patent,yes,13,0,10,10,0,G01T1/2018;;H01L27/14661;;G01T1/2019;;H01L27/14661;;G01T1/2018;;G01T7/00;;H01L27/14623;;H01L27/14634;;H01L27/14663;;H05K1/0218;;H05K1/025,G01T1/20;;G01T7/00;;H01L27/146;;H05K1/02,,4,0,,,"International Written Opinion received for PCT Patent Application No. PCT/US2015/050934, dated Mar. 11, 2016, 10 pages.;;International Search Report received for PCT Patent Application No. PCT/US2015/050934, dated Mar. 11, 2016, 16 pages.;;Chinese Office Action and Search Report dated Dec. 17, 2018, for CN Application No. 201580080365, 18 pages with translation.;;European Communication pursuant to Article 94(3) EPC for European Application No. 15775308.8, dated Jun. 16, 2020, 8 pages.",ACTIVE
103,AU,A,AU 2001/062986 A,191-922-682-525-207,2001-11-20,2001,AU 2001/062986 A,2001-05-07,US 20229900 P;;US 20229600 P;;US 20229800 P;;US 0114618 W,2000-05-05,Systems and methods for diagnosing faults in computer networks,,APRISMA MAN TECHNOLOGIES INC,GREENWALD JOSEPH;;BALL SCOTT;;BUIA CHRISTOPHER A;;CARON JONATHAN P;;TAYLOR DAVID K,,https://lens.org/191-922-682-525-207,Patent Application,no,0,0,6,21,0,G06F11/2257;;G06F11/0748;;G06F11/079;;H04L41/0213;;H04L41/0631;;H04L41/22;;H04L41/5003;;H04L41/5009;;H04L41/5012;;H04L41/5025;;H04L41/5093;;H04L43/00;;H04L43/0817,G06F11/07;;G06F11/25;;H04L12/24;;H04L12/26,,0,0,,,,PENDING
104,WO,A9,WO 2002/089081 A9,021-970-033-741-665,2003-04-10,2003,US 0212805 W,2002-04-23,US 28685901 P,2001-04-26,PC CARD SECURITY SYSTEM,"A security system including a removable circuit card (10) having an unauthorized movement detection subsystem including a motion sensor (36), a processor (38) responsive to the motion sensor for detecting whether motion sensed thereby is indicative of unauthorized movement and a response circuit activated by the processor in response to unauthorized movement. The security system also includes a power source (30) integrated with the circuit card for powering the unauthorized movement detection subsystem in the event of a lack of available external power including removal of the circuit card.",CAVEO TECHNOLOGY LLC,VERPLAETSE CHRISTOPHER;;LEE W DAVID;;EVANS THOMAS P;;GREENWALD C GAIL;;KELLY RICHARD,,https://lens.org/021-970-033-741-665,Patent Application,no,0,0,3,3,0,G08B13/1418;;G08B13/1418;;G06F21/88;;G06F21/88;;G08B13/1436;;G08B13/1436,G06F21/00;;G08B13/14;;H04L9/10,,0,0,,,,PENDING
105,CA,C,CA 2364070 C,063-882-275-785-015,2007-09-11,2007,CA 2364070 A,2001-11-30,US 73125800 A;;US 97501701 A,2000-12-06,BRAKE LATHE SUSPENSION ARM,"An articulated arm assembly adapted to carry machine means comprising a first member, a second member pivotally connected at one end thereof to said first member for pivotal movement thereabout, a third member extending outwardly from another end of said second member, said third member including means for connection to said machine means, means for adjusting the position of said machine means.",COX DAVID E JR;;GREENWALD CHRISTOPHER L;;YEO HAROLD O;;HASTINGS JEFFREY P,COX DAVID E JR;;GREENWALD CHRISTOPHER L;;YEO HAROLD O;;HASTINGS JEFFREY P,,https://lens.org/063-882-275-785-015,Granted Patent,no,0,0,2,8,0,,B23B5/04,,0,0,,,,EXPIRED
106,US,A1,US 2020/0393581 A1,080-503-258-085-387,2020-12-17,2020,US 202017008889 A,2020-09-01,US 202017008889 A;;US 201916378168 A;;US 2015/0050934 W;;US 201562147306 P,2015-04-14,"DETECTOR ARRAY FOR A RADIATION SYSTEM, AND RELATED SYSTEM","A detector array for a radiation system includes a radiation detection sub-assembly, a routing sub-assembly, and an electronics sub-assembly. The routing sub-assembly is disposed between the radiation detection sub-assembly and the electronics sub-assembly and includes one or more layers of shielding material. For example, the routing sub-assembly may include a printed circuit board having embedded therein a shielding material configured to shield the electronics sub-assembly from at least some radiation. In some embodiments, the shielding material defines at least one opening through which a conductive element(s) passes to deliver signals between the radiation detection sub-assembly and the electronics sub-assembly.",ANALOGIC CORP,LUHTA RANDY;;MARSDEN LANE;;DEYCH RUVIN;;GREENWALD JEFFREY;;CHOQUETTE MARTIN;;TIBBETTS CHRISTOPHER DAVID,,https://lens.org/080-503-258-085-387,Patent Application,yes,0,2,10,10,0,G01T1/2018;;H01L27/14661;;G01T1/2019;;H01L27/14661;;G01T1/2018;;G01T7/00;;H01L27/14623;;H01L27/14634;;H01L27/14663;;H05K1/0218;;H05K1/025,G01T7/00;;G01T1/20;;H05K1/02,,0,0,,,,ACTIVE
107,US,B2,US 11275187 B2,048-372-341-680-980,2022-03-15,2022,US 202017008889 A,2020-09-01,US 202017008889 A;;US 201916378168 A;;US 2015/0050934 W;;US 201562147306 P,2015-04-14,"Detector array for a radiation system, and related system","A detector array for a radiation system includes a radiation detection sub-assembly, a routing sub-assembly, and an electronics sub-assembly. The routing sub-assembly is disposed between the radiation detection sub-assembly and the electronics sub-assembly and includes one or more layers of shielding material. For example, the routing sub-assembly may include a printed circuit board having embedded therein a shielding material configured to shield the electronics sub-assembly from at least some radiation. In some embodiments, the shielding material defines at least one opening through which a conductive element(s) passes to deliver signals between the radiation detection sub-assembly and the electronics sub-assembly.",ANALOGIC CORP,LUHTA RANDY;;MARSDEN LANE;;DEYCH RUVIN;;GREENWALD JEFFREY;;CHOQUETTE MARTIN;;TIBBETTS CHRISTOPHER DAVID,,https://lens.org/048-372-341-680-980,Granted Patent,yes,16,0,10,10,0,G01T1/2018;;H01L27/14661;;G01T1/2019;;H01L27/14661;;G01T1/2018;;G01T7/00;;H01L27/14623;;H01L27/14634;;H01L27/14663;;H05K1/0218;;H05K1/025,G01T1/20;;G01T7/00;;H01L27/146;;H05K1/02,,8,0,,,"European Communication pursuant to Article 94(3) EPC for European Application No. 15775308.8, dated Feb. 18, 2021, 5 pages.;;Chinese Office Action and Search Report dated Dec. 17, 2018, for CN Application No. 201580080365, 18 pages with translation.;;European Communication pursuant to Article 94(3) EPC for European Application No. 15775308.8, dated Jun. 16, 2020, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US15/50934, dated Oct. 26, 2017, 12 pages.;;International Search Report cited in related application No. PCT/US2015/050934 dated Mar. 11, 2016 (18 pgs).;;International Search Report received for PCT Patent Application No. PCT/US2015/050934, dated Mar. 11, 2016, 16 pages.;;International Written Opinion received for PCT Patent Application No. PCT/US2015/050934, dated Mar. 11, 2016, 10 pages.;;European Communication pursuant to Article 94(3) EPC for European Application No. 15775308, dated Nov. 4, 2021, 4 pages.",ACTIVE
108,WO,A1,WO 2001/086444 A1,152-584-409-842-646,2001-11-15,2001,US 0114618 W,2001-05-07,US 20229900 P;;US 20229600 P;;US 20229800 P,2000-05-05,SYSTEMS AND METHODS FOR DIAGNOSING FAULTS IN COMPUTER NETWORKS,"The network management system (10) includes a fault diagnosis system (12) connectable to a communications network (20). The fault diagnosis system includes a fault object factory, a path determination module, and a fault diagnosis engine. The fault object factory is constructed and arranged to receive fault data and create fault objects. The path determination module is constructed to determine, in a communications network, a path related to the fault data. The fault diagnosis engine is constructed to perform, using the determined path, a fault analysis on the fault data to diagnose a fault related to the communications network. The network management may also include a help desk system (18), a topology mapper (14) or an impact analyzer (16).",APRISMA MAN TECHNOLOGIES INC;;GREENWALD JOSEPH;;BALL SCOTT;;BUIA CHRISTOPHER A;;CARON JONATHAN P;;TAYLOR DAVID K,GREENWALD JOSEPH;;BALL SCOTT;;BUIA CHRISTOPHER A;;CARON JONATHAN P;;TAYLOR DAVID K,,https://lens.org/152-584-409-842-646,Patent Application,yes,1,10,6,21,0,G06F11/2257;;G06F11/0748;;G06F11/079;;H04L41/0213;;H04L41/0631;;H04L41/22;;H04L41/5003;;H04L41/5009;;H04L41/5012;;H04L41/5025;;H04L41/5093;;H04L43/00;;H04L43/0817,G06F11/07;;G06F11/25;;H04L12/24;;H04L12/26,,0,0,,,,PENDING
109,CA,A1,CA 2364326 A1,000-280-310-632-29X,2002-06-06,2002,CA 2364326 A,2001-12-04,US 73125800 A,2000-12-06,BRAKE LATHE STATION,"An improved brake lathe station has an on-vehicle brake lathe and a lift wi th one or more support posts for raising a vehicle. A support structure is provided to support the lathe while allowing it to be moved with respect to a horizontal plane about the vehicle to assist the lathe operator in positioning the lathe with respect to wheel hubs of the vehicle. The lathe is preferably connected to the support structure by an adjustable coupling which allows vertically tilting a lathe rotation axis of the lathe, as well as allowing rotation of the lathe substantially about its lat he rotation axis. Preferably, the lathe can also be moved with respect to a vertical plane. To prevent transmission of vibrations during the machining process, it is preferred for the lathe to be floated with respect to the support structure while the lath e is mounted on the wheel hub. The coupling can be designed to allow attaching a dolly to the lathe while it is still supported by the support structure, and to allow the lathe thereafter to be released from the support structure so the lathe can be mov ed on the dolly.",YEO HAROLD O;;COX DAVID E JR;;HASTINGS JEFFREY P;;GREENWALD CHRISTOPHER L,YEO HAROLD O;;COX DAVID E JR;;HASTINGS JEFFREY P;;GREENWALD CHRISTOPHER L,,https://lens.org/000-280-310-632-29X,Patent Application,no,0,0,4,8,0,B23B5/04;;Y10T82/2522;;Y10T82/21;;Y10T82/2522;;Y10T82/21;;B23B5/04,B23B5/04,,0,0,,,,EXPIRED
110,US,B2,US 6679144 B2,051-312-097-811-97X,2004-01-20,2004,US 97501701 A,2001-10-12,US 97501701 A;;US 23990900 P,2000-10-13,Brake lathe suspension arm,"
    An articulated arm assembly adapted to carry machine means comprising a first member, a second member pivotally connected at one end thereof to said first member for pivotal movement thereabout, a third member extending outwardly from another end of said second member, said third member including means for connection to said machine means, means for adjusting the position of said machine means. 
",WHEELTRONIC LTD,YEO HAROLD O;;GREENWALD CHRISTOPHER L;;HASTINGS JEFFREY P;;COX JR DAVID E,,https://lens.org/051-312-097-811-97X,Granted Patent,yes,27,13,2,8,0,B23B5/04;;B25J9/026;;B25J9/042;;B66C23/20;;B66F7/26;;Y10T82/25;;Y10T82/21;;Y10T82/25;;Y10T82/21;;B25J9/042;;B66F7/26;;B66C23/20;;B23B5/04;;B25J9/026,B23B5/04;;B25J9/02;;B25J9/04;;B66C23/20;;B66F7/26,82/112;;82/117;;X254 89 R,1,0,,,Article copyrighted by Hein-Werner Collision Repair Equipment Group showing work bench stations shown with MultiBenchLift from Blackhawk.,EXPIRED
111,US,B2,US 6546832 B2,052-324-277-213-971,2003-04-15,2003,US 73125800 A,2000-12-06,US 73125800 A,2000-12-06,Brake lathe station,"
    A brake lathe station has an on-vehicle brake lathe and a lift with support posts for raising a vehicle. A support structure supports the lathe while allowing it to be moved with respect to a horizontal plane about the vehicle to assist the lathe operator in positioning the lathe with respect to wheel hubs of the vehicle. The lathe is preferably connected to the support structure by an adjustable coupling which allows vertically tilting a lathe rotation axis of the lathe, as well as allowing rotation of the lathe substantially about its lathe rotation axis. The lathe can also be moved with respect to a vertical plane. The lathe can be floated with respect to the support structure while the lathe is mounted on the wheel hub. The coupling can be designed to allow attaching a dolly to the lathe while it is still supported by the support structure. 
",PRO CUT LICENSING LLC;;WHEELTRONIC LTD,GREENWALD CHRISTOPHER L;;HASTINGS JEFFREY P;;YEO HAROLD O;;COX JR DAVID E,PRO-CUT LICENSING LLC (2002-12-03);;WHEELTRONIC LTD (2003-02-17),https://lens.org/052-324-277-213-971,Granted Patent,yes,12,3,4,8,0,B23B5/04;;Y10T82/2522;;Y10T82/21;;Y10T82/2522;;Y10T82/21;;B23B5/04,B23B5/04,82/112;;82/128,1,0,,,Information obtained on the Internet at URL: http://www.hein-werner. com/WSO/WSO.html.,EXPIRED
112,CA,C,CA 2364326 C,157-678-429-847-03X,2010-02-23,2010,CA 2364326 A,2001-12-04,US 73125800 A,2000-12-06,BRAKE LATHE STATION,"An improved brake lathe station has an on-vehicle brake lathe and a lift with one or more support posts for raising a vehicle. A support structure is provided to support the lathe while allowing it to be moved with respect to a horizontal plane about the vehicle to assist the lathe operator in positioning the lathe with respect to wheel hubs of the vehicle. The lathe is preferably connected to the support structure by an adjustable coupling which allows vertically tilting a lathe rotation axis of the lathe, as well as allowing rotation of the lathe substantially about its lathe rotation axis. Preferably, the lathe can also be moved with respect to a vertical plane. To prevent transmission of vibrations during the machining process, it is preferred for the lathe to be floated with respect to the support structure while the lathe is mounted on the wheel hub. The coupling can be designed to allow attaching a dolly to the lathe while it is still supported by the support structure, and to allow the lathe thereafter to be released from the support structure so the lathe can be moved on the dolly.",YEO HAROLD O;;GREENWALD CHRISTOPHER L;;HASTINGS JEFFREY P;;COX DAVID E JR,YEO HAROLD O;;GREENWALD CHRISTOPHER L;;HASTINGS JEFFREY P;;COX DAVID E JR,,https://lens.org/157-678-429-847-03X,Granted Patent,no,0,0,4,8,0,B23B5/04;;Y10T82/2522;;Y10T82/21;;Y10T82/2522;;Y10T82/21;;B23B5/04,B23B5/04,,0,0,,,,EXPIRED
113,WO,A1,WO 2002/089081 A1,125-603-950-715-006,2002-11-07,2002,US 0212805 W,2002-04-23,US 28685901 P,2001-04-26,PC CARD SECURITY SYSTEM,"A security system including a removable circuit card (10) having an unauthorized movement detection subsystem including a motion sensor (36), a processor (38) responsive to the motion sensor for detecting whether motion sensed thereby is indicative of unauthorized movement and a response circuit activated by the processor in response to unauthorized movement. The security system also includes a power source (30) integrated with the circuit card for powering the unauthorized movement detection subsystem in the event of a lack of available external power including removal of the circuit card.",CAVEO TECHNOLOGY LLC,VERPLAETSE CHRISTOPHER;;LEE W DAVID;;EVANS THOMAS P;;GREENWALD C GAIL;;KELLY RICHARD,,https://lens.org/125-603-950-715-006,Patent Application,yes,9,0,3,3,0,G08B13/1418;;G08B13/1418;;G06F21/88;;G06F21/88;;G08B13/1436;;G08B13/1436,G06F21/00;;G08B13/14;;H04L9/10,,0,0,,,,PENDING
114,US,A1,US 2004/0171591 A1,072-991-592-945-608,2004-09-02,2004,US 37708803 A,2003-02-28,US 37708803 A,2003-02-28,Method for decreasing low density lipoprotein,"
   The present invention relates to a method for decreasing elevated serum/plasma LDL-cholesterol levels or LDL-cholesterol levels and CRP levels in a mammal in need thereof. The methods comprises administering an effective amount of a tetracycline formulation. In one embodiment, the tetracycline formulation is a non-antibacterial tetracycline. In another embodiment, the tetracycline formulation is an antibacterial tetracycline at a sub-antibacterial amount. 
",BROWN DAVID;;GOLUB LORNE M.;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA;;DESAI KAVITA,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA;;DESAI KAVITA,ALBERT EINSTEIN COLLEGE OF MEDICINE YESHEVIA UNIVERSITY (2003-07-10);;THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (2003-08-28);;ALBERT EINSTEIN COLLEGE OF MEDICINE INC (2015-09-09);;MONTEFIORE MEDICAL CENTER (2003-07-16),https://lens.org/072-991-592-945-608,Patent Application,yes,1,1,4,4,0,A61K31/65;;A61K31/65,A61K31/65,514/152,0,0,,,,EXPIRED
115,WO,A2,WO 2004/078129 A2,019-691-471-882-114,2004-09-16,2004,US 2004/0006302 W,2004-03-01,US 37708803 A,2003-02-28,METHOD FOR DECREASING LOW DENSITY LIPOPROTEIN,"ABSTRACT The present invention relates to a method for decreasing elevated serum/plasma LDL-cholesterol levels or LDL-cholesterol levels and CRP levels in a mammal in need thereof. The methods comprises administering an effective amount of a tetracycline formulation. In one embodiment, the tetracycline formulation is a non-antibacterial tetracycline. In another embodiment, the tetracycline formulation is an antibacterial tetracycline at a sub-antibacterial amount.",UNIV NEW YORK STATE RES FOUND;;EINSTEIN COLL MED;;MONTEFIORE MEDICAL CT;;BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA;;DESAI KAVITA,,https://lens.org/019-691-471-882-114,Patent Application,yes,0,1,4,4,0,A61K31/65;;A61K31/65,A61K31/65,,0,0,,,,PENDING
116,US,A1,US 2003/0046390 A1,184-652-094-805-05X,2003-03-06,2003,US 28286902 A,2002-10-29,US 28286902 A;;US 0114767 W;;US 20229600 P;;US 20229900 P;;US 20229800 P,2000-05-05,Systems and methods for construction multi-layer topological models of computer networks,"
   A network management system includes a fault diagnosis engine, a topology mapper, an impact analyzer and a help desk system. The topology mapper includes a discovery module, a memory, and a presentation module. The discovery module is constructed and arranged to discover network elements in a communications network. The memory constructed and arranged to store topology data received from the discovery module. The presentation module constructed and arranged to present data related to topology of the communication network. 
",BALL SCOTT;;GREENWALD JOSEPH;;BUIA CHRISTOPHER;;TAYLOR DAVID K.;;CARON JONATHAN P.;;HE JUN,BALL SCOTT;;GREENWALD JOSEPH;;BUIA CHRISTOPHER;;TAYLOR DAVID K;;CARON JONATHAN P;;HE JUN,APRISMA MANAGEMENT TECHNOLOGIES INC (2004-10-29);;COMPUTER ASSOCIATES THINK INC (2007-02-08);;CONCORD COMMUNICATIONS INC (2007-02-08),https://lens.org/184-652-094-805-05X,Patent Application,yes,99,261,2,21,0,H04L41/0213;;H04L41/046;;H04L41/0631;;H04L41/12;;H04L41/12;;H04L41/0213;;H04L41/0631;;H04L41/046,G06F15/173;;G09G5/00,709/224;;345/736;;709/242,0,0,,,,EXPIRED
117,US,B2,US 7752024 B2,031-886-659-464-998,2010-07-06,2010,US 28286902 A,2002-10-29,US 28286902 A;;US 0114767 W;;US 20229600 P;;US 20229900 P;;US 20229800 P,2000-05-05,Systems and methods for constructing multi-layer topological models of computer networks,"A network management system includes a fault diagnosis engine, a topology mapper, an impact analyzer and a help desk system. The topology mapper includes a discovery module, a memory, and a presentation module. The discovery module is constructed and arranged to discover network elements in a communications network. The memory constructed and arranged to store topology data received from the discovery module. The presentation module constructed and arranged to present data related to topology of the communication network.",COMPUTER ASS THINK INC,BALL SCOTT;;GREENWALD JOSEPH;;BUIA CHRISTOPHER;;TAYLOR DAVID K;;CARON JONATHAN P;;HE JUN,APRISMA MANAGEMENT TECHNOLOGIES INC (2004-10-29);;COMPUTER ASSOCIATES THINK INC (2007-02-08);;CONCORD COMMUNICATIONS INC (2007-02-08),https://lens.org/031-886-659-464-998,Granted Patent,yes,108,39,2,21,0,H04L41/0213;;H04L41/046;;H04L41/0631;;H04L41/12;;H04L41/12;;H04L41/0213;;H04L41/0631;;H04L41/046,G06F17/50;;G06F15/173;;G09G5/00,703/13;;703/1;;709/220;;709/225;;709/226;;715/771;;715/853,8,3,153-272-118-177-192;;163-279-439-912-615;;184-717-642-201-404,10.17487/rfc1965;;10.17487/rfc1058;;10.17487/rfc2178,"Harry Newton, Netwon's Telecom Dictionary, 2004, CMP Books, Twentieth Edition, p. 491.;;Microsoft Computer Dictionary, 2002, Microsoft Press, Fifth Edition, p. 291.;;P. Traina, ""Autonomous System Confederations for BGP"", Jun. 1996, Network Working Group RFC 1965, pp. 1-8.;;C. Hedrick, ""Routing Information Protocol"", Jun. 1988, Network Working Group RFC 1058, pp. 1-34.;;J. Moy, ""OSPF Version 2"", Jul. 1997, Network Working Group RFC 2178, pp. 1-212.;;IEEE Computer Society, ""ANSI/IEEE Std 802.1D, 1998 Edition, Part 3: Media Access Control (MAC) Bridges"", 1998, IEEE Computer Society, pp. 1-373.;;Peregrine Systems Partners with Motive Communications to Offer IT Solutions that Enhance Employee Self-Service, 1999, Peregrine Systems, Inc., 4 pages.;;International Search Report issued in PCT/US01/14767 dated Jul. 13, 2001.",EXPIRED
118,US,B2,US 6841547 B2,199-753-729-082-906,2005-01-11,2005,US 37708803 A,2003-02-28,US 37708803 A,2003-02-28,Method for decreasing low density lipoprotein,"The present invention relates to a method for decreasing elevated serum/plasma LDL-cholesterol levels or LDL-cholesterol levels and CRP levels in a mammal in need thereof. The methods comprises administering an effective amount of a tetracycline formulation. In one embodiment, the tetracycline formulation is a non-antibacterial tetracycline. In another embodiment, the tetracycline formulation is an antibacterial tetracycline at a sub-antibacterial amount.",EINSTEIN COLL MED;;MONTEFIORE MEDICAL CT;;UNIV NEW YORK STATE RES FOUND,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA;;DESAI KAVITA,ALBERT EINSTEIN COLLEGE OF MEDICINE YESHEVIA UNIVERSITY (2003-07-10);;THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (2003-08-28);;ALBERT EINSTEIN COLLEGE OF MEDICINE INC (2015-09-09);;MONTEFIORE MEDICAL CENTER (2003-07-16),https://lens.org/199-753-729-082-906,Granted Patent,yes,2,90,4,4,0,A61K31/65;;A61K31/65,A61K31/65,514/152,8,8,032-862-904-621-433;;026-835-076-069-979;;130-544-875-163-531;;055-890-399-760-717;;026-027-207-141-526;;061-418-436-648-248;;046-003-170-706-237;;016-487-344-909-25X,11434828;;10.1001/jama.286.1.64;;4253277;;7199310;;6740216;;10.1080/00365521.1984.12005742;;10.1159/000249321;;2938993;;12432042;;10.1056/nejmoa021993;;4741941;;10.1161/01.res.33.4.393;;10.1016/0742-8413(85)90071-4;;2861024,"Albert, M.A., et al., ""Effect of Statin Therapy on C-Reactive Protein Levels"", JAMA 2001, 286(1):64-74.;;Berchev, Kr., et al., ""Effect of Chlortetracycline on the Pathogenesis of Experimental Atherosclerosis"", Nauchni Tr, Vissh Med Inst Sofii 1970, 49(4):43-47.;;Bocker, R., et al., ""Comparative Evaluation of the Effects of Tetracycline and Doxycycline on Blood and Liver Lipids of Male and Female Mice"", Arzneim-Forsch/Drug Res. 1981, 31(12):2118-2120.;;Korpela, J.T., et al., ""Effect of Oxytetracycline on Bacterial Intestinal Metabolism of Neutral Sterols and on Serum Lipids"", Scand J. Gastroenterol 1984, 19:401-404.;;Pigatto, P.D., et al., ""Isotretinoin versus Minocycline in Cystic Acne: A Study of Lipid Metabolism"", Dermatologica 1986, 172:154-159.;;Ridker, P.M., et al., ""Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events"", N. Engl. J. Med. 2002, 347(20):1557-1565.;;Samuel, Paul, et al., ""Effect of Neomycin and Other Antibiotics on Serum Cholesterol Levels and on 7alpha-Dehydroxylation of Bile Acids by the Fecal Bacterial Flora in Man"", Circulation Research 1973, vol. XXXIII:393-402.;;Shaddad, Sania A.I., et al., ""The Effect of Oxytetracycline on Growth and Lipid Metabolism in Poultry"", Comp. Biochem. Physiol. 1985, 80C(2):375-380.",EXPIRED
119,WO,A3,WO 2004/078129 A3,180-018-493-807-681,2004-12-02,2004,US 2004/0006302 W,2004-03-01,US 37708803 A,2003-02-28,METHOD FOR DECREASING LOW DENSITY LIPOPROTEIN,"ABSTRACT The present invention relates to a method for decreasing elevated serum/plasma LDL-cholesterol levels or LDL-cholesterol levels and CRP levels in a mammal in need thereof. The methods comprises administering an effective amount of a tetracycline formulation. In one embodiment, the tetracycline formulation is a non-antibacterial tetracycline. In another embodiment, the tetracycline formulation is an antibacterial tetracycline at a sub-antibacterial amount.",UNIV NEW YORK STATE RES FOUND;;EINSTEIN COLL MED;;MONTEFIORE MEDICAL CT;;BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA,BROWN DAVID;;GOLUB LORNE M;;LEE HSI-MING;;GREENWALD ROBERT;;RYAN MARIA;;DESAI KAVITA,,https://lens.org/180-018-493-807-681,Search Report,yes,2,0,4,4,0,A61K31/65;;A61K31/65,A61K31/65,,1,1,130-544-875-163-531,7199310,"BOCKER ET AL.: ""Comparative evaluation of the Effects of Tetracycline and Doxycycline on Blood and Liver Lipids of Male and Female Mice"", ARZNEIM.-FORSCH./DRUG RES., vol. 31, no. 12, 1981, pages 2118 - 2120",PENDING
120,US,B2,US 10004543 B2,015-264-654-745-268,2018-06-26,2018,US 201414765402 A,2014-02-04,US 201414765402 A;;US 201361760385 P;;US 2014/0014661 W,2013-02-04,Minimally invasive pedicle screw extension sleeve system,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,GENESYS SPINE (2014-02-04),https://lens.org/015-264-654-745-268,Granted Patent,yes,7,3,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/04;;A61B17/70;;A61B17/84;;A61F2/08,,1,0,,,"International Searching Authority, “Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority,” dated May 1, 2014, in International application No. PCT/US2014/014661.",ACTIVE
121,US,A1,US 2023/0074780 A1,097-674-358-209-344,2023-03-09,2023,US 202217895099 A,2022-08-25,US 202217895099 A;;US 202016828082 A;;US 201815981445 A;;US 201514765402 A;;US 2014/0014661 W;;US 201361760385 P,2013-02-04,MINIMALLY INVASIVE PEDICLE SCREW EXTENSION SLEEVE SYSTEM,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,,https://lens.org/097-674-358-209-344,Patent Application,no,0,0,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/70,,0,0,,,,PENDING
122,AU,A,AU 2001/057561 A,070-624-609-215-410,2001-11-20,2001,AU 2001/057561 A,2001-05-07,US 20229600 P;;US 20229900 P;;US 20229800 P;;US 0114767 W,2000-05-05,Systems and methods for constructing multi-layer topological models of computer networks,,APRISMA MAN TECHNOLOGIES INC,BALL SCOTT;;GREENWALD JOSEPH;;BUIA CHRISTOPHER A;;TAYLOR DAVID K;;CARON JONATHAN P;;HE JUN,,https://lens.org/070-624-609-215-410,Patent Application,no,0,0,6,21,0,G06F11/2257;;G06F11/0748;;G06F11/079;;H04L41/0213;;H04L41/0631;;H04L41/22;;H04L41/5003;;H04L41/5009;;H04L41/5012;;H04L41/5025;;H04L41/5093;;H04L43/00;;H04L43/0817,G06F11/07;;G06F11/25;;H04L12/24;;H04L12/26,,0,0,,,,PENDING
123,US,A1,US 2020/0222085 A1,109-099-235-477-256,2020-07-16,2020,US 202016828082 A,2020-03-24,US 202016828082 A;;US 201815981445 A;;US 201514765402 A;;US 2014/0014661 W;;US 201361760385 P,2013-02-04,MINIMALLY INVASIVE PEDICLE SCREW EXTENSION SLEEVE SYSTEM,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,,https://lens.org/109-099-235-477-256,Patent Application,yes,0,0,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/70,,0,0,,,,ACTIVE
124,US,A1,US 2018/0256212 A1,039-093-193-976-190,2018-09-13,2018,US 201815981445 A,2018-05-16,US 201815981445 A;;US 201514765402 A;;US 2014/0014661 W;;US 201361760385 P,2013-02-04,MINIMALLY INVASIVE PEDICLE SCREW EXTENSION SLEEVE SYSTEM,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,,https://lens.org/039-093-193-976-190,Patent Application,yes,1,1,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/70,,0,0,,,,ACTIVE
125,US,B2,US 10603086 B2,196-090-391-804-321,2020-03-31,2020,US 201815981445 A,2018-05-16,US 201815981445 A;;US 201514765402 A;;US 2014/0014661 W;;US 201361760385 P,2013-02-04,Minimally invasive pedicle screw extension sleeve system,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,,https://lens.org/196-090-391-804-321,Granted Patent,yes,7,0,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/70,,1,0,,,"International Searching Authority, “Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority,” dated May 1, 2014 in international application No. PCT/US2014/014661.",ACTIVE
126,US,A1,US 2016/0008034 A1,131-254-126-733-067,2016-01-14,2016,US 201414765402 A,2014-02-04,US 201414765402 A;;US 201361760385 P;;US 2014/0014661 W,2013-02-04,MINIMALLY INVASIVE PEDICLE SCREW EXTENSION SLEEVE SYSTEM,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,GENESYS SPINE (2014-02-04),https://lens.org/131-254-126-733-067,Patent Application,yes,2,17,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/70,,0,0,,,,ACTIVE
127,US,B2,US 11426214 B2,153-098-597-056-273,2022-08-30,2022,US 202016828082 A,2020-03-24,US 202016828082 A;;US 201815981445 A;;US 201514765402 A;;US 2014/0014661 W;;US 201361760385 P,2013-02-04,Minimally invasive pedicle screw extension sleeve system,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,,https://lens.org/153-098-597-056-273,Granted Patent,yes,7,0,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61B17/70,,1,0,,,"International Searching Authority, “Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority,” dated May 1, 2014 in international application No. PCT/US2014/014661.",ACTIVE
128,WO,A1,WO 2001/086844 A1,057-804-837-578-608,2001-11-15,2001,US 0114767 W,2001-05-07,US 20229600 P;;US 20229900 P;;US 20229800 P,2000-05-05,SYSTEMS AND METHODS FOR CONSTRUCTING MULTI-LAYER TOPOLOGICAL MODELS OF COMPUTER NETWORKS,"A network management system (10) includes a fault diagnosis engine (12), a topology mapper (14), an impact analyzer (16) and a help desk system (18). The topology mapper includes a discovery module, a memory, and a presentation module. The discovery module is constructed and arranged to discover network elements in a communications network. The memory constructed and arranged to store topology data received from the discovery module. The presentation module constructed and arranged to present data related to topology of the communication network.",APRISMA MAN TECHNOLOGIES INC;;BALL SCOTT;;GREENWALD JOSEPH;;BUIA CHRISTOPHER A;;TAYLOR DAVID K;;CARON JONATHAN P;;HE JUN,BALL SCOTT;;GREENWALD JOSEPH;;BUIA CHRISTOPHER A;;TAYLOR DAVID K;;CARON JONATHAN P;;HE JUN,,https://lens.org/057-804-837-578-608,Patent Application,yes,4,3,6,21,0,G06F11/2257;;G06F11/0748;;G06F11/079;;H04L41/0213;;H04L41/0631;;H04L41/22;;H04L41/5003;;H04L41/5009;;H04L41/5012;;H04L41/5025;;H04L41/5093;;H04L43/00;;H04L43/0817,G06F11/07;;G06F11/25;;H04L12/24;;H04L12/26,,0,0,,,,PENDING
129,WO,A1,WO 2014/121269 A1,030-641-568-297-264,2014-08-07,2014,US 2014/0014661 W,2014-02-04,US 201361760385 P,2013-02-04,MINIMALLY INVASIVE PEDICLE SCREW EXTENSION SLEEVE SYSTEM,"An embodiment includes a system comprising: a tulip including a slot to receive a linkage, first and second side walls that define a portion of the slot, and a ring that couples the first side wall to the second side wall; wherein the ring couples to the first side wall at a thinned first proximal fulcrum and to the second side wall at a thinned second proximal fulcrum and the ring pivots about the first and second proximal fulcrums when the ring is forced proximally; wherein the first side wall includes a first sidewall projection that projects past the first proximal fulcrum and the second side wall includes a second sidewall projection that projects past the second proximal fulcrum. Other embodiments are described herein.",GENESYS SPINE,STOKES JOHN;;GREENWALD DAVID L;;KAUFMANN JOSH;;CALBERT GREG;;BRYANT SCOTT;;GILKEY LANDON;;BERGERON BRIAN,,https://lens.org/030-641-568-297-264,Patent Application,yes,5,1,8,8,0,A61B17/7085;;A61B17/708;;A61B2090/037;;A61B17/7085;;A61B17/708,A61F2/44;;A61B17/70;;A61F2/46,,0,0,,,,PENDING
130,US,A,US 4769247 A,025-593-749-038-574,1988-09-06,1988,US 91517086 A,1986-10-03,US 91517086 A,1986-10-03,Method for adhering spices on the surface of pasta,"The present invention is concerned with a continuous process for preparing a non-segregating, free-flowing dried instant pasta and sauce dish comprising preheating pasta followed by conveying the pre-heated pasta to a rotating coating reel then applying a first layer of melted fat to the pasta into the rotating coating reel and contacting the fat coated pasta with dry ingredients then applying a second and third layer of fat to the spice coated pasta and finally adding vegetable inlays to the fat coated pasta and cool for packaging.",GEN FOODS CORP,ROTHENBERG JOAN R;;RAMOS HECTOR V;;FAGAN JR KENNETH W;;SMITH DAVID L;;GREENWALD GARY F,GENERAL FOODS CORPORATION (1986-11-03),https://lens.org/025-593-749-038-574,Granted Patent,yes,1,15,2,2,0,A23P20/12;;A23L7/109;;A23L7/109;;A23P20/12,A23L1/00;;A23L7/109,426/291;;426/250;;426/292;;426/293;;426/94,0,0,,,,EXPIRED
131,CA,C,CA 1316755 C,115-692-545-202-500,1993-04-27,1993,CA 547311 A,1987-09-18,US 91517086 A,1986-10-03,METHOD FOR ADHERING SPICES ON THE SURFACE OF PASTA,"METHOD FOR ADHERING SPICES ON THE SURFACE OF PASTA ABSTRACT The present invention is concerned with a continuous process for preparing a non-segregating, free-flowing dried instant pasta and sauce dish comprising preheating pasta followed by conveying the pre-heated pasta to a rotating coating reel then applying a first layer of melted fat to the pasta into the rotating coating reel and contacting the fat coated pasta with dry ingredients then applying a second and third layer of fat to the spice coated pasta and finally adding vegetable inlays to the fat coated pasta and cool for packaging. 30031-D",GEN FOODS CORP,RAMOS HECTOR V;;ROTHENBERG JOAN R;;FAGAN KENNETH W JR;;SMITH DAVID L;;GREENWALD GARY F,,https://lens.org/115-692-545-202-500,Granted Patent,no,0,0,2,2,0,A23P20/12;;A23L7/109;;A23L7/109;;A23P20/12,A23L1/00;;A23L7/109,D10990118    M,0,0,,,,EXPIRED
132,US,A1,US 2008/0146981 A1,118-057-638-166-760,2008-06-19,2008,US 78011507 A,2007-07-19,US 78011507 A;;US 83236306 P,2006-07-21,DYNAMIC BODY PROTECTOR,"The present invention provides a novel means of joint and body protection using engineered textiles to provide dynamic kinematic control within the device itself and for the underlying body part. The apparatus may be used in apparel or orthosis wherein a textile is organized about the proximal and distal aspects of a joint or body part and uses the mechanical and material characteristics of the engineered textile to dynamically control the kinetics of the body part and more specifically to prevent the body part from reaching extremes in range of motion. The engineered textiles can be designed to provide non-uniform increases in stiffness in any direction. The engineered textile may incorporate strain or strain rate dependant materials in which case stiffness properties would vary non-uniformly with velocity and/or acceleration within the device allowing for protection from blunt trauma, blast, or ballistic events anywhere on the body. A further aspect of the present invention is to provide a novel means of dynamically fitting and anchoring apparel, orthosis, body protection devices or other objects that need to be securely fixed to the body anatomy during joint flexion or extension, by using motion at a body joint to actuate a closure mechanism and bracing system that actively closes upon the body anatomy surrounding the joint and transfers loads created during dynamic restraint of the joint to anchor zones on the body.",SIMBEX LLC,GREENWALD RICHARD M;;CHU JEFFREY J;;JESSIMAN ALEXANDER W;;BUCK AARON T;;BERTONI DAVID W;;GWIN JOSEPH T,SIMBEX LLC (2007-07-19),https://lens.org/118-057-638-166-760,Patent Application,yes,39,43,2,2,0,A41D13/088;;A61F5/01;;A61F5/01;;A41D13/088,A41D13/08;;A61F5/00,602/13;;602/21;;602/5;;2/16,0,0,,,,INACTIVE
133,US,B2,US 7837640 B2,065-695-960-796-213,2010-11-23,2010,US 78011507 A,2007-07-19,US 78011507 A;;US 83236306 P,2006-07-21,Dynamic body protector,"The present invention provides a novel means of joint and body protection using engineered textiles to provide dynamic kinematic control within the device itself and for the underlying body part. The apparatus may be used in apparel or orthosis wherein a textile is organized about the proximal and distal aspects of a joint or body part and uses the mechanical and material characteristics of the engineered textile to dynamically control the kinetics of the body part and more specifically to prevent the body part from reaching extremes in range of motion. The engineered textiles can be designed to provide non-uniform increases in stiffness in any direction. The engineered textile may incorporate strain or strain rate dependant materials in which case stiffness properties would vary non-uniformly with velocity and/or acceleration within the device allowing for protection from blunt trauma, blast, or ballistic events anywhere on the body. A further aspect of the present invention is to provide a novel means of dynamically fitting and anchoring apparel, orthosis, body protection devices or other objects that need to be securely fixed to the body anatomy during joint flexion or extension, by using motion at a body joint to actuate a closure mechanism and bracing system that actively closes upon the body anatomy surrounding the joint and transfers loads created during dynamic restraint of the joint to anchor zones on the body.",SIMBEX LLC,GREENWALD RICHARD M;;CHU JEFFREY J;;JESSIMAN ALEXANDER W;;BUCK AARON T;;BERTONI DAVID W;;GWIN JOSEPH T,SIMBEX LLC (2007-07-19),https://lens.org/065-695-960-796-213,Granted Patent,yes,39,7,2,2,0,A41D13/088;;A61F5/01;;A61F5/01;;A41D13/088,A61F5/00,602/20;;602/21,13,10,019-692-767-956-164;;104-994-701-968-431;;052-759-261-491-70X;;072-756-981-769-505;;006-751-344-856-60X;;045-463-535-849-435;;042-595-930-717-841;;001-545-850-765-007;;007-707-759-781-708;;004-134-579-649-836,8927007;;7630213;;10.4065/70.8.752;;10.1097/00005373-199906000-00015;;10372625;;11101105;;10.1177/03635465000280061001;;9934425;;10.1177/03635465990270012301;;10.1016/s0196-0644(97)70198-7;;9174522;;10424221;;10.1177/03635465990270041501;;8929359;;10.1056/nejm199611283352202;;8629753;;10.1016/s0196-0644(96)70324-4;;10.1177/03635465980260061501;;9850786,"Centers for Disease Control and Prevention. Incidence and Costs to Medicare of Fractures Among Medicare Beneficiaries Aged greater than or equal to 65 years-United States, Jul. 1991-Jun. 1992. Morbidity and Mortality Weekly Report 1996; 45(41): 877-883.;;Malanga, G., Stuart, M., ""In-Line Skating Safety Statistics"", National Electronic Injury Surveillance System, 1995 Mayo Clinic Proceedings 70, 752-754.;;Greenwald R.M., Senner V., Swanson S.C., ""Biomechanics of Carving Skis"", 2001 Sportmedizin und Sporttraumatologie, 49(1): 40-44.;;Sasaki K., Takagi M., Kiyoshig Y., Ogino T., ""Snowboarder's wrist: its severity compared with alpine skiing"" 1999 The Journal of Trauma: Injury, Infection, and Critical Care 46, 1059-1061.;;Idzikowski J., Janes P., Abbot P., ""Upper extremity snowboarding injuries: ten-year results from the Colorado Snowboard Injury Survey"" 2000 The Merican Journal of Sports Medicine 28, 825-832.;;O'Neill D., McGlone M., ""Injury risk in first-time snowboarders versus first-time skiers"", 1999, The American Journal of Sports Medicine 27, 94-97.;;National Institute of Arthritis and Musculoskeletal and Skin Diseases, ""Osteoporosis: Progress and Promise"", Health Topics, Aug. 2000.;;US Consumer Product Safety Commission, ""CPSC Projects Sharp Rise in In-Line Skating Injuries"", News from CPSC, Jun. 21, 1995, Release #95-135.;;Lewis L., West O., Standeven J., Jarvis H., ""Do wrist guards protect against fractures"", Annals of Emergency Medicine, Jun. 1997, 29, 766-769.;;Staebler M., Moore D., Akelman E., Weiss A., Fadale P., Crisco J., ""The effect of wrist guards on bone strain in the distal forearm"", The American Journal of Sports Medicine, 1999, 27, 500-506.;;Schieber R., Branche-Dorsey C., Ryan G., Rutherford G., Stevens J., O'Neill J., ""Risk factors for injuris from in-line skating and the effectiveness of safety gear"", The New England Journal of Medicine, 1996, 335, 1630-1635.;;Orenstein J., ""Injuries and small-wheel skates"", Annals of Emergency Medicine, 1996, 27, 204-209.;;Greenwald R.M., Janes P., Swanson S. C., MacDonald T. R., ""Dynamic Impact Response of Human Cadaveric Forearms Using a Wrist Brace"", American Journal of Sports Medicine, 1998, 26(6): 1-6.",INACTIVE
134,EP,A1,EP 1328793 A1,003-802-449-180-333,2003-07-23,2003,EP 01964585 A,2001-08-09,US 0141643 W;;US 65018200 A,2000-08-29,COLORIMETER HAVING FIELD PROGRAMMABLE GATE ARRAY,,APPLIED COLOR SYSTEMS INC,SLOCUM DAVID;;LOUISE JUSTIN R;;MERLE CORMIC K;;BOLES JOHN A;;EASTMAN JAY M;;FOX WILLIAM J;;GREENWALD ROGER J;;HUTCHINSON ROBERT J,,https://lens.org/003-802-449-180-333,Patent Application,yes,0,0,7,7,0,G01J3/02;;G01J1/06;;G01J3/0229;;G01J3/0289;;G01J3/465;;G01J3/51;;G01J3/513,G01N21/25;;G01J1/06;;G01J3/36;;G01J3/51;;G01J5/60;;G01N21/27,,0,0,,,,DISCONTINUED
135,US,B1,US 6816262 B1,143-041-360-527-76X,2004-11-09,2004,US 65018200 A,2000-08-29,US 65018200 A;;US 36005199 A,1999-07-23,Colorimeter having field programmable gate array,"
    A colorimeter capable of calibrating color monitors, whether having cathode ray tube or liquid crystal (LCD) displays, is provided by a photometric array of photodetector and optical filter pairs. The filters include long-pass, edge filters which cover overlapping regions at the upper end of the visible spectrum and a filter which covers the entire visible spectrum. The outputs of the photodetectors are digitally synthesized to provide a response which mimics the response established by the Commission Internationale de 1Eclairage (CIE) xyz (bar) functions almost perfectly. The response which is mimicked may be represented by the CIE color matching functions. The pairs and the associated components are mounted on a printed circuit board captured in a clamshell housing and having an array of apertures which define angularly constrained fields of view of a surface from which the light, to be colormetrically analyzed, emanates. The printed circuit board includes a field programmable gate array programmed to read data from the plurality of filter/detector pairs in parallel. The colorimeter is capable generally of measuring the color characteristics, especially the color temperatures of radiation radiating and reflecting bodies (sources), including so-called black bodies. 
",COLORVISION ADMINISTRATIVE AG,SLOCUM DAVID;;LOUISE JUSTIN R;;MERLE CORMIC K;;BOLES JOHN A;;EASTMAN JAY M;;FOX WILLIAM J;;GREENWALD ROGER J;;HUTCHINSON ROBERT J,COLORVISION ADMINISTRATIVE AG (2004-02-09);;CV US INC (2001-01-22);;DATACOLOR HOLDING AG (2005-12-21),https://lens.org/143-041-360-527-76X,Granted Patent,yes,6,20,10,10,0,G01J1/06;;G01J1/06;;G01J3/02;;G01J3/02;;G01J3/0256;;G01J3/0256;;G01J3/0264;;G01J3/0264;;G01J3/0291;;G01J3/0291;;G01J3/465;;G01J3/465;;G01J3/51;;G01J3/51;;G01J3/513;;G01J3/513;;G01J5/602;;G01J5/602,G01J1/06;;G01J3/02;;G01J3/51;;G01J5/60,356/416;;356/419,0,0,,,,EXPIRED
136,CA,A1,CA 2420686 A1,024-957-994-198-262,2002-03-07,2002,CA 2420686 A,2001-08-09,US 65018200 A;;US 0141643 W,2000-08-29,COLORIMETER HAVING FIELD PROGRAMMABLE GATE ARRAY,"A colorimeter capable of calibrating color monitors, is provided by a photometric array of photodetectors (38) and opticlal filter pairs (50). The filters include long-pass, edge filters which cover overlapping regions at t he upper end of the visible spectrum and a filter which covers the entire visib le spectrum. The outputs of the photodetectors are digitally synthesized to provide a response which mimics the response established by the Commission Internationale de l'Eclairage (CIE) xyz (bar) functions almost perfectly. Th e response which is mimicked may be represented by the CIE color matching functions. The pairs and the associated components are mounted on a printed circuit board (32) captured in a clamshell housing and having an array of apertures which define angularly constrained fields of view of a surface fro m which the light emanates.",APPLIED COLOR SYSTEMS INC,SLOCUM DAVID;;EASTMAN JAY M;;FOX WILLIAM J;;GREENWALD ROGER J;;HUTCHINSON ROBERT J;;BOLES JOHN A;;MERLE CORMIC K;;LOUISE JUSTIN R,,https://lens.org/024-957-994-198-262,Patent Application,no,0,0,7,7,0,G01J3/02;;G01J1/06;;G01J3/0229;;G01J3/0289;;G01J3/465;;G01J3/51;;G01J3/513,G01J1/06;;G01J3/36;;G01J3/51;;G01J5/60;;G01N21/27,,0,0,,,,DISCONTINUED
137,AU,A,AU 2001/085423 A,134-422-167-880-046,2002-03-13,2002,AU 2001/085423 A,2001-08-09,US 65018200 A;;US 0141643 W,2000-08-29,Colorimeter having field programmable gate array,,APPLIED COLOR SYSTEMS INC,SLOCUM DAVID;;LOUISE JUSTIN R;;MERLE CORMIC K;;BOLES JOHN A;;EASTMAN JAY M;;FOX WILLIAM J;;GREENWALD ROGER J;;HUTCHINSON ROBERT J,,https://lens.org/134-422-167-880-046,Patent Application,no,0,0,7,7,0,G01J3/02;;G01J1/06;;G01J3/0229;;G01J3/0289;;G01J3/465;;G01J3/51;;G01J3/513,G01J1/06;;G01J3/36;;G01J3/51;;G01J5/60;;G01N21/27,,0,0,,,,PENDING
138,EP,A4,EP 1328793 A4,180-502-089-160-606,2006-09-20,2006,EP 01964585 A,2001-08-09,US 0141643 W;;US 65018200 A,2000-08-29,COLORIMETER HAVING FIELD PROGRAMMABLE GATE ARRAY,,APPLIED COLOR SYSTEMS INC,SLOCUM DAVID;;LOUISE JUSTIN R;;MERLE CORMIC K;;BOLES JOHN A;;EASTMAN JAY M;;FOX WILLIAM J;;GREENWALD ROGER J;;HUTCHINSON ROBERT J,,https://lens.org/180-502-089-160-606,Search Report,no,2,0,7,7,0,G01J1/06;;G01J3/02;;G01J3/0229;;G01J3/0289;;G01J3/465;;G01J3/51;;G01J3/513,G01N21/25;;G01J1/06;;G01J3/36;;G01J3/51;;G01J5/60;;G01N21/27,,1,0,,,See also references of WO 0218916A1,DISCONTINUED
139,WO,A1,WO 2002/018916 A1,016-075-512-675-595,2002-03-07,2002,US 0141643 W,2001-08-09,US 65018200 A,2000-08-29,COLORIMETER HAVING FIELD PROGRAMMABLE GATE ARRAY,"A colorimeter capable of calibrating color monitors, is provided by a photometric array of photodetectors (38) and opticlal filter pairs (50). The filters include long-pass, edge filters which cover overlapping regions at the upper end of the visible spectrum and a filter which covers the entire visible spectrum. The outputs of the photodetectors are digitally synthesized to provide a response which mimics the response established by the Commission Internationale de l'Eclairage (CIE) xyz (bar) functions almost perfectly. The response which is mimicked may be represented by the CIE color matching functions. The pairs and the associated components are mounted on a printed circuit board (32) captured in a clamshell housing and having an array of apertures which define angularly constrained fields of view of a surface from which the light emanates.",APPLIED COLOR SYSTEMS INC,SLOCUM DAVID;;LOUISE JUSTIN R;;MERLE CORMIC K;;BOLES JOHN A;;EASTMAN JAY M;;FOX WILLIAM J;;GREENWALD ROGER J;;HUTCHINSON ROBERT J,,https://lens.org/016-075-512-675-595,Patent Application,yes,3,4,7,7,0,G01J3/02;;G01J1/06;;G01J3/0229;;G01J3/0289;;G01J3/465;;G01J3/51;;G01J3/513,G01J1/06;;G01J3/36;;G01J3/51;;G01J5/60;;G01N21/27,,1,0,,,See also references of EP 1328793A4,PENDING
140,FI,C,FI 54288 C,099-335-716-993-121,1978-11-10,1978,FI 218770 A,1970-08-07,US 84873669 A;;US 87821069 A;;US 88232769 A;;US 3389070 A;;US 3389170 A;;US 3389270 A;;US 3389370 A;;US 3397170 A;;US 3397270 A;;US 3397370 A;;US 3397470 A;;US 3397570 A;;US 3397670 A,1969-08-08,FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA SUBSTITUERADE INDENYLAETTIKSSYROR OCH DERAS SALTER OCH CIS-TRANS-ISOMERER,,MERCK & CO INC,BOLLINGER FREDERICK WILLIAM;;CONN JOHN BYRON;;HARMETZ RONALD;;HINKLEY DAVID FRED;;JONES HOWARD;;LINN BRUCE OSCAR;;REINHOLD DONALD FLOYD;;SHEN TSUNG-YING;;SLETZINGER MEYER;;WITZEL BRUCE EDWARD;;GREENWALD RICHARD BARRY,,https://lens.org/099-335-716-993-121,Granted Patent,no,0,0,10,156,0,C07C317/00,A61K31/19;;A61K31/21;;A61K31/275,,0,0,,,,EXPIRED
141,FI,B,FI 54288 B,123-117-780-114-681,1978-07-31,1978,FI 218770 A,1970-08-07,US 84873669 A;;US 87821069 A;;US 88232769 A;;US 3389070 A;;US 3389170 A;;US 3389270 A;;US 3389370 A;;US 3397170 A;;US 3397270 A;;US 3397370 A;;US 3397470 A;;US 3397570 A;;US 3397670 A,1969-08-08,FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA SUBSTITUERADE INDENYLAETTIKSSYROR OCH DERAS SALTER OCH CIS-TRANS-ISOMERER,,MERCK & CO INC,BOLLINGER FREDERICK WILLIAM;;CONN JOHN BYRON;;HARMETZ RONALD;;HINKLEY DAVID FRED;;JONES HOWARD;;LINN BRUCE OSCAR;;REINHOLD DONALD FLOYD;;SHEN TSUNG-YING;;SLETZINGER MEYER;;WITZEL BRUCE EDWARD;;GREENWALD RICHARD BARRY,,https://lens.org/123-117-780-114-681,Patent Application,no,0,0,10,156,0,C07C317/00,A61K31/19;;A61K31/21;;A61K31/275,,0,0,,,,EXPIRED
142,WO,A1,WO 2013/152262 A1,031-568-968-657-300,2013-10-10,2013,US 2013/0035386 W,2013-04-05,US 201261620542 P,2012-04-05,METHODS AND SYSTEMS FOR INTERACTIVE SOLUTIONING AND VISUALIZATION OF WORKING CAPITAL PRODUCTS,"Methods and systems for real-time, interactive solutioning and visualization of working capital for an enterprise employ a processor coupled to memory and other computer hardware and software components for storing fixed data consisting at least in part of information regarding financial institution products and information regarding governmental regulations; storing variable data consisting at least in part of information regarding operations of the enterprise; receiving variable data interactively consisting at least in part of information regarding enterprise preferences; and generating at least one recommendation for a proposed structure for the enterprise based at least in part on the fixed data and the variable data.",CITIGROUP TECHNOLOGY INC,ONG SHI WEI;;NEOH E MAY;;CHAN STEPHEN;;LEE KENG MUN;;PARK KWAN HOON;;KEHOE ANDREW;;MARTIN ALFONSO;;NAPPI ANTHONY;;YIP GERALDINE;;CHALLENOR DIANNE;;YADAV SUNDEEP;;SHAH GOURANG;;JACCARD PHILIPPE;;BATMAM JASON;;DAVID MIKE;;JOHNSON DANIELLE;;WILLIAM PETER;;TOWLER ELIZABETH;;GREENWALD GARY;;AJINKYA YOGESH,,https://lens.org/031-568-968-657-300,Patent Application,yes,12,0,2,2,0,G06Q40/00;;G06Q40/02;;G06Q40/00,G06F17/30;;G06F3/048;;G06Q10/06,,0,0,,,,PENDING
143,LT,T,LT 3347379 T,026-948-506-779-817,2020-05-11,2020,LT 17797429 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/026-948-506-779-817,Unknown,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
144,US,A1,US 2013/0268420 A1,028-657-111-350-154,2013-10-10,2013,US 201313857285 A,2013-04-05,US 201313857285 A;;US 201261620542 P,2012-04-05,Methods and Systems for Interactive Solutioning and Visualization of Working Capital Products,"Methods and systems for real-time, interactive solutioning and visualization of working capital for an enterprise employ a processor coupled to memory and other computer hardware and software components for storing fixed data consisting at least in part of information regarding financial institution products and information regarding governmental regulations; storing variable data consisting at least in part of information regarding operations of the enterprise; receiving variable data interactively consisting at least in part of information regarding enterprise preferences; and generating at least one recommendation for a proposed structure for the enterprise based at least in part on the fixed data and the variable data.",CITIGROUP TECHNOLOGY INC,ONG SHI WEI;;NEOH E MAY;;CHAN STEPHEN;;LEE KENG MUN;;PARK KWAN HOON;;KEHOE ANDREW;;MARTIN ALFONSO;;NAPPI ANTHONY;;YIP GERALDINE;;CHALLENOR DIANNE;;YADAV SUDEEP;;SHAH GOURANG;;JACCARD PHILIPPE;;BATMAN JASON;;DAVID MIKE;;JOHNSON DANIELLE;;WILLIAMS PETER;;TOWLER ELIZABETH;;GREENWALD GARY;;AJINKYA YOGESH;;KAZI SABIHA,,https://lens.org/028-657-111-350-154,Patent Application,yes,11,4,2,2,0,G06Q40/00;;G06Q40/02;;G06Q40/00,G06Q40/02,705/35,0,0,,,,DISCONTINUED
145,SG,A,SG 11201901077R A,004-006-214-513-761,2019-03-28,2019,SG 11201901077R A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/004-006-214-513-761,Unknown,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
146,HU,T2,HU E048313 T2,196-415-130-852-483,2020-07-28,2020,HU E17797429 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/196-415-130-852-483,Amended Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
147,MX,A,MX 2019001878 A,043-320-648-790-600,2019-07-01,2019,MX 2019001878 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF.",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,ERAN OPHIR;;LIAT DASSA;;MARK WHITE;;SANDEEP KUMAR;;CHRISTOPHER CHAN;;SPENCER LIANG;;LANCE STAPLETON;;YOSI GOZLAN;;ZOHAR TIRAN;;LEONARD PRESTA;;RICHARD THEOLIS;;ILAN VAKNIN;;ANDREW W DRAKE;;SHIRLEY SAMEAH-GREENWALD;;GAD S COJOCARU;;MAYA KOTTURI;;HSIN-YUAN CHENG;;KYLE HANSEN;;DAVID NISIM GILADI;;EINAV SAFYON;;RADHIKA DESAI;;PATRICK WALL,,https://lens.org/043-320-648-790-600,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
148,HR,T1,HR P20200189 T1,170-271-144-987-019,2020-05-01,2020,HR P20200189 T,2020-02-05,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;EP 17797429 A;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/170-271-144-987-019,Granted Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
149,US,B2,US 10213505 B2,015-787-101-918-416,2019-02-26,2019,US 201815937784 A,2018-03-27,US 201815937784 A;;US 201715795135 A;;US 201715680187 A;;US 201662376335 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P;;US 201662376334 P;;US 201762513771 P,2016-08-17,"Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/015-787-101-918-416,Granted Patent,yes,53,5,50,52,612,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/00;;A61K39/00;;A61K39/395;;C07K16/28,,13,10,020-883-295-175-85X;;003-204-276-209-117;;003-082-950-776-533;;026-314-498-200-929;;100-399-671-580-29X;;022-608-838-432-215;;042-879-791-960-298;;028-947-110-430-895;;082-735-005-968-62X;;047-792-343-788-48X,10.4161/viru.26153;;pmc5359721;;23979029;;26870003;;pmc4740385;;10.3389/fmicb.2016.00022;;19815499;;pmc2764881;;10.1073/pnas.0903474106;;10.1038/ni.1674;;19011627;;10.1084/jem.20150785;;26755705;;pmc4749091;;25465800;;10.1016/j.ccell.2014.10.018;;24959420;;pmc4050364;;10.3389/fonc.2014.00134;;28978021;;pmc5620161;;10.18632/oncotarget.18004;;22437872;;10.1038/nrc3236;;10.1016/j.cell.2012.02.034;;pmc3310896;;22424219,"Nosanchuk JD., the interdependence of antibody C and V regions on specificity and affinity: significant implications for the engineering of therapeutic antibodies., Virulence. Aug. 15, 2013;4(6):439-40. doi: 10.4161/viru.26153.;;Janda et al., Ig Constant Region Effects on Variable Region Structure and Function., Front Microbiol. Feb. 4, 2016;7:22. doi: 10.3389/fmicb.2016.00022. eCollection 2016.;;Gene ID: PVRIG antibody—middle region, Rabbit Polyclonal Antibody Catalog #AI13083, retrieved from the internet: URL:http://www.funakoshi.co.jp/data/datasheet/ABG/AI13083.pdf.;;Stanietsky et al., The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity., Proc Natl Acad Sci U S A. Oct. 20, 2009;106(42):17858-63.;;Yu et al., The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells., Nat Immunol. Jan. 2009;10(1):48-57.;;Zhu et al., Identification of CD112R as a novel checkpoint for human T cells., J Exp Med. Feb. 8, 2016;213(2):167-76.;;Rotman et al., Identification of novel immune checkpoints as targets for cancer immunotherapy., J Immunother Cancer. 2013; 1(Suppl 1): P135.;;Johnston et al., The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function., Cancer Cell. Dec. 8, 2014;26(6):923-37.;;Orentas et al., Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison., Front Oncol. Jun. 10, 2014;4:134.;;Quinones et al., 2205 High-throughput cellular assays using a well-less plate format. Genentech, South San Francisco, CA, Curiox Biosystems, Singapore, New Technologies and Frontiers, Dec. 6, 2011.;;He et al., Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies., Oncotarget. May 19, 2007;8(40):67129-67139. doi: 10.18632/oncotarget.18004. eCollection Sep. 15, 2017.;;Scott et al., Antibody therapy of cancer., 2012, Nature Reviews, vol. 12: 278-287.;;Weiner et al., Antibody-based immunotherapy of cancer., Cell. Mar 16, 2012;148(6):1081-4. doi: 10.1016/j.ce11.2012.02.034.",ACTIVE
150,PL,T3,PL 3347379 T3,015-560-857-709-044,2020-05-18,2020,PL 17797429 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;EP 17797429 A;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/015-560-857-709-044,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
151,MX,A,MX 2021006235 A,046-114-925-295-598,2021-08-11,2021,MX 2021006235 A,2019-02-15,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF.",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,OPHIR ERAN;;DASSA LIAT;;KUMAR SANDEEP;;GOZLAN YOSI;;TIRAN ZOHAR;;VAKNIN ILAN;;DRAKE ANDREW W;;SAMEAH-GREENWALD SHIRLEY;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;DESAI RADHIKA;;WALL PATRICK;;LIANG SPENCER;;CHAN CHRISTOPHER;;WHITE MARK;;STAPLETON LANCE;;PRESTA LEONARD;;THEOLIS RICHARD,,https://lens.org/046-114-925-295-598,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00;;A61K39/395,,0,0,,,,PENDING
152,CY,T1,CY 1122653 T1,085-495-381-895-523,2021-05-05,2021,CY 201100108 T,2020-02-05,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΤΙGΙΤ, ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΡVRIG ΚΑΙ ΣΥΝΔΥΑΣΜΟΙ ΕΞ ΑΥΤΩΝ",Αντισώματα αντι-ΡVRIG και αντι-ΤΙGΙΤ παρέχονται.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/085-495-381-895-523,Granted Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
153,CL,A1,CL 2021002836 A1,091-862-107-109-832,2022-07-29,2022,CL 2021002836 A,2021-10-28,US 201662376334 P;;US 201962376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P,2016-08-17,"Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos (divisional de la solicitud n° 201900424)",Se proporcionan anticuerpos anti-PVRIG y anti-TIGIT.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK;;COJOCARU GAD S,,https://lens.org/091-862-107-109-832,Patent Application,no,0,0,1,52,0,,A61K39/00;;C07K16/28,,0,0,,,,PENDING
154,UA,C2,UA 126802 C2,103-169-583-526-467,2023-02-08,2023,UA A201902564 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/103-169-583-526-467,Limited Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,,,0,0,,,,ACTIVE
155,CN,A,CN 110088132 A,187-891-290-918-163,2019-08-02,2019,CN 201780050131 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/187-891-290-918-163,Patent Application,no,4,6,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,1,0,,,"NOA STANIETSKY等: ""The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity"", 《PNAS》",ACTIVE
156,KR,A,KR 20230145510 A,117-086-777-755-561,2023-10-17,2023,KR 20237033526 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;KR 20227009297 A;;IB 2017001256 W,2016-08-17,-TIGIT -PVRIG ANTI-TIGIT ANTIBODIES ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF,항-PVRIG 및 항-TIGIT 항체가 제공된다.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/117-086-777-755-561,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00;;A61P35/00,,0,0,,,,DISCONTINUED
157,US,B2,US 10124061 B2,093-509-912-677-82X,2018-11-13,2018,US 201715795135 A,2017-10-26,US 201715795135 A;;US 201715680187 A;;US 201762513771 P;;US 201662376335 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P;;US 201662376334 P,2016-08-17,"Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/093-509-912-677-82X,Granted Patent,yes,53,7,50,52,612,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,A61K39/395;;A61K39/00;;C07K16/28,,13,10,020-883-295-175-85X;;003-204-276-209-117;;003-082-950-776-533;;026-314-498-200-929;;100-399-671-580-29X;;022-608-838-432-215;;042-879-791-960-298;;028-947-110-430-895;;082-735-005-968-62X;;047-792-343-788-48X,10.4161/viru.26153;;pmc5359721;;23979029;;26870003;;pmc4740385;;10.3389/fmicb.2016.00022;;19815499;;pmc2764881;;10.1073/pnas.0903474106;;10.1038/ni.1674;;19011627;;10.1084/jem.20150785;;26755705;;pmc4749091;;25465800;;10.1016/j.ccell.2014.10.018;;24959420;;pmc4050364;;10.3389/fonc.2014.00134;;28978021;;pmc5620161;;10.18632/oncotarget.18004;;22437872;;10.1038/nrc3236;;10.1016/j.cell.2012.02.034;;pmc3310896;;22424219,"Nosanchuk JD., The interdependence of antibody C and V regions on specificity and affinity: significant implications for the engineering of therapeutic antibodies., Virulence. Aug. 15, 2013;4(6):439-40. doi: 10.4161/viru.26153.;;Janda et al., Ig Constant Region Effects on Variable Region Structure and Function., Front Microbiol. Feb. 4, 2016;7:22. doi: 10.3389/fmicb.2016.00022. eCollection 2016.;;Gene ID: PVRIG antibody—middle region, Rabbit Polyclonal Antibody Catalog #Al13083, retrieved from the internet: URL:http://www.funakoshi.co.jp/data/datasheet/ABG/Al1308.pdf.;;Stanietsky et al., The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity., Proc Natl Acad Sci U S A. Oct. 20, 2009;106(42):17858-63.;;Yu et al., The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells., Nat Immunol. Jan. 2009;10(1):48-57.;;Zhu et al., Identification of CD112R as a novel checkpoint for human T cells., J Exp Med. Feb. 8, 2016;213(2):167-76.;;Rotman et al., Identification of novel immune checkpoints as targets for cancer immunotherapy., J Immunother Cancer. 2013; 1(Suppl 1): P135.;;Johnston et al., The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function., Cancer Cell. Dec. 8, 2014;26(6):923-37.;;Orentas et al., Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison., Front Oncol. Jun. 10, 2014;4:134.;;Quinones et al., 2205 High-throughput cellular assays using a well-less plate format. Genentech, South San Francisco, CA, Curiox Biosystems, Singapore, New Technologies and Frontiers, Dec. 6, 2011.;;He et al., Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies., Oncotarget. May 19, 2017;8(40):67129-67139. doi: 10.18632/oncotarget.18004. eCollection Sep. 15, 2017.;;Scott et al., Antibody therapy of cancer., 2012, Nature Reviews, vol. 12: 278-287.;;Weiner et al., Antibody-based immunotherapy of cancer., Cell. Mar. 16, 2012;148(6):1081-4. doi: 10.1016/j.cell.2012.02.034.",ACTIVE
158,WO,A1,WO 2018/033798 A1,122-889-475-937-044,2018-02-22,2018,IB 2017001256 W,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513775 P;;US 201762513916 P;;US 201762513771 P;;US 201762538561 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/122-889-475-937-044,Patent Application,yes,66,64,50,52,611,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,93,79,020-883-295-175-85X;;003-204-276-209-117;;055-941-254-232-339;;010-801-824-793-588;;079-191-303-518-861;;061-453-882-230-419;;000-631-306-299-887;;012-165-170-835-272;;082-472-766-436-845;;012-780-527-944-741;;024-956-179-363-052;;005-018-877-991-494;;006-451-527-297-818;;039-289-782-216-880;;043-632-912-449-253;;109-281-805-500-720;;141-009-316-280-461;;059-063-827-066-032;;032-412-591-971-193;;032-462-237-933-86X;;049-134-753-209-354;;006-574-964-805-278;;045-094-249-115-990;;012-273-285-250-15X;;002-141-834-487-41X;;006-574-964-805-278;;042-204-626-457-327;;030-323-674-660-051;;066-419-294-278-929;;009-483-512-107-343;;044-522-255-085-902;;017-677-372-355-841;;039-004-732-914-566;;013-142-717-038-23X;;015-395-754-996-662;;106-032-800-597-23X;;116-193-705-533-609;;072-548-742-004-170;;019-090-814-439-613;;014-113-432-888-031;;055-627-013-189-514;;097-637-621-469-520;;004-458-031-333-650;;033-955-564-406-161;;005-219-687-670-471;;026-164-216-541-151;;032-728-154-591-070;;056-201-471-905-934;;028-862-168-091-90X;;094-244-865-622-863;;025-440-140-405-971;;050-672-300-487-304;;072-042-364-654-214;;076-912-994-506-04X;;066-486-712-233-96X;;077-640-818-602-884;;131-380-770-470-779;;060-699-153-259-75X;;045-623-729-340-346;;002-171-587-882-558;;013-242-591-207-277;;007-681-485-057-727;;004-701-625-088-792;;088-434-716-536-224;;048-961-183-736-197;;100-399-671-580-29X;;057-692-130-684-50X;;026-314-498-200-929;;003-082-950-776-533;;022-608-838-432-215;;001-581-530-503-356;;041-466-573-640-315;;038-569-018-972-189;;075-341-946-006-056;;087-161-446-916-210;;052-956-966-509-490;;000-846-337-409-979;;114-078-098-241-965;;002-391-233-537-014,10.4161/viru.26153;;pmc5359721;;23979029;;26870003;;pmc4740385;;10.3389/fmicb.2016.00022;;10.1016/j.semcancer.2005.07.009;;16140545;;10.1146/annurev.immunol.23.021704.115611;;15771580;;15771565;;10.1146/annurev.immunol.23.021704.115839;;10.1158/1078-0432.ccr-07-0016;;17606736;;pmc2867907;;20385810;;10.1073/pnas.1003345107;;10.1158/0008-5472.can-11-2637;;22205715;;pmc3288235;;24667641;;pmc4001555;;10.1172/jci73639;;10.1093/intimm/5.8.957;;8398989;;10.1002/dvg.22938;;pmc5084746;;27012318;;10.1073/pnas.63.1.78;;5257969;;pmc534037;;12148987;;10.1021/ja027007w;;12404640;;10.1002/1439-7633(20021104)3:11<1135::aid-cbic1135>3.0.co;2-m;;10.1073/pnas.172226299;;12154230;;pmc123203;;1409642;;10.1073/pnas.89.20.9367;;pmc50132;;10.1016/j.tig.2004.09.013;;15522458;;15138302;;10.1073/pnas.0401517101;;pmc419646;;12920298;;10.1126/science.1084772;;10.1034/j.1600-065x.2002.19009.x;;12493010;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/321522a0;;3713831;;10.1126/science.2451287;;2451287;;10.1021/bp030070k;;15176864;;10.1016/b978-012053641-2/50034-4;;10.1038/321522a0;;3713831;;3127726;;10.1038/332323a0;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;9551944;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;9377574;;pmc51622;;10.1073/pnas.88.10.4181;;1903536;;8302875;;pmc521435;;10.1073/pnas.91.3.969;;10556035;;10.1006/jmbi.1999.3141;;9099717;;10.1074/jbc.272.16.10678;;10.1074/jbc.271.37.22611;;8798431;;9671778;;pmc21176;;10.1073/pnas.95.15.8910;;14600205;;10.1093/protein/gzg096;;10.4049/jimmunol.169.2.1119;;12097421;;12218124;;10.4049/jimmunol.169.6.3076;;11849310;;10.1046/j.0019-2805.2001.01341.x;;pmc1782638;;10.1016/s0165-2478(02)00019-6;;12008035;;11096108;;10.1074/jbc.m009483200;;10.1038/nri2761;;20414204;;10.1093/nar/gks1370;;3382986;;10.1093/bioinformatics/4.1.11;;10.1016/0022-2836(70)90057-4;;5420325;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;23386332;;10.1007/978-1-62703-296-4_1;;10.1016/s1074-7613(00)70060-4;;8673704;;10.1016/s0092-8674(00)81683-9;;10647931;;21376230;;10.1016/j.cell.2011.02.013;;24122236;;pmc4255306;;10.1002/path.4287;;23890065;;10.1016/j.immuni.2013.06.014;;10.1073/pnas.1607836113;;pmc5137776;;27837027;;27079802;;pmc5381938;;10.1038/nrc.2016.36;;10.1158/1078-0432.ccr-15-1849;;27084739;;pmc4872712;;10.1038/nrc3239;;pmc4856023;;22437870;;10.1007/3-540-30683-8_443;;25860605;;pmc5905674;;10.1016/j.cell.2015.03.030;;24871131;;pmc4558099;;10.1126/scitranslmed.3008211;;10.1158/1078-0432.ccr-15-1088;;26180060;;10.1038/nature13954;;pmc4246418;;25428505;;10.21417/b7z59d;;22285893;;10.1016/j.coi.2012.01.009;;25743219;;10.1038/nri3799;;10.1084/jem.20150785;;26755705;;pmc4749091;;10.1084/jem.20030788;;pmc2194180;;12913096;;10.1038/ni.1674;;19011627;;19815499;;pmc2764881;;10.1073/pnas.0903474106;;25465800;;10.1016/j.ccell.2014.10.018;;26842126;;10.1007/s00262-016-1799-4;;10.1038/ni.2850;;24658051;;10.4049/jimmunol.172.7.3994;;15034010;;10.1158/0008-5472.can-07-3119;;18339883;;10.1007/s00251-011-0519-7;;21390552;;22461641;;pmc3568523;;10.1126/scitranslmed.3003689;;24432022;;10.3389/fimmu.2013.00508;;pmc3882864;;24343663;;10.1038/icb.2013.95;;pmc2212458;;10.1084/jem.188.2.277;;9670040,"JOSHUA D. NOSANCHUK: ""The interdependence of antibody C and V regions on specificity and affinity : Significant implications for the engineering of therapeutic antibodies"", VIRULENCE, vol. 4, no. 6, 15 August 2013 (2013-08-15), US, pages 439 - 440, XP055436928, ISSN: 2150-5594, DOI: 10.4161/viru.26153;;ALENA JANDA ET AL: ""Ig Constant Region Effects on Variable Region Structure and Function"", FRONTIERS IN MICROBIOLOGY, vol. 7, 4 February 2016 (2016-02-04), XP055436953, DOI: 10.3389/fmicb.2016.00022;;WANG: ""Immune Suppression by Tumor Specific CD4+ Regulatory T cells in Cancer"", SEMIN. CANCER. BIOL., vol. 16, 2006, pages 73 - 79, XP024908039, DOI: doi:10.1016/j.semcancer.2005.07.009;;GREENWALD ET AL.: ""The B7 Family Revisited"", ANN. REV. IMMUNOL., vol. 23, 2005, pages 515 - 548, XP002481408, DOI: doi:10.1146/annurev.immunol.23.021704.115611;;WATTS: ""TNF/TNFR Family Members in Co-stimulation of T Cell Responses"", ANN. REV. IMMUNOL., vol. 23, 2005, pages 23 - 68, XP008051583, DOI: doi:10.1146/annurev.immunol.23.021704.115839;;SADUM ET AL.: ""Immune Signatures of Murine and Human Cancers Reveal Unique Mechanisms of Tumor Escape and New Targets for Cancer Immunotherapy"", CLIN. CANE. RES., vol. 13, no. 13, 2007, pages 4016 - 4025, XP055248327, DOI: doi:10.1158/1078-0432.CCR-07-0016;;AHMADZADEH ET AL., BLOOD, vol. 114, 2009, pages 1537;;MATSUZAKI ET AL., PNAS, vol. 107, no. 17, 2010, pages 7875 - 7880;;FOURCADE ET AL., CANCER RES., vol. 72, no. 4, 2012, pages 887 - 896;;GROS ET AL., J. CLINICAL INVEST, vol. 124, no. 5, 2014, pages 2246;;KOENTGEN ET AL., INT IMMUNOL, vol. 5, 1993, pages 957 - 964;;KOENTGEN ET AL., GENESIS, vol. 54, 2016, pages 326 - 333;;EDELMAN ET AL., PROC NATL ACAD SCI USA, vol. 63, 1969, pages 78 - 85;;J. W. CHIN ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 124, 2002, pages 9026 - 9027;;J. W. CHIN; P. G. SCHULTZ, CHEMBIOCHEM, vol. 11, 2002, pages 1135 - 1137;;J. W. CHIN ET AL., PICAS UNITED STATES OF AMERICA, vol. 99, 2002, pages 11020 - 11024;;L. WANG; P. G. SCHULTZ, CHEM., 2002, pages 1 - 10;;SIMON ET AL., PNAS USA, vol. 89, no. 20, 1992, pages 9367;;CROPP; SHULTZ, TRENDS GENET, vol. 20, no. 12, 2004, pages 625 - 630;;ANDERSON ET AL., PROC NATL ACAD SCI USA, vol. 101, no. 2, 2004, pages 7566 - 7571;;CHIN ET AL., SCIENCE, vol. 301, no. 5635, 2003, pages 964 - 967;;DAVIS; 2002 ET AL., IMMUNOLOGICAL REVIEWS, vol. 190, pages 123 - 136;;KABAT ET AL.: ""SEQUENCES OF PROTEINS OF IMMUNOLOGICAL INTEREST"", 1991, NATIONAL INSTITUTES OF HEALTH;;CHOTHIA; LESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;LAFRANC ET AL., DEV. COMP. IMMUNOL., vol. 27, no. 1, 2003, pages 55 - 77;;JONES, NATURE, vol. 321, 1986, pages 522 - 525;;VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534 - 1536;;ROQUE ET AL., BIOTECHNOL. PROG., vol. 20, 2004, pages 639 - 654;;TSURUSHITA; VASQUEZ: ""Humanization of Monoclonal Antibodies, Molecular Biology of B Cells"", 2004, ELSEVIER SCIENCE, article ""Humanization of Monoclonal Antibodies, Molecular Biology of B Cells"", pages: 533 - 545;;JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525;;RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329;;QUEEN ET AL., PROC NATL ACAD SCI, USA, vol. 86, 1989, pages 10029 - 10033;;HE ET AL., J. IMMUNOL., vol. 160, 1998, pages 1029 - 1035;;CARTER ET AL., PROC NATL ACAD SCI USA, vol. 89, 1992, pages 4285 - 4289;;PRESTA ET AL., CANCER RES., vol. 57, no. 20, 1997, pages 4593 - 4599;;GORMAN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 4181 - 4185;;O'CONNOR ET AL., PROTEIN ENG, vol. 11, 1998, pages 321 - 328;;ROGUSKA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 969 - 973;;WU ET AL., J. MOL. BIOL., vol. 294, 1999, pages 151 - 162;;BACA ET AL., J. BIOL. CHEM., vol. 272, no. 16, 1997, pages 10678 - 10684;;ROSOK ET AL., J. BIOL. CHEM., vol. 271, no. 37, 1996, pages 22611 - 22618;;RADER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 8910 - 8915;;KRAUSS ET AL., PROTEIN ENGINEERING, vol. 16, no. 10, 2003, pages 753 - 759;;TAN ET AL., J. IMMUNOL., vol. 169, 2002, pages 1119 - 1125;;DE PASCALIS ET AL., J. IMMUNOL., vol. 169, 2002, pages 3076 - 3084;;AALBERSE, RC; SCHUURMAN J., IMMUNOLOGY, vol. 105, 2002, pages 9 - 19;;JEFFERIS ET AL., IMMUNOL LETT, vol. 82, 2002, pages 57 - 65;;SHIELDS, R. L. ET AL., J. BIOL. CHEM., vol. 276, 2001, pages 6591 - 6604;;CHAN CA; CARTER PJ, NATURE REVLMMUNOL, vol. 10, 2010, pages 301 - 316;;YE ET AL., NUCLEIC ACIDS RES., vol. 41, 2013, pages W34 - W40;;E. MEYERS; W. MILLER, COMPUT. APPL. BIOSCI., vol. 4, 1988, pages 11 - 17;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 444 - 453;;ALTSCHUL ET AL., J MOL. BIOL., vol. 215, 1990, pages 403 - 410;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402;;OSOL A.: ""Remington's Pharmaceutical Sciences. 16th Ed."", 1980;;AGNEW, CHEM INTL. ED. ENGL., vol. 33, 1994, pages 183 - 186;;GOODKIND ET AL., COMPUTERS AND CHEM. ENG., vol. 29, no. 3, 2005, pages 589;;HAN ET AL., BIOINFORM. BIOL. INSIGHTS, vol. 9, no. 1, 15 November 2015 (2015-11-15), pages 29 - 46;;CAMPO ET AL., NOD. PATHOL., vol. 26, no. 1, January 2013 (2013-01-01), pages S97 - S110;;WANG ET AL.: ""Recent Advances in Capillary Electrophoresis-Based Proteomic Techniques for Biomarker Discovery"", METHODS. MOL. BIOL., vol. 984, 2013, pages 1 - 12;;TAYLOR ET AL., BIOMED RES, vol. 2014, pages 8;;BECERK ET AL., MUTAT. RES, vol. 722, no. 2, 17 June 2011 (2011-06-17), pages 171 - 182;;SHIBUYA ET AL., IMMUNITY, vol. 4, no. 6, 1 June 1996 (1996-06-01), pages 573 - 581;;ZHU, J. EXP. MED., 2016, pages 1 - 10;;AALBERSE ET AL., IMMUNOLOGY, vol. 202, no. 105, pages 9 - 19;;HANAHAN D; WEINBERG RA: ""The hallmarks of cancer"", CELL, vol. 100, no. 1, 2000, pages 57 - 70;;HANAHAN D; WEINBERG RA: ""Hallmarks of cancer: the next generation"", CELL, vol. 144, no. 5, 2011, pages 646 - 674, XP028185429, DOI: doi:10.1016/j.cell.2011.02.013;;GALON J; MLECNIK B; BINDEA G; ANGELL HK; BERGER A; LAGORCE C ET AL.: ""Towards the introduction of the 'Immunoscore' in the classification of malignant tumours"", J PATHOL, vol. 232, no. 2, 2014, pages 199 - 209, XP055246049, DOI: doi:10.1002/path.4287;;ZITVOGEL L; GALLUZZI L; SMYTH MJ; KROEMER G: ""Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance"", IMMUNITY, vol. 39, no. l, 2013, pages 74 - 88;;DANILOVA L; WANG H; SUNSHINE J; KAUNITZ GJ; COTTRELL TR; XU H ET AL.: ""Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors"", PROC NATL ACAD SCI U S A, vol. 113, no. 48, 2016, pages E7769 - E7777;;TOPALIAN SL; TAUBE JM; ANDERS RA; PARDOLL DM: ""Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy"", NAT REV CANCER, vol. 16, no. 5, 2016, pages 275 - 287, XP055375806, DOI: doi:10.1038/nrc.2016.36;;ZAROUR HM: ""Reversing T-cell Dysfunction and Exhaustion in Cancer"", CLIN CANCER RES, vol. 22, no. 8, 2016, pages 1856 - 1864;;PARDOLL DM: ""The blockade of immune checkpoints in cancer immunotherapy"", NAT REV CANCER, vol. 12, no. 4, 2012, pages 252 - 64, XP055415943, DOI: doi:10.1038/nrc3239;;SHARMA P; ALLISON JP: ""Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential"", CELL, vol. 161, no. 2, 2015, pages 205 - 214, XP055427087, DOI: doi:10.1016/j.cell.2015.03.030;;CHA E; KLINGER M; HOU Y; CUMMINGS C; RIBAS A; FAHAM M ET AL.: ""Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients"", SCI TRANSL MED, vol. 6, no. 238, 2014, pages 238ra70, XP055219304, DOI: doi:10.1126/scitranslmed.3008211;;ROBERT L; TSOI J; WANG X; EMERSON R; HORNET B; CHODON T ET AL.: ""CTLA4 blockade broadens the peripheral T-cell receptor repertoire"", CLIN CANCER RES, vol. 20, no. 9, 2014, pages 2424 - 2432, XP055145637, DOI: doi:10.1158/1078-0432.CCR-13-2648;;TUMEH PC; HARVIEW CL; YEARLEY JH; SHINTAKU IP; TAYLOR EJ; ROBERT L ET AL.: ""PD-1 blockade induces responses by inhibiting adaptive immune resistance"", NATURE, vol. 515, no. 7528, 2014, pages 568 - 571, XP055247294, DOI: doi:10.1038/nature13954;;CHAN CJ; ANDREWS DM; SMYTH MJ: ""Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer"", CURR OPIN IMMUNOL, vol. 24, no. 2, 2012, pages 246 - 251, XP055147483, DOI: doi:10.1016/j.coi.2012.01.009;;MARTINET L; SMYTH MJ: ""Balancing natural killer cell activation through paired receptors"", NAT REV IMMUNOL, vol. 15, no. 4, 2015, pages 243 - 254, XP055424277, DOI: doi:10.1038/nri3799;;ZHU Y; PANICCIA A; SCHULICK AC; CHEN W; KOENIG MR; BYERS JT ET AL.: ""Identification of CD112R as a novel checkpoint for human T cells"", J EXP MED, vol. 213, no. 2, 2016, pages 167 - 176, XP055314642, DOI: doi:10.1084/jem.20150785;;BOTTINO C; CASTRICONI R; PENDE D; RIVERA P; NANNI M; CARNEMOLLA B ET AL.: ""Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule"", J EXP MED, vol. 198, no. 4, 2003, pages 557 - 567, XP055011690, DOI: doi:10.1084/jem.20030788;;YU X; HARDEN K; GONZALEZ LC; FRANCESCO M; CHIANG E; IRVING B ET AL.: ""The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells"", NAT IMMUNOL, vol. 10, no. 1, 2009, pages 48 - 57, XP055273979, DOI: doi:10.1038/ni.1674;;STANIETSKY N; SIMIC H; ARAPOVIC J; TOPORIK A; LEVY O; NOVIK A ET AL.: ""The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity"", PROC NATL ACAD SCI USA, vol. 106, no. 42, 2009, pages 17858 - 17863, XP055215810, DOI: doi:10.1073/pnas.0903474106;;JOHNSTON RJ; COMPS-AGRAR L; HACKNEY J; YU X; HUSENI M; YANG Y ET AL.: ""The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function"", CANCER CELL, vol. 26, no. 6, 2014, pages 923 - 937, XP029111576, DOI: doi:10.1016/j.ccell.2014.10.018;;ZHANG B; ZHAO W; LI H; CHEN Y; TIAN H; LI L ET AL.: ""Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155"", CANCER IMMUNOL IMMUNOTHER, vol. 65, no. 3, 2016, pages 305 - 314, XP035871383, DOI: doi:10.1007/s00262-016-1799-4;;CHAN CJ; MARTINET L; GILFILLAN S; SOUZA-FONSECA-GUIMARAES F; CHOW MT; TOWN L ET AL.: ""The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions"", NAT IMMUNOL, vol. 15, no. 5, 2014, pages 431 - 438, XP055344476, DOI: doi:10.1038/ni.2850;;FUCHS A; CELLA M; GIURISATO E; SHAW AS; COLONNA M: ""Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155"", J IMMUNOL, vol. 172, no. 7, 2004, pages 3994 - 3998, XP055344481, DOI: doi:10.4049/jimmunol.172.7.3994;;MACHLENKIN A; UZANA R; FRANKENBURG S; EISENBERG G; EISENBACH L; PITCOVSKI J ET AL.: ""Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs"", CANCER RES, vol. 68, no. 6, 2008, pages 2006 - 2013;;OHTANI H; NAKAJIMA T; AKARI H; ISHIDA T; KIMURA A: ""Molecular evolution of immunoglobulin superfamily genes in primates"", IMMUNOGENETICS, vol. 63, no. 7, 2011, pages 417 - 428, XP019914282, DOI: doi:10.1007/s00251-011-0519-7;;TAUBE JM; ANDERS RA; YOUNG GD; XU H; SHARMA R; MCMILLER TL ET AL.: ""Colocalization of inflammatory response with B7-hl expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape"", SCI TRANSL MED, vol. 4, no. 127, 2012, pages 127ra37, XP055370851, DOI: doi:10.1126/scitranslmed.3003689;;CERBONI C; FIONDA C; SORIANI A; ZINGONI A; DORIA M; CIPPITELLI M ET AL.: ""The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells"", FRONT IMMUNOL, vol. 4, 2014, pages 508;;DE ANDRADE LF; SMYTH MJ; MARTINET L: ""DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins"", IMMUNOL CELL BIOL, vol. 92, no. 3, 2014, pages 237 - 244;;OVERWIJK WW; TSUNG A; IRVINE KR; PARKHURST MR; GOLETZ TJ; TSUNG K ET AL.: ""gplOO/pmel 17 is a murine tumor rejection antigen: induction of ''self'-reactive, tumoricidal T cells using high-affinity, altered peptide ligand"", J EXP MED, vol. 188, no. 2, 1998, pages 277 - 286, XP002938364, DOI: doi:10.1084/jem.188.2.277",PENDING
159,AU,A1,AU 2017/313405 A1,167-100-830-751-415,2019-02-28,2019,AU 2017/313405 A,2017-08-17,US 201762513916 P;;US 201662376335 P;;US 201662376334 P;;US 201762513771 P;;US 201762538561 P;;US 201762477974 P;;US 201762513775 P;;US 201662417217 P;;IB 2017001256 W,2016-08-17,"Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/167-100-830-751-415,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
160,US,B2,US 10751415 B2,030-388-164-789-75X,2020-08-25,2020,US 201715680187 A,2017-08-17,US 201715680187 A;;US 201662376334 P;;US 201762513771 P;;US 201662376335 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P,2016-08-17,"Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/030-388-164-789-75X,Granted Patent,yes,53,2,50,52,612,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K16/28,,15,12,020-883-295-175-85X;;003-204-276-209-117;;003-082-950-776-533;;026-314-498-200-929;;100-399-671-580-29X;;022-608-838-432-215;;042-879-791-960-298;;028-947-110-430-895;;082-735-005-968-62X;;047-792-343-788-48X;;051-707-000-800-833;;016-291-551-264-744,10.4161/viru.26153;;pmc5359721;;23979029;;26870003;;pmc4740385;;10.3389/fmicb.2016.00022;;19815499;;pmc2764881;;10.1073/pnas.0903474106;;10.1038/ni.1674;;19011627;;10.1084/jem.20150785;;26755705;;pmc4749091;;25465800;;10.1016/j.ccell.2014.10.018;;24959420;;pmc4050364;;10.3389/fonc.2014.00134;;28978021;;pmc5620161;;10.18632/oncotarget.18004;;22437872;;10.1038/nrc3236;;10.1016/j.cell.2012.02.034;;pmc3310896;;22424219;;12079396;;10.1016/s0022-2836(02)00264-4;;1512548;;10.1084/jem.176.3.855;;pmc2119366,"Nosanchuk JD., The interdependence of antibody C and V regions on specificity and affinity: significant implications for the engineering of therapeutic antibodies., Virulence. Aug. 15, 2013;4(6):439-40. doi: 10.4161/viru.26153.;;Janda et al., Ig Constant Region Effects on Variable Region Structure and Function., Front Microbiol. Feb. 4, 2016;7:22. doi: 10.3389/fmicb.2016.00022. eCollection 2016.;;Gene ID: PVRIG antibody—middle region, Rabbit Polyclonal Antibody Catalog #Al13083, retrieved from the internet: URL:http://www.funakoshi.co.jp/data/datasheet/ABG/Al13083.pdf.;;Stanietsky et al., The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity., Proc Natl Acad Sci U S A. Oct. 20, 2009;106(42):17858-63.;;Yu et al., The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells., Nat Immunol. Jan. 2009;10(1):48-57.;;Zhu et al., Identification of CD112R as a novel checkpoint for human T cells., J Exp Med. Feb. 8, 2016;213(2):167-76.;;Rotman et al., Identification of novel immune checkpoints as targets for cancer immunotherapy., J Immunother Cancer. 2013; 1(Suppl 1): p. 135.;;Johnston et al., The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function., Cancer Cell. Dec. 8, 2014;26(6):923-37.;;Orentas et al., Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison., Front Oncol. Jun. 10, 2014;4:134.;;Quinones et al., 2205 High-throughput cellular assays using a well-less plate format. Genentech, South San Francisco, CA, Curiox Biosystems, Singapore, New Technologies and Frontiers, Dec. 6, 2011.;;He et al., Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies., Oncotarget. May 19, 2017;8(40):67129-67139. doi: 10.18632/oncotarget.18004. eCollection Sep. 15, 2017.;;Scott et al., Antibody therapy of cancer., 2012, Nature Reviews, vol. 12: 278-287.;;Weiner et al., Antibody-based immunotherapy of cancer., Cell. Mar. 16, 2012;148(6):1081-4. doi: 10.1016/j.ce11.2012.02.034.;;Vajdos et al., 2002, Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis, J. Mol. Biol. vol. 320: 415-428.;;Chen et al., 1992, Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen., J. Exp. Med. vol. 176: 855-866.",ACTIVE
161,CA,A1,CA 3032331 A1,176-801-279-699-683,2018-02-22,2018,CA 3032331 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/176-801-279-699-683,Patent Application,no,0,0,50,52,611,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
162,US,A1,US 2018/0305456 A1,131-999-408-581-256,2018-10-25,2018,US 201715680187 A,2017-08-17,US 201715680187 A;;US 201662376334 P;;US 201762513771 P;;US 201662376335 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/131-999-408-581-256,Patent Application,yes,0,2,50,52,611,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61P35/00,,0,0,,,,ACTIVE
163,DK,T3,DK 3347379 T3,033-649-797-493-176,2020-02-17,2020,DK 17797429 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT-ANTISTOFFER, ANTI-PVRIG-ANTISTOFFER OG KOMBINATIONER DERAF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/033-649-797-493-176,Granted Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
164,EP,B1,EP 3347379 B1,026-565-982-430-909,2019-11-06,2019,EP 17797429 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/026-565-982-430-909,Granted Patent,yes,7,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,2,0,,,"JOSHUA D. NOSANCHUK: ""The interdependence of antibody C and V regions on specificity and affinity : Significant implications for the engineering of therapeutic antibodies"", VIRULENCE, vol. 4, no. 6, 15 August 2013 (2013-08-15) , pages 439-440, XP055436928, US ISSN: 2150-5594, DOI: 10.4161/viru.26153;;ALENA JANDA ET AL: ""Ig Constant Region Effects on Variable Region Structure and Function"", FRONTIERS IN MICROBIOLOGY, vol. 7, 4 February 2016 (2016-02-04), XP055436953, DOI: 10.3389/fmicb.2016.00022",ACTIVE
165,EP,A1,EP 3347379 A1,041-681-662-980-17X,2018-07-18,2018,EP 17797429 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/041-681-662-980-17X,Patent Application,yes,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
166,MX,A,MX 2021006237 A,019-997-387-779-028,2021-08-11,2021,MX 2021006237 A,2019-02-15,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF.",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,OPHIR ERAN;;DASSA LIAT;;KUMAR SANDEEP;;GOZLAN YOSI;;TIRAN ZOHAR;;VAKNIN ILAN;;DRAKE ANDREW W;;SAMEAH-GREENWALD SHIRLEY;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;DESAI RADHIKA;;WALL PATRICK;;LIANG SPENCER;;CHAN CHRISTOPHER;;WHITE MARK;;STAPLETON LANCE;;PRESTA LEONARD;;THEOLIS RICHARD,,https://lens.org/019-997-387-779-028,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00;;A61K39/395,,0,0,,,,PENDING
167,US,A1,US 2018/0169238 A1,046-541-834-863-066,2018-06-21,2018,US 201715795135 A,2017-10-26,US 201715795135 A;;US 201715680187 A;;US 201762513771 P;;US 201662376335 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P;;US 201662376334 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/046-541-834-863-066,Patent Application,yes,0,9,50,52,611,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,A61K39/395,,0,0,,,,ACTIVE
168,BR,A2,BR 112019003129 A2,041-962-038-800-391,2019-07-09,2019,BR 112019003129 A,2017-08-17,IB 2017001256 W;;US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P,2016-08-17,"composição compreendendo um domínio de ligação a antígeno que se liga a tigit humano, composição de ácido nucleico e de vetor de expressão, célula hospedeira, e, métodos para preparação de um anticorpo anti-tigit e para tratar cancer.","composição compreendendo um domínio de ligação a antígeno que se liga a tigit humano, composição de ácido nucleico e de vetor de expressão, célula hospedeira, e, métodos para preparação de um anticorpo anti-tigit e para tratar cancer são fornecidos anticorpos anti-pvrig e anti-tigit.",COMPUGEN LTD,ANDREW W DRAKE;;CHRISTOPHER CHAN;;DAVID NISIM GILADI;;EINAV SAFYON;;ERAN OPHIR;;GAD S COJOCARU;;HSIN-YUAN CHENG;;ILAN VAKNIN;;KYLE HANSEN;;LANCE STAPLETON;;LEONARD PRESTA;;LIAT DASSA;;MARK WHITE;;MAYA KOTTURI;;PATRICK WALL;;RADHIKA DESAI;;RICHARD THEOLIS;;SANDEEP KUMAR;;SHIRLEY SAMEAH-GREENWALD;;SPENCER LIANG;;YOSI GOZLAN;;ZOHAR TIRAN,,https://lens.org/041-962-038-800-391,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
169,KR,A,KR 20190039421 A,065-548-639-121-439,2019-04-11,2019,KR 20197006497 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"항-TIGIT 항체, 항-PVRIG 항체 및 이들의 조합",항-PVRIG 및 항-TIGIT 항체가 제공된다.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/065-548-639-121-439,Patent Application,no,7,0,50,52,1224,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00;;A61K39/395;;A61P35/00,,0,0,,,,ACTIVE
170,CO,A2,CO 2019001980 A2,135-839-638-619-70X,2019-03-08,2019,CO 2019001980 A,2019-02-28,IB 2017001256 W;;US 201762513771 P;;US 201662376334 P;;US 201662376335 P;;US 201762513916 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762538561 P,2016-08-17,"Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos",Se proporcionan anticuerpos anti-PVRIG y anti-TIGIT,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/135-839-638-619-70X,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,PENDING
171,US,A1,US 2024/0075137 A1,138-257-400-837-167,2024-03-07,2024,US 18322545,2023-05-23,,,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,Compugen Ltd.,Mark White;;Sandeep Kumar;;Christopher Chan;;Spencer Liang;;Lance Stapleton;;Andrew W. Drake;;Yosi Gozlan;;Ilan Vaknin;;Shirley Sameah-Greenwald;;Liat Dassa;;Zohar Tiran;;Gad S. Cojocaru;;Maya Kotturi;;Hsin-Yuan Cheng;;Kyle Hansen;;David Nisim Giladi;;Einav Safyon;;Eran Ophir;;Leonard Presta;;Richard Theolis;;Radhika Desai;;Patrick Wall,,https://lens.org/138-257-400-837-167,Patent Application,yes,0,0,1,1,0,A61K39/39558;;A61K39/39541;;A61P35/00;;C07K16/2803;;C07K16/2809;;C07K16/2818;;C07K16/2827;;A61K2039/505,A61K39/395;;A61P35/00;;C07K16/28,,0,0,,,,UNKNOWN
172,EP,B9,EP 3347379 B9,136-520-184-060-455,2020-03-25,2020,EP 17797429 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/136-520-184-060-455,Amended Patent,yes,7,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,2,0,,,"JOSHUA D. NOSANCHUK: ""The interdependence of antibody C and V regions on specificity and affinity : Significant implications for the engineering of therapeutic antibodies"", VIRULENCE, vol. 4, no. 6, 15 August 2013 (2013-08-15) , pages 439-440, XP055436928, US ISSN: 2150-5594, DOI: 10.4161/viru.26153;;ALENA JANDA ET AL: ""Ig Constant Region Effects on Variable Region Structure and Function"", FRONTIERS IN MICROBIOLOGY, vol. 7, 4 February 2016 (2016-02-04), XP055436953, DOI: 10.3389/fmicb.2016.00022",ACTIVE
173,SI,T1,SI 3347379 T1,021-793-221-187-484,2020-04-30,2020,SI 201730157 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W;;EP 17797429 A,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/021-793-221-187-484,Granted Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/00;;A61K39/00,,0,0,,,,ACTIVE
174,EP,A1,EP 3617232 A1,178-641-151-006-49X,2020-03-04,2020,EP 19199752 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;EP 17797429 A;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF","Anti-PVRIG and anti-TIGIT antibodies are provided.
",COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/178-641-151-006-49X,Patent Application,yes,71,0,50,52,611,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00;;A61K39/395,,87,75,055-941-254-232-339;;010-801-824-793-588;;079-191-303-518-861;;061-453-882-230-419;;000-631-306-299-887;;012-165-170-835-272;;082-472-766-436-845;;012-780-527-944-741;;024-956-179-363-052;;005-018-877-991-494;;006-451-527-297-818;;039-289-782-216-880;;043-632-912-449-253;;109-281-805-500-720;;141-009-316-280-461;;059-063-827-066-032;;032-412-591-971-193;;032-462-237-933-86X;;017-677-372-355-841;;049-134-753-209-354;;006-574-964-805-278;;045-094-249-115-990;;012-273-285-250-15X;;038-569-018-972-189;;042-204-626-457-327;;030-323-674-660-051;;066-419-294-278-929;;009-483-512-107-343;;044-522-255-085-902;;039-004-732-914-566;;013-142-717-038-23X;;015-395-754-996-662;;106-032-800-597-23X;;116-193-705-533-609;;072-548-742-004-170;;014-113-432-888-031;;055-627-013-189-514;;097-637-621-469-520;;004-458-031-333-650;;033-955-564-406-161;;005-219-687-670-471;;026-164-216-541-151;;032-728-154-591-070;;056-201-471-905-934;;028-862-168-091-90X;;008-493-575-849-013;;094-244-865-622-863;;025-440-140-405-971;;050-672-300-487-304;;072-042-364-654-214;;076-912-994-506-04X;;066-486-712-233-96X;;077-640-818-602-884;;131-380-770-470-779;;060-699-153-259-75X;;045-623-729-340-346;;002-171-587-882-558;;013-242-591-207-277;;007-681-485-057-727;;004-701-625-088-792;;088-434-716-536-224;;048-961-183-736-197;;100-399-671-580-29X;;057-692-130-684-50X;;026-314-498-200-929;;003-082-950-776-533;;022-608-838-432-215;;001-581-530-503-356;;041-466-573-640-315;;075-341-946-006-056;;087-161-446-916-210;;052-956-966-509-490;;000-846-337-409-979;;114-078-098-241-965;;002-391-233-537-014,10.1016/j.semcancer.2005.07.009;;16140545;;10.1146/annurev.immunol.23.021704.115611;;15771580;;15771565;;10.1146/annurev.immunol.23.021704.115839;;10.1158/1078-0432.ccr-07-0016;;17606736;;pmc2867907;;20385810;;10.1073/pnas.1003345107;;10.1158/0008-5472.can-11-2637;;22205715;;pmc3288235;;24667641;;pmc4001555;;10.1172/jci73639;;10.1093/intimm/5.8.957;;8398989;;10.1002/dvg.22938;;pmc5084746;;27012318;;10.1073/pnas.63.1.78;;5257969;;pmc534037;;12148987;;10.1021/ja027007w;;12404640;;10.1002/1439-7633(20021104)3:11<1135::aid-cbic1135>3.0.co;2-m;;10.1073/pnas.172226299;;12154230;;pmc123203;;1409642;;10.1073/pnas.89.20.9367;;pmc50132;;10.1016/j.tig.2004.09.013;;15522458;;15138302;;10.1073/pnas.0401517101;;pmc419646;;12920298;;10.1126/science.1084772;;10.1034/j.1600-065x.2002.19009.x;;12493010;;pmc51622;;10.1073/pnas.88.10.4181;;1903536;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/321522a0;;3713831;;10.1126/science.2451287;;2451287;;10.1021/bp030070k;;15176864;;10.4049/jimmunol.172.7.3994;;15034010;;3127726;;10.1038/332323a0;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;9551944;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;9377574;;8302875;;pmc521435;;10.1073/pnas.91.3.969;;10556035;;10.1006/jmbi.1999.3141;;9099717;;10.1074/jbc.272.16.10678;;10.1074/jbc.271.37.22611;;8798431;;9671778;;pmc21176;;10.1073/pnas.95.15.8910;;14600205;;10.1093/protein/gzg096;;12218124;;10.4049/jimmunol.169.6.3076;;11849310;;10.1046/j.0019-2805.2001.01341.x;;pmc1782638;;10.1016/s0165-2478(02)00019-6;;12008035;;11096108;;10.1074/jbc.m009483200;;10.1038/nri2761;;20414204;;10.1093/nar/gks1370;;3382986;;10.1093/bioinformatics/4.1.11;;10.1016/0022-2836(70)90057-4;;5420325;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;26609224;;10.4137/bbi.s28991;;pmc4648566;;23386332;;10.1007/978-1-62703-296-4_1;;10.1016/s1074-7613(00)70060-4;;8673704;;10.1016/s0092-8674(00)81683-9;;10647931;;21376230;;10.1016/j.cell.2011.02.013;;24122236;;pmc4255306;;10.1002/path.4287;;23890065;;10.1016/j.immuni.2013.06.014;;10.1073/pnas.1607836113;;pmc5137776;;27837027;;27079802;;pmc5381938;;10.1038/nrc.2016.36;;10.1158/1078-0432.ccr-15-1849;;27084739;;pmc4872712;;10.1038/nrc3239;;pmc4856023;;22437870;;10.1007/3-540-30683-8_443;;25860605;;pmc5905674;;10.1016/j.cell.2015.03.030;;24871131;;pmc4558099;;10.1126/scitranslmed.3008211;;10.1158/1078-0432.ccr-15-1088;;26180060;;10.1038/nature13954;;pmc4246418;;25428505;;10.21417/b7z59d;;22285893;;10.1016/j.coi.2012.01.009;;25743219;;10.1038/nri3799;;10.1084/jem.20150785;;26755705;;pmc4749091;;10.1084/jem.20030788;;pmc2194180;;12913096;;10.1038/ni.1674;;19011627;;19815499;;pmc2764881;;10.1073/pnas.0903474106;;25465800;;10.1016/j.ccell.2014.10.018;;26842126;;10.1007/s00262-016-1799-4;;10.1038/ni.2850;;24658051;;10.1158/0008-5472.can-07-3119;;18339883;;10.1007/s00251-011-0519-7;;21390552;;22461641;;pmc3568523;;10.1126/scitranslmed.3003689;;24432022;;10.3389/fimmu.2013.00508;;pmc3882864;;24343663;;10.1038/icb.2013.95;;pmc2212458;;10.1084/jem.188.2.277;;9670040,"WANG: ""Immune Suppression by Tumor Specific CD4+ Regulatory T cells in Cancer"", SEMIN. CANCER. BIOL., vol. 16, 2006, pages 73 - 79, XP024908039, doi:10.1016/j.semcancer.2005.07.009;;GREENWALD ET AL.: ""The B7 Family Revisited"", ANN. REV. IMMUNOL., vol. 23, 2005, pages 515 - 48, XP002481408, doi:10.1146/annurev.immunol.23.021704.115611;;WATTS: ""TNF/TNFR Family Members in Co-stimulation of T Cell Responses"", ANN. REV. IMMUNOL., vol. 23, 2005, pages 23 - 68;;SADUM ET AL.: ""Immune Signatures of Murine and Human Cancers Reveal Unique Mechanisms of Tumor Escape and New Targets for Cancer Immunotherapy"", CLIN. CANE. RES., vol. 13, no. 13, 2007, pages 4016 - 4025, XP055248327, doi:10.1158/1078-0432.CCR-07-0016;;AHMADZADEH ET AL., BLOOD, vol. 114, 2009, pages 1537;;MATSUZAKI ET AL., PNAS, vol. 107, no. 17, 2010, pages 7875 - 7880;;FOURCADE ET AL., CANCER RES., vol. 72, no. 4, 2012, pages 887 - 896;;GROS ET AL., J. CLINICAL INVEST., vol. 124, no. 5, 2014, pages 2246;;KOENTGEN ET AL., INT IMMUNOL, vol. 5, 1993, pages 957 - 964;;KOENTGEN ET AL., GENESIS, vol. 54, 2016, pages 326 - 333;;EDELMAN ET AL., PROC NATL ACAD SCI USA, vol. 63, 1969, pages 78 - 85;;J. W. CHIN ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 124, 2002, pages 9026 - 9027;;J. W. CHINP. G. SCHULTZ, CHEMBIOCHEM, vol. 11, 2002, pages 1135 - 1137;;J. W. CHIN ET AL., PICAS UNITED STATES OF AMERICA, vol. 99, 2002, pages 11020 - 11024;;L. WANGP. G. SCHULTZ, CHEM., 2002, pages 1 - 10;;SIMON ET AL., PNAS USA, vol. 89, no. 20, 1992, pages 9367;;CROPPSHULTZ, TRENDS GENET, vol. 20, no. 12, 2004, pages 625 - 30;;ANDERSON ET AL., PROC NATL ACAD SCI USA, vol. 101, no. 2, 2004, pages 7566 - 71;;CHIN ET AL., SCIENCE, vol. 301, no. 5635, 2003, pages 964 - 7;;DAVIS ET AL., IMMUNOLOGICAL REVIEWS, vol. 190, 2002, pages 123 - 136;;GORMAN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 4181 - 4185;;CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;LAFRANC ET AL., DEV. COMP. IMMUNOL., vol. 27, no. 1, 2003, pages 55 - 77;;JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525;;VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534 - 1536;;ROQUE ET AL., BIOTECHNOL. PROG., vol. 20, 2004, pages 639 - 654;;FUCHS ACELLA MGIURISATO ESHAW ASCOLONNA M: ""Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155"", J IMMUNOL, vol. 172, no. 7, 2004, pages 3994 - 545, XP055344481, doi:10.4049/jimmunol.172.7.3994;;RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329;;QUEEN ET AL., PROC NATL ACAD SCI, vol. 86, 1989, pages 10029 - 33;;HE ET AL., J. IMMUNOL., vol. 160, 1998, pages 1029 - 1035;;CARTER ET AL., PROC NATL ACAD SCI USA, vol. 89, 1992, pages 4285 - 9;;PRESTA ET AL., CANCER RES., vol. 57, no. 20, 1997, pages 4593 - 9;;O'CONNOR ET AL., PROTEIN ENG, vol. 11, 1998, pages 321 - 8;;ROGUSKA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 969 - 973;;WU ET AL., J. MOL. BIOL., vol. 294, 1999, pages 151 - 162;;BACA ET AL., J. BIOL. CHEM., vol. 272, no. 16, 1997, pages 10678 - 10684;;ROSOK ET AL., J. BIOL. CHEM., vol. 271, no. 37, 1996, pages 22611 - 22618;;RADER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 8910 - 8915;;KRAUSS ET AL., PROTEIN ENGINEERING, vol. 16, no. 10, 2003, pages 753 - 759;;DE PASCALIS ET AL., J. IMMUNOL., vol. 169, 2002, pages 3076 - 3084;;AALBERSE, RCSCHUURMAN J., IMMUNOLOGY, vol. 105, 2002, pages 9 - 19;;JEFFERIS ET AL., IMMUNOL LETT, vol. 82, 2002, pages 57 - 65;;SHIELDS, R. L ET AL., J. BIOL. CHEM., vol. 276, 2001, pages 6591 - 6604;;CARTER PJ, NATURE REV IMMUNOL, vol. 10, 2010, pages 301 - 316;;YE ET AL., NUCLEIC ACIDS RES., vol. 41, 2013, pages W34 - W40;;E. MEYERSW. MILLER, COMPUT. APPL. BIOSCI., vol. 4, 1988, pages 11 - 17;;NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 444 - 453;;ALTSCHUL ET AL., J MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402;;""Remington's Pharmaceutical Sciences"", 1980;;AGNEW, CHEM INTL. ED. ENGL., vol. 33, 1994, pages 183 - 186;;GOODKIND ET AL., COMPUTERS AND CHEM. ENG., vol. 29, no. 3, 2005, pages 589;;HAN ET AL., BIOINFORM. BIOL. INSIGHTS, vol. 9, no. 1, pages 29 - 46;;CAMPO ET AL., NOD. PATHOL., vol. 26, no. 1, January 2013 (2013-01-01), pages S97 - S110;;WANG ET AL.: ""Recent Advances in Capillary Electrophoresis-Based Proteomic Techniques for Biomarker Discovery"", METHODS. MOL. BIOL., vol. 984, 2013, pages 1 - 12;;TAYLOR ET AL., BIOMED RES., vol. 2014, pages 8;;BECERK ET AL., MUTAT. RES, vol. 722, no. 2, 17 June 2011 (2011-06-17), pages 171 - 182;;SHIBUYA ET AL., IMMUNITY, vol. 4, no. 6, 1 June 1996 (1996-06-01), pages 573 - 581;;ZHU, J. EXP. MED., 2016, pages 1 - 10;;AALBERSE ET AL., IMMUNOLOGY, vol. 202, no. 105, pages 9 - 19;;HANAHAN DWEINBERG RA: ""The hallmarks of cancer"", CELL, vol. 100, no. 1, 2000, pages 57 - 70, XP055447752;;HANAHAN DWEINBERG RA: ""Hallmarks of cancer: the next generation"", CELL, vol. 144, no. 5, 2011, pages 646 - 74, XP028185429, doi:10.1016/j.cell.2011.02.013;;GALON JMLECNIK BBINDEA GANGELL HKBERGER ALAGORCE C ET AL.: ""Towards the introduction of the 'Immunoscore' in the classification of malignant tumours"", J PATHOL, vol. 232, no. 2, 2014, pages 199 - 209, XP055246049, doi:10.1002/path.4287;;ZITVOGEL LGALLUZZI LSMYTH MJKROEMER G: ""Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance"", IMMUNITY, vol. 39, no. l, 2013, pages 74 - 88;;DANILOVA LWANG HSUNSHINE JKAUNITZ GJCOTTRELL TRXU H ET AL.: ""Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors"", PROC NATL ACAD SCI U S A, vol. 113, no. 48, 2016, pages E7769 - E77;;TOPALIAN SLTAUBE JMANDERS RAPARDOLL DM: ""Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy"", NAT REV CANCER, vol. 16, no. 5, 2016, pages 275 - 87, XP002771342, doi:10.1038/nrc.2016.36;;ZAROUR HM: ""Reversing T-cell Dysfunction and Exhaustion in Cancer"", CLIN CANCER RES, vol. 22, no. 8, 2016, pages 1856 - 64;;PARDOLL DM: ""The blockade of immune checkpoints in cancer immunotherapy"", NAT REV CANCER, vol. 12, no. 4, 2012, pages 252 - 64, XP055415943, doi:10.1038/nrc3239;;SHARMA PALLISON JP: ""Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential"", CELL, vol. 161, no. 2, 2015, pages 205 - 14, XP055427087, doi:10.1016/j.cell.2015.03.030;;CHA EKLINGER MHOU YCUMMINGS CRIBAS AFAHAM M ET AL.: ""Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients"", SCI TRANSL MED, vol. 6, no. 238, 2014, pages 238ra70, XP055433328, doi:10.1126/scitranslmed.3008211;;ROBERT LTSOI JWANG XEMERSON RHORNET BCHODON T ET AL.: ""CTLA4 blockade broadens the peripheral T-cell receptor repertoire"", CLIN CANCER RES, vol. 20, no. 9, 2014, pages 2424 - 32, XP055145637, doi:10.1158/1078-0432.CCR-13-2648;;TUMEH PCHARVIEW CLYEARLEY JHSHINTAKU IPTAYLOR EJROBERT L ET AL.: ""PD-1 blockade induces responses by inhibiting adaptive immune resistance"", NATURE, vol. 515, no. 7528, 2014, pages 568 - 71, XP055247294, doi:10.1038/nature13954;;CHAN CJANDREWS DMSMYTH MJ: ""Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer"", CURR OPIN IMMUNOL, vol. 24, no. 2, 2012, pages 246 - 51, XP055147483, doi:10.1016/j.coi.2012.01.009;;MARTINET LSMYTH MJ: ""Balancing natural killer cell activation through paired receptors"", NAT REV IMMUNOL, vol. 15, no. 4, 2015, pages 243 - 54, XP055424277, doi:10.1038/nri3799;;ZHU YPANICCIA ASCHULICK ACCHEN WKOENIG MRBYERS JT ET AL.: ""Identification of CD112R as a novel checkpoint for human T cells"", J EXP MED, vol. 213, no. 2, 2016, pages 167 - 76, XP055314642, doi:10.1084/jem.20150785;;BOTTINO CCASTRICONI RPENDE DRIVERA PNANNI MCARNEMOLLA B ET AL.: ""Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule"", J EXP MED, vol. 198, no. 4, 2003, pages 557 - 67, XP055011690, doi:10.1084/jem.20030788;;YU XHARDEN KGONZALEZ LCFRANCESCO MCHIANG EIRVING B ET AL.: ""The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells"", NAT IMMUNOL, vol. 10, no. 1, 2009, pages 48 - 57;;STANIETSKY NSIMIC HARAPOVIC JTOPORIK ALEVY ONOVIK A ET AL.: ""The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity"", PROC NATL ACAD SCI USA, vol. 106, no. 42, 2009, pages 17858 - 63, XP055215810, doi:10.1073/pnas.0903474106;;JOHNSTON RJCOMPS-AGRAR LHACKNEY JYU XHUSENI MYANG Y ET AL.: ""The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function"", CANCER CELL, vol. 26, no. 6, 2014, pages 923 - 37, XP029111576, doi:10.1016/j.ccell.2014.10.018;;ZHANG BZHAO WLI HCHEN YTIAN HLI L ET AL.: ""Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155"", CANCER IMMUNOL IMMUNOTHER, vol. 65, no. 3, 2016, pages 305 - 14, XP035871383, doi:10.1007/s00262-016-1799-4;;CHAN CJMARTINET LGILFILLAN SSOUZA-FONSECA-GUIMARAES FCHOW MTTOWN L ET AL.: ""The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions"", NAT IMMUNOL, vol. 15, no. 5, 2014, pages 431 - 8, XP055344476, doi:10.1038/ni.2850;;MACHLENKIN AUZANA RFRANKENBURG SEISENBERG GEISENBACH LPITCOVSKI J ET AL.: ""Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs"", CANCER RES, vol. 68, no. 6, 2008, pages 2006 - 13;;OHTANI HNAKAJIMA TAKARI HISHIDA TKIMURA A: ""Molecular evolution of immunoglobulin superfamily genes in primates"", IMMUNOGENETICS, vol. 63, no. 7, 2011, pages 417 - 28, XP019914282, doi:10.1007/s00251-011-0519-7;;TAUBE JMANDERS RAYOUNG GDXU HSHARMA RMCMILLER TL ET AL.: ""Colocalization of inflammatory response with B7-hl expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape"", SCI TRANSL MED, vol. 4, no. 127, 2012, pages 127ra37, XP055370851, doi:10.1126/scitranslmed.3003689;;CERBONI CFIONDA CSORIANI AZINGONI ADORIA MCIPPITELLI M ET AL.: ""The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells"", FRONT IMMUNOL, vol. 4, 2014, pages 508;;DE ANDRADE LFSMYTH MJMARTINET L: ""DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins"", IMMUNOL CELL BIOL, vol. 92, no. 3, 2014, pages 237 - 44;;OVERWIJK WWTSUNG AIRVINE KRPARKHURST MRGOLETZ TJTSUNG K ET AL.: ""gplOO/pmel 17 is a murine tumor rejection antigen: induction of ''self'-reactive, tumoricidal T cells using high-affinity, altered peptide ligand"", J EXP MED, vol. 188, no. 2, 1998, pages 277 - 86, XP002938364, doi:10.1084/jem.188.2.277",PENDING
175,DK,T5,DK 3347379 T5,031-576-500-012-187,2020-06-15,2020,DK 17797429 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"ANTI-TIGIT-ANTISTOFFER, ANTI-PVRIG-ANTISTOFFER OG KOMBINATIONER DERAF",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/031-576-500-012-187,Amended Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
176,ES,T9,ES 2774320 T9,111-886-709-475-848,2020-07-21,2020,ES 17797429 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"Anticuerpos anti-TIGIT, anticuerpos anti-PVRIG y combinaciones de los mismos",,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/111-886-709-475-848,Unknown,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
177,MY,A,MY 194032 A,124-190-073-020-771,2022-11-09,2022,MY PI2019000633 A,2017-08-17,IB 2017001256 W;;US 201762513771 P;;US 201662376334 P;;US 201662376335 P;;US 201762513916 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762538561 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided. (FIG.1),COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/124-190-073-020-771,Granted Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
178,CL,A1,CL 2019000424 A1,045-514-153-558-357,2019-07-05,2019,CL 2019000424 A,2019-02-15,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P,2016-08-17,"Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos.",Se proporcionan anticuerpos anti-PVRIG y anti-TIGIT.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/045-514-153-558-357,Patent Application,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28,,0,0,,,,PENDING
179,KR,A,KR 20220041246 A,065-225-718-423-738,2022-03-31,2022,KR 20227009297 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;KR 20197006497 A;;IB 2017001256 W,2016-08-17,-TIGIT -PVRIG ANTI-TIGIT ANTIBODIES ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF,항-PVRIG 및 항-TIGIT 항체가 제공된다.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/065-225-718-423-738,Patent Application,no,7,0,50,52,1224,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61P35/00,,0,0,,,,ACTIVE
180,CN,A,CN 112274637 A,196-930-612-909-266,2021-01-29,2021,CN 202011070171 A,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513775 P;;US 201762513916 P;;US 201762538561 P;;CN 201780050131 A,2016-08-17,"Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof","The invention belongs to the technical field of biology, and provides an anti-TIGIT antibody, an anti-PVRIG antibody and a combination thereof. The present invention provides compositions comprising afirst antibody that binds to human TIGIT and a second antibody that binds to human PVRIG. The present invention also provides compositions comprising an antibody that binds to human TIGIT. The present invention also provides compositions comprising an anti-PVRIG antibody. The present invention also provides anti-TIGIT antibodies. The invention also provides the use of the antigen binding domain in the preparation of a reagent for activating T cells and/or NK cells of a cancer patient. The invention also provides bispecific antibodies that bind to a first target and a second target, where thefirst target is human TIGIT. The invention also provides the use of anti-PDL1 antibodies and anti-PVRIG antibodies in the preparation of reagents for activating T cells and/or NK cells in cancer patients.",COMPUGEN LTD,WHITE MALCOLM;;KUMAR SAMARTH;;CHEN CHUNHUA;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/196-930-612-909-266,Patent Application,no,3,9,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,A61K39/395;;A61P35/00,,1,0,,,"NOA STANIETSKY等: ""The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity"", PNAS, vol. 106, no. 42, pages 17858 - 17863, XP055215810, DOI: 10.1073/pnas.0903474106",PENDING
181,US,A1,US 2021/0000952 A1,083-640-503-698-153,2021-01-07,2021,US 202016904511 A,2020-06-17,US 202016904511 A;;US 201715680187 A;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P;;US 201662376334 P;;US 201762513771 P;;US 201662376335 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/083-640-503-698-153,Patent Application,yes,1,2,50,52,612,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,A61K39/395;;A61P35/00;;C07K16/28,,0,0,,,,ACTIVE
182,US,A1,US 2018/0280506 A1,127-281-651-999-508,2018-10-04,2018,US 201815937784 A,2018-03-27,US 201815937784 A;;US 201715795135 A;;US 201715680187 A;;US 201662376335 P;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P;;US 201662376334 P;;US 201762513771 P,2016-08-17,"ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/127-281-651-999-508,Patent Application,yes,0,1,50,52,612,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,A61K39/395;;A61K39/00;;C07K16/28,,0,0,,,,ACTIVE
183,US,B2,US 11701424 B2,013-226-743-974-10X,2023-07-18,2023,US 202016904511 A,2020-06-17,US 202016904511 A;;US 201715680187 A;;US 201662417217 P;;US 201762513775 P;;US 201762477974 P;;US 201762513916 P;;US 201762538561 P;;US 201662376334 P;;US 201762513771 P;;US 201662376335 P,2016-08-17,"Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof",Anti-PVRIG and anti-TIGIT antibodies are provided.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,COMPUGEN LTD (2017-09-03);;COMPUGEN USA INC (2017-10-16),https://lens.org/013-226-743-974-10X,Granted Patent,yes,53,0,50,52,612,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/00;;A61K39/00;;A61K39/395;;A61P35/00;;C07K16/28,,14,12,016-291-551-264-744;;028-947-110-430-895;;003-204-276-209-117;;022-608-838-432-215;;020-883-295-175-85X;;042-879-791-960-298;;082-735-005-968-62X;;003-082-950-776-533;;051-707-000-800-833;;047-792-343-788-48X;;026-314-498-200-929;;100-399-671-580-29X,1512548;;10.1084/jem.176.3.855;;pmc2119366;;28978021;;pmc5620161;;10.18632/oncotarget.18004;;26870003;;pmc4740385;;10.3389/fmicb.2016.00022;;25465800;;10.1016/j.ccell.2014.10.018;;10.4161/viru.26153;;pmc5359721;;23979029;;24959420;;pmc4050364;;10.3389/fonc.2014.00134;;22437872;;10.1038/nrc3236;;19815499;;pmc2764881;;10.1073/pnas.0903474106;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1016/j.cell.2012.02.034;;pmc3310896;;22424219;;10.1038/ni.1674;;19011627;;10.1084/jem.20150785;;26755705;;pmc4749091,"Chen et al., 1992, Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen., J. Exp. Med. vol. 176: 855-866.;;He et al., Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies., Oncotarget. May 19, 2017;8(40):67129-67139. doi: 10.18632/oncotarget.18004. eCollection Sep. 15, 2017.;;Janda et al., Ig Constant Region Effects on Variable Region Structure and Function., Front Microbiol. Feb. 4, 2016;7:22. doi: 10.3389/fmicb.2016.00022. eCollection 2016.;;Johnston et al., The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function., Cancer Cell. Dec. 8, 2014;26(6):923-37.;;Nosanchuk JD., The interdependence of antibody C and V regions on specificity and affinity: significant implications for the engineering of therapeutic antibodies., Virulence. Aug. 15, 2013;4(6):439-40. doi: 10.4161/viru.26153.;;Orentas et al., Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison., Front Oncol. Jun. 10, 2014;4:134.;;Quinones et al., 2205 High-throughput cellular assays using a well-less plate format. Genentech, South San Francisco, CA, Curiox Biosystems, Singapore, New Technologies and Frontiers, Dec. 6, 2011.;;Rotman et al., Identification of novel immune checkpoints as targets for cancer immunotherapy., J Immunother Cancer. 2013; 1(Suppl 1): p. 135.;;Scott et al., Antibody therapy of cancer., 2012, Nature Reviews, vol. 12: 278-287.;;Stanietsky et al., The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity., Proc Natl Acad Sci U S A. Oct. 20, 2009;106(42):17858-63.;;Vajdos et al., 2002, Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis, J. Mol. Biol. vol. 320: 415-428.;;Weiner et al., Antibody-based immunotherapy of cancer., Cell. Mar. 16, 2012;148(6):1081-4. doi: 10.1016/j.cell.2012.02.034.;;Yu et al., The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells., Nat Immunol. Jan. 2009;10(1):48-57.;;Zhu et al., Identification of CD112R as a novel checkpoint for human T cells., J Exp Med. Feb. 8, 2016;213(2):167-76.",ACTIVE
184,ES,T3,ES 2774320 T3,108-141-361-920-087,2020-07-20,2020,ES 17797429 T,2017-08-17,US 201662376334 P;;US 201662376335 P;;US 201662417217 P;;US 201762477974 P;;US 201762513771 P;;US 201762513916 P;;US 201762513775 P;;US 201762538561 P;;IB 2017001256 W,2016-08-17,"Anticuerpos anti-TIGIT, anticuerpos anti-PVRIG y combinaciones de los mismos",Una composición que comprende un dominio de unión a antígeno que se une a TIGIT humano (SEQ ID NO:97) que comprende: a) un dominio pesado variable que comprende la SEQ ID NO: 160; y b) un dominio ligero variable que comprende la SEQ ID NO: 165.,COMPUGEN LTD,WHITE MARK;;KUMAR SANDEEP;;CHAN CHRISTOPHER;;LIANG SPENCER;;STAPLETON LANCE;;DRAKE ANDREW W;;GOZLAN YOSI;;VAKNIN ILAN;;SAMEAH-GREENWALD SHIRLEY;;DASSA LIAT;;TIRAN ZOHAR;;COJOCARU GAD S;;KOTTURI MAYA;;CHENG HSIN-YUAN;;HANSEN KYLE;;GILADI DAVID NISIM;;SAFYON EINAV;;OPHIR ERAN;;PRESTA LEONARD;;THEOLIS RICHARD;;DESAI RADHIKA;;WALL PATRICK,,https://lens.org/108-141-361-920-087,Granted Patent,no,0,0,50,52,0,C07K16/2803;;C07K16/2809;;C07K16/2818;;A61P35/00;;C07K2317/565;;C07K2317/76;;C07K2317/522;;C07K2317/53;;C07K2317/55;;C07K2317/622;;C07K2317/21;;C07K2317/732;;C07K2317/34;;C07K2317/524;;C07K2317/526;;C07K2317/56;;C07K2317/33;;C07K2317/94;;C07K2317/24;;C07K2317/92;;C07K2319/33;;A61K2039/507;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P35/00;;Y02A50/30;;A61K39/39558;;A61P35/00;;C07K2319/33;;C07K2317/24;;C07K2317/565;;C07K2317/622;;A61K2039/572;;C07K2317/53;;C07K2317/33;;C07K2317/56;;C07K2317/524;;C07K16/2827;;C07K2319/035;;C07K16/2809;;C07K16/2803;;C07K2317/55;;A61K39/39541;;C07K2317/522;;C07K16/2818;;C07K2317/732;;A61K2039/505;;A61K2039/507;;C07K2317/34;;C07K2317/526;;C07K2317/94;;C07K2317/21;;C07K2317/92;;C07K2317/76;;A61P35/00;;C07K16/2803;;C07K16/2809;;A61K2039/505;;C07K2317/33;;C07K2317/24;;C07K2317/21;;C07K2317/92;;C07K2317/76;;C07K16/2896;;C07K16/2803;;C07K16/2818;;C07K16/2827;;A61K2039/505;;C07K2317/21;;C07K2317/24;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;Y02A50/30;;A61K39/39541;;A61K39/39558;;A61K2039/507;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/56;;C07K2317/732;;C07K2319/035;;C07K2319/33;;A61P35/00;;A61K2039/572;;C07K16/2809;;C07K2317/522;;C07K2317/55;;C07K2317/565;;C07K2317/622;;C07K2317/94,C07K16/28;;A61K39/00,,0,0,,,,ACTIVE
